{
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" Let me look at the provided context to find the answer.\n\nLooking at the context, there are multiple entries with the title \"Estimating the number of infections and the impact of non-\" followed by \"Passage: Lockdown\" and one entry with \"banned Implemented with lockdown.57 24/3/2020\". \n\nHmm, the titles and passages are a bit fragmented. The main keyword here is \"lockdown\". The context mentions \"banned Implemented with lockdown\" on 24/3/2020. Maybe that's a typo or part of a larger sentence. The word \"banned\" might be a mistake, perhaps it should be \"measures implemented with lockdown\". \n\nSince the user is asking for a definition of a lockdown, and the context doesn't provide a detailed explanation, I need to infer based on common knowledge. A lockdown typically refers to strict restrictions on movement and activities to control the spread of a disease, like during a pandemic. The context mentions the date 24/3/2020, which is around when many countries started implementing lockdowns due to COVID-19. \n\nThe answer should define a lockdown as a public health measure involving restrictions on movement and gatherings to prevent disease spread. Since the context is limited, I'll rely on general knowledge but mention that the context refers to its implementation around March 2020.\n</think>\n\nA **lockdown** is a public health measure implemented to restrict movement and gatherings of people, typically during a pandemic or outbreak, to slow the spread of infectious diseases. It involves strict limitations on non-essential activities, closures of businesses, schools, and public spaces, and often requires individuals to stay at home except for essential needs. The context provided references its implementation on **24 March 2020**, aligning with global responses to the early stages of the COVID-19 pandemic.",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which I know stands for Chikungunya virus. The context provided is a passage from a study or report.\n\nFirst, I need to read through the passage carefully. The first part mentions that mothers can transmit CHIKV to their babies during the perinatal period, and this is linked to high morbidity. Morbidity here means the rate of disease or illness, so that's a complication. Then it says that by day 4 of life, all neonates were symptomatic with common CHIKF symptoms. CHIKF is probably Chikungunya fever. The symptoms here are part of the complications.\n\nNext, six neonates had confirmed CHIKV and developed meningoencephalitis. That's a serious condition affecting the brain and meninges. Then another part reports nineteen cases of neonatal infection from mothers with intrapartum viremia, which led to encephalitis due to vertical transmission. Vertical transmission means from mother to child during birth. So encephalitis is another complication here.\n\nThe last sentence mentions that during the La Reunion Island epidemic, mothers infected long before delivery had only three fetal deaths. Fetal death is a complication, but it's noted that this was when the infection occurred long before delivery, so maybe the timing affects the complication type.\n\nPutting this together, the main complications from CHIKV in neonates are meningoencephalitis and encephalitis. Also, there's high morbidity mentioned. Fetal death is a complication but only when the mother was infected long before delivery. The answer should list the complications directly stated in the context. Need to make sure not to include fetal death unless it's clearly a complication here. The passage says three fetal deaths were reported when mothers were infected long before delivery, so that's a possible complication too. But the main ones are the neurological issues in the neonates. So the answer should include meningoencephalitis, encephalitis, high morbidity, and maybe fetal death. Wait, the question is about complications associated with CHIKV in general? The context is about neonatal transmission, so the complications are in the neonates. The answer should list the complications mentioned: meningoencephalitis, encephalitis, high morbidity, and fetal death. But need to check the exact wording",
      "retrieved_chunks": [
        "Passage: and complications.",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis.",
        "reported nineteen cases of neonatal infection associated with intrapartum maternal viremia that progressed to develop encephalitis owing to vertical transmission from infected mothers .",
        "Of those mothers who, during the La Reunion Island epidemic, were infected long before delivery, only three fetal deaths were reported .",
        "Passage: A similar study by Gerardin et al."
      ],
      "computed_relevance": 0.5714285714285714,
      "computed_utilization": 0.7142857142857143,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what Clade A contains based on the provided context. The user is asking about Clade A, but looking through the passages, I don't see any mention of a clade labeled \"A.\" The passages talk about clades like 1B, 1A.1, 1A.1.1, 1C.2, and others. The titles and passages discuss different lineages such as the 1B human seasonal lineage, 1C swine lineage, and mention various clades within those. However, there's no specific information about a Clade A here. The answer might be that Clade A isn't mentioned in the provided context. But I need to check again to make sure I didn't miss any part. The user might have confused the clade numbering with letters, but the text uses numerical designations like 1A.1, etc. Since there's no Clade A explicitly discussed, the answer would be that the information isn't provided here.\n</think>\n\nThe provided context does not mention a clade specifically labeled \"Clade A.\" The passages discuss clades such as 1B, 1A.1, 1A.1.1, 1C.2, and others within the phylogeny of swine influenza A viruses, but there is no explicit information about a clade designated as \"A.\" The nomenclature used in the text follows numerical and hierarchical designations (e.g., 1C.2) rather than single-letter labels like \"A.\" \n\n**Answer:** The provided context does not specify what Clade A contains, as it does not mention a clade labeled \"A.\" The text references clades with numerical designations (e.g., 1A.1, 1C.2) but no \"Clade A.\"",
      "retrieved_chunks": [
        "Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception.",
        "For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade.",
        "The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 .",
        "Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 .",
        "The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades. The numerically dominant clades reflected intensive surveillance in the United States , investigator sequencing efforts in Canada , and the rapid dissemination of the 2009 H1N1 pandemic virus across global swine populations ."
      ],
      "computed_relevance": 0.375,
      "computed_utilization": 0.375,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. \n\nFirst, I need to look at the provided context. The passage mentions that the S1 subunit of 2019-nCoV shares around 70% identity with the two bat SARS-like CoVs and human SARS-CoV. Also, the core domain of the RBD (receptor binding domain) is highly conserved. \n\nWait, the context also says that unlike 2019-nCoV and human SARS-CoV, most bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain. So, the S1 subunit's RBD in bat viruses has deletions compared to human SARS-CoV. But 2019-nCoV's RBD core is conserved, similar to human SARS-CoV.\n\nPutting this together: The S1 subunit of 2019-nCoV has about 70% identity with bat SARS-like and human SARS-CoV. The RBD core is conserved, but bat viruses have deletions there. So, the S1 subunit in 2019-nCoV is less identical (70%) compared to the S2 which is 99% identical. The key difference is in the RBD where bat viruses have deletions, but 2019-nCoV's RBD is more similar to human SARS-CoV.\n\nThe answer should state that the S1 subunit of 2019-nCoV shares about 70% identity with bat SARS-like and human SARS-CoV, and that the RBD core is conserved, unlike in most bat viruses which have deletions there. Also, note that the S2 is more conserved (99%) but the question is about S1.\n</think>\n\nThe S1 subunit of 2019-nCoV shares approximately **70% identity** with the S1 subunits of bat SARS-like CoVs and human SARS-CoV. However, while the **core domain of the receptor binding domain (RBD)** in 2019-nCoV is highly conserved compared to human SARS-CoV,",
      "retrieved_chunks": [
        "Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV .",
        "Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ).",
        "The 2019-nCoV had the same SL6, SL7, and SL8 as SARS-CoV, and an additional",
        "The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" and I need to answer based on the provided context.\n\nFirst, I'll look through the context given. There are three passages here. The first one mentions that Bacillus spp. subtilis produces surfactins, fengycins, and iturins in a specific ratio. The second passage talks about how Bacillus and Lactobacillus species are found in fermented foods and used in probiotics. The third passage states that Bacillus species, unlike Lactobacillus, weren't considered part of the normal intestinal microbiome but were isolated from feces. It also mentions that B. subtilis helps retain gut barrier integrity, reduces endotoxins, and decreases gut inflammation.\n\nSo, putting this together, Bacillus subtilis is a species of Bacillus that produces certain compounds (surfactins, etc.), is used in probiotics, and has beneficial effects on the gut. The answer should include its role in producing those substances, its use in probiotics, and its benefits for gut health. I should also note that it's part of the Bacillus genus, which isn't traditionally considered part of the intestinal microbiome but is found in the environment and in fermented foods.\n\nI need to make sure the answer is concise and covers all the key points from the context without adding extra information. Let me check if there's anything else. The first context mentions the ratio of the substances produced, but the question is about what B. subtilis is, so maybe the ratio isn't necessary unless it's a key point. The main points are the production of those compounds, use in probiotics, and gut benefits. Also, the environment where it's found, like near decomposing plants. The title mentions the secretome as a natural guard against pathologies, so maybe mention that it's part of the secretome that protects against pathologies.\n\nWait, the first passage's title is \"Secretome of Intestinal Bacilli: A Natural Guard against Pathologies,\" so B. subtilis is part of that secretome. The answer should probably mention that it's a probiotic bacterium contributing to gut health through its secreted substances. Also, the fact that it's used in various probiotic products like the ones listed (DE111, Enterogermina, etc.) is important.\n\nSo, the answer",
      "retrieved_chunks": [
        "Bacillus spp.",
        "subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 .",
        "In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B.",
        "subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp.",
        "subtilis also retained gut barrier integrity, decreased the endotoxin concentration and reduced gut inflammation Bene et al., 2017) ."
      ],
      "computed_relevance": 0.5,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. I need to look through the provided contexts to find relevant information.\n\nFirst, looking at the first context titled \"The origins of the great pandemic,\" it mentions the 1889 pandemic with three major waves from 1889 to 1892, specifically noting the 1892 wave as the most intense. The passage also speculates about herald waves of the 1918 pandemic possibly starting as early as 1915. However, the 1918 pandemic is known for having multiple waves, so maybe this isn't directly relevant unless they're discussing single-wave aspects. The second part talks about viruses with similar genomes in early 1918 before the recognized pandemic, but again, the 1918 case isn't a single wave.\n\nNext, the second context about the 2009 pandemic in Hong Kong discusses convalescent plasma treatment and research on epidemiology, impact, and control. It mentions studies outside their review scope but doesn't specify single-wave pandemics.\n\nThe third context from Taiwan's study on influenza strains from 2008-2014 refers to multi-wave epidemics and uses a Richards model variation. They mention the 2009 pH1N1 pandemic, which had multiple waves, so that's not single-wave. They also talk about pandemic severity gradations and interventions but not specifically single-wave research.\n\nThe fourth context is an economic analysis of mitigation strategies for five pandemic severity categories. It references studies using simulation models but doesn't mention single-wave pandemics specifically.\n\nWait, the first context's 1889 pandemic had three waves, but maybe the 1892 wave being the most intense is considered a severe single wave within the overall multi-wave pandemic? The question is about severe, single-wave pandemics. The 1889 pandemic as a whole isn't single-wave, but perhaps the 1892 wave is an example. However, the passage doesn't explicitly state that the 1892 wave was a single wave pandemic on its own. It's part of a multi-wave pandemic.\n\nLooking again, the first passage says \"the 1892 wave being the most intense, at least on the East Coast of the USA.\" So maybe the 1892",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies.",
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review.",
        "Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave.",
        "The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic.",
        "To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.125,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's see. The user is asking how many reported viral pneumonia cases there are based on the provided context. Let me go through each of the passages to find any numbers related to viral pneumonia.\n\nFirst, the context mentions several documents. The first one is about primary influenza viral pneumonia. It talks about bacterial co-infection in the 2009 H1N1 pandemic, but the number there is 29% of 77 fatal cases, which is 22.33, but that's not a total number of cases. Not helpful for the total reported.\n\nNext, there's a passage about pneumonia in adults with seasonal influenza in the US from 2005\u20132008. It mentions that patients with pneumonia were more likely to receive antiviral therapy, but no specific numbers on total cases here either.\n\nThen there's the rapid advice guideline for 2019-nCoV. This one has a specific number: as of January 26, 2020, the National Health Commission recorded 2744 confirmed cases of pneumonia with 2019-nCoV infection. That's a key number. Also, there are 461 severe cases and 80 deaths mentioned here. But the question is about viral pneumonia in general, not just nCoV. However, the other passages don't give total numbers for other viruses. The 2009 H1N1 passage only mentions 77 fatal cases, which is a small sample.\n\nThe last passage under the Clinical review title talks about attack rates during seasonal and pandemic influenza. For example, in La Gloria, the attack rate was 29% in adults and 61% in children. But again, these are percentages, not total numbers. The user is asking for the total number of reported cases. The only concrete number given is the 2744 confirmed cases of 2019-nCoV pneumonia. \n\nThe question is phrased as \"How many reported viral pneumonia?\" which is a bit vague. But considering the context provided, the only specific number given for confirmed cases of viral pneumonia is the 2744 from the 2019-nCoV. The other passages don't provide total numbers for other types of viral pneumonia. The H1N1 example is about a study of 77 fatal cases, which isn't",
      "retrieved_chunks": [
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients .",
        "Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01].",
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths.",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age .",
        "A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded, 32,799 with close contacts to the confirmed patients have been tracked, 583 people were released from medical observation that day, and 30,453 people were still undergoing medical observation."
      ],
      "computed_relevance": 0.1111111111111111,
      "computed_utilization": 0.1111111111111111,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, it says, \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. The key terms here are \"high throughput\" and \"deep sequencing methods.\" \n\nI should check the other passages to make sure there's no conflicting information. The second passage mentions studies from 2015 about genetic recombination, but it doesn't talk about the methods used for analysis. The third passage discusses genome analyses focusing on specific parts of the genome, but again, the method mentioned is still sequencing. The fourth passage talks about vigilance and data sharing but doesn't mention the analysis methods. \n\nSo the first passage clearly states that high throughput or deep sequencing is the primary method. The answer should be that most analysis has been done using these methods for complete genome deduction. I need to present this answer concisely, making sure to include the key terms from the passage.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods** for complete genome deduction. This approach was highlighted as the first widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable.",
        "Continued laboratory testing, sequencing, analysis, timely data sharing and clear communication are essential for such vigilance to be effective.",
        "While human and camel whole genome sequences have retained >99 % identity with each other, members of genetically distinct lineages can and do swap genetic material when suitable conditions and coinfections co-occur ."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided context and passages to find the methods mentioned.\n\nFirst, the context mentions that images show GFP-expressing cells in white and non-GFP in black. Then, looking at the first passage under the influenza title, they used IVIS for whole-organ imaging of the lungs ex vivo and also flow cytometry to analyze infection progression in antigen-presenting cells. The imaging of murine lungs showed infection starting near large airways and spreading deeper.\n\nAnother passage mentions using an inverted fluorescence microscope to monitor plates after applying an overlay until GFP expression was seen. The third title talks about generating single-cell clones with GFP, using puromycin and limiting dilution, but that might be more about cell preparation than tracking spread.\n\nSo the main methods for tracking spread would be IVIS for whole-organ imaging, fluorescence microscopy for observing in cell cultures, and possibly flow cytometry for analyzing specific cell populations. The answer should combine these methods as the ways they tracked the spread.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using **whole-organ imaging of murine lungs** (via IVIS) to observe GFP distribution ex vivo, **fluorescence microscopy** to monitor GFP expression in cell cultures (e.g., during viral dynamics in bat cell lines), and **flow cytometry** to analyze infection progression in antigen-presenting cells. These methods collectively revealed spatial and temporal patterns of viral spread, such as initial infection near airways and subsequent progression to deeper lung regions.",
      "retrieved_chunks": [
        "One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black .",
        "Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs .",
        "Title: Illuminating the Sites of Enterovirus Replication in Living Cells by Using a Split-GFP-Tagged Viral Protein\nPassage: transduction, the MLV particles were 5 to 10 times concentrated using a 100-kDa concentrator .",
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed .",
        "For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution."
      ],
      "computed_relevance": 0.42857142857142855,
      "computed_utilization": 0.42857142857142855,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with similar titles and mentions of CT disinfection procedures.\n\nFirst, I need to parse the context. The titles all mention \"The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\" and the passages talk about noncontaminated CT disinfection procedures after suspected cases, fever-CT disinfection, and preparing to disinfect imaging equipment immediately after examination.\n\nThe key points here are that after examining a suspected COVID-19 case, the CT equipment needs to be disinfected. The passages mention \"immediately after the examination\" and \"sterilization procedures.\" The term \"noncontaminated CT disinfection procedures\" might be a bit confusing, but since it's after a suspected case, maybe they mean that even though the patient is suspected, the CT is disinfected regardless. \n\nThe answer should probably include steps like using appropriate disinfectants, following sterilization protocols, and doing it right after the exam. The context doesn't give specific steps, but the general procedure is to disinfect the imaging equipment immediately post-examination. Since the user is asking for the recommended procedure, the answer would be based on the information given in the context, which emphasizes immediate disinfection after the examination using proper sterilization methods.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment following the examination** using established sterilization protocols. The context emphasizes that healthcare personnel should prepare and apply disinfection measures promptly after examining suspected or confirmed COVID-19 cases to prevent cross-contamination. Specific steps likely include using approved disinfectants and adhering to guidelines for high-touch surfaces and equipment sterilization, though the exact details (e.g., specific products or contact times) are not provided in the given context.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 10,
      "dataset_id": "790",
      "question": "What can RNA sequencing be used to monitor?",
      "ground_truth_answer": "RNA sequencing can be used to monitor transcripts that may not be in the existing genomic annotation, allowing the search for novel transcripts, and even identification of SNPs and other variants, as well as for transcriptome profiling in cancers such as breast cancer, gastrointestinal tumors, and prostate cancer.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What can RNA sequencing be used to monitor?\" and they provided some context from different passages.\n\nFirst, I need to look through the given context to find relevant information. The first passage mentions spike-in controls for quality control and estimating absolute RNA levels in scRNA-seq. The second passage talks about RNA-Seq's advantages over qRT-PCR and microarrays, like higher coverage, precision, and detecting novel transcripts. The third passage discusses RNAseq's ability to discern RNA changes and detect novel interactions during influenza infections. The fourth passage mentions single-cell RNA analysis steps, including sequencing and bioinformatics.\n\nSo, putting this together, RNA sequencing can monitor RNA expression levels, detect novel transcripts, identify SNPs and variants, and track changes in RNA magnitude. It's also used for quality control with spike-ins. The answer should list these points. The alternatives like qRT-PCR and microarrays are less effective, which highlights RNAseq's benefits. The answer should be concise, using the key points from the context without adding external info.\n</think>\n\nRNA sequencing (RNA-Seq) can be used to monitor **RNA expression levels, detect novel transcripts, identify single nucleotide polymorphisms (SNPs) and other genetic variants, and quantify the magnitude of RNA changes in response to biological conditions** (e.g., influenza infection). It provides higher resolution and sensitivity compared to alternatives like qRT-PCR or microarrays, enabling the discovery of previously unannotated transcripts and reliable detection of dynamic transcriptomic responses, such as innate immune pathways during viral infections. Additionally, spike-in controls in RNA-Seq can serve as quality control metrics and help estimate absolute RNA levels in single-cell RNA sequencing (scRNA-seq).",
      "retrieved_chunks": [
        "Spike-in controls can be used as quality control and also to estimate the absolute levels of RNA expression since in scRNA-seq the exact number of cells\n\nTitle: RNA Sequencing of H3N2 Influenza Virus-Infected Human Nasal Epithelial Cells from Multiple Subjects Reveals Molecular Pathways Associated with Tissue Injury and Complications\nPassage: changes to serve as potential reference markers of the innate responses of influenza infection.",
        "Alternatives to RNA sequencing are qRT-PCR and microarrays. The former is laborious and has a limited number of targets, while microarrays demand previously established transcriptomic probes and might have some background noise interfering on low abundant transcripts .",
        "Title: Personal genomes, quantitative dynamic omics and personalized medicine\nPassage: The development of RNA sequencing brought higher coverage, better precision and quantitation, and higher resolution and sensitivity, bringing RNA-Seq technology and transcriptomics on par with genomic sequencing . RNA-Seq considers reads that correspond to millions of transcriptomic fragments that are mapped to the reference genome, to provide information on transcripts that may not be in the existing genomic annotation, allowing the search for novel transcripts, and even identification of SNPs and other variants, while showing remarkable reproducibility .",
        "Given that RNAseq functions by reading virtually all the RNAs present in the samples tested, we can also discern the magnitude of each RNA change and mark them as the canonical responses. In addition, as RNAseq is not constrained by probe usage as in microarrays, they are therefore more reliable in detecting novel interactions during influenza infections of hNECs. Hence, RNAseq analysis will further augment the transcriptomic data established previously by microarray analysis.",
        "These methods\n\nTitle: A Single Cell but Many Different Transcripts: A Journey into the World of Long Non-Coding RNAs\nPassage: Final steps of single-cell RNA analysis are the sequencing and bioinformatic analyses."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.3333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.38095238095238093,
      "gt_utilization": 0.09523809523809523,
      "gt_completeness": 0.25,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 11,
      "dataset_id": "480",
      "question": "In what direction does the Vesicular stomatitis virus spread through the nervous system?",
      "ground_truth_answer": "The Vesicular stomatitis virus spreads in a retrograde direction through the nervous system.",
      "generated_response": "<think>\nOkay, let's try to figure out the answer to the question: \"In what direction does the Vesicular stomatitis virus spread through the nervous system?\" based on the provided context.\n\nFirst, I need to look through the given passages. The context mentions \"rVSV\" which I assume stands for recombinant Vesicular Stomatitis Virus. The title says that when it's modified with the rabies virus glycoprotein, it directs retrograde transsynaptic transport among neurons in vivo. \n\nLooking at the first passage: \"These data show that rVSV can spread in a retrograde direction from the injection site, but do not address whether the virus can spread exclusively in the retrograde direction.\" So here, they're saying that the virus spreads retrograde, meaning backwards, from where it's injected. But they're not sure if it can only go that way or if it can also spread in the opposite direction (antidromic or anterograde?).\n\nAnother part says: \"Injections of rVSV into M1 should not label neurons in the CP if the virus can only label cells across synapses in the retrograde direction.\" Then it mentions that at 2 days post-injection (dpi), areas directly... (maybe they mean that the labeling was restricted as expected if it's only retrograde). \n\nAnother passage states: \"Labeling remained well-restricted to the expected corticostriatal circuits at 5 dpi, suggesting that viral spread becomes less efficient after crossing one or two connections, consistent with injections into V1.\" This seems to support that the spread is limited, maybe only retrograde since it's following specific circuits and not spreading widely.\n\nPutting this together, the key term here is \"retrograde direction.\" The virus is spreading from the injection site back towards the cell body, moving against the usual direction of signal transmission in neurons. Normally, signals go from dendrites to cell body to axon (anterograde), but retrograde would be the opposite. The studies here are using this virus to trace neural connections because it moves in a specific direction. The fact that they mention it's modified with the rabies virus glycoprotein might be important because rabies virus is known for its retrograde spread. \n\nThe answer should be that the Vesicular stomatitis virus (rVSV) spreads in a retrograde direction through the nervous system. The context repeatedly mentions retrograde transsynaptic transport",
      "retrieved_chunks": [
        "Title: Vesicular stomatitis virus with the rabies virus glycoprotein directs retrograde transsynaptic transport among neurons in vivo\nPassage: These data show that rVSV can spread in a retrograde direction from the injection site, but do not address whether the virus can spread exclusively in the retrograde direction.",
        "Title: Vesicular stomatitis virus with the rabies virus glycoprotein directs retrograde transsynaptic transport among neurons in vivo\nPassage: dpi, as previously observed .",
        "Injections of rVSV into M1 should not label neurons in the CP if the virus can only label cells across synapses in the retrograde direction. Indeed, at 2 dpi, areas directly\n\nTitle: Vesicular stomatitis virus with the rabies virus glycoprotein directs retrograde transsynaptic transport among neurons in vivo\nPassage: These data show that rVSV can spread in a retrograde direction from the injection site, but do not address whether the virus can spread exclusively in the retrograde direction.",
        "Injections of rVSV into M1 should not label neurons in the CP if the virus can only label cells across synapses in the retrograde direction. Indeed, at 2 dpi, areas directly\n\nTitle: Vesicular stomatitis virus with the rabies virus glycoprotein directs retrograde transsynaptic transport among neurons in vivo\nPassage: dpi, as previously observed . Labeling remained well-restricted to the expected corticostriatal circuits at 5 dpi, suggesting that viral spread becomes less efficient after crossing one or two connections, consistent with injections into V1 .",
        "Labeling remained well-restricted to the expected corticostriatal circuits at 5 dpi, suggesting that viral spread becomes less efficient after crossing one or two connections, consistent with injections into V1 ."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 12,
      "dataset_id": "1585",
      "question": "How do these exact processes ultimately restrict viral infectivity?",
      "ground_truth_answer": "These processes ultimately restrict viral infectivity by triggering a legion of cellular defense and antiviral systems, inducing inflammatory factors and activating innate and adaptive immunity. Additionally, these mechanisms include the activation of direct antiviral activity against the replicative stages of viruses, targeting common pathways or structures that are essential for viral replication. This evolutionary arms race between countermeasures and species-specific factors ultimately prevent effective viral envelope clustering, decrease fluidity and imposes rigidity, and induce an outward membrane curvature that opposes the forces exerted by viral fusion machinery, ultimately inhibiting the ins and outs of HIV replication and restricting viral infectivity.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the exact processes mentioned in the context restrict viral infectivity. I need to look through the provided passages to find the mechanisms described.\n\nFirst, the context mentions that when mammalian cells are infected with TBFV, cellular defense systems are triggered. These include general antiviral systems and specific factors that limit virus reproduction. Then there's a part about HIV replication and cell-intrinsic restrictions at the plasma membrane. The passage talks about processes common to all enveloped viruses, like entry and exit, and how the host has evolved mechanisms to inhibit these. These mechanisms are regulated by type 1 interferons and pattern recognition responses, linking to the broader immune response.\n\nAnother part mentions IFITM proteins forming a meshwork in the membrane, decreasing fluidity and inducing curvature that opposes viral fusion machinery. This affects both enveloped viruses (like IAV) and non-enveloped ones (like reoviruses) by disrupting endosomal membranes. Also, TRIM79a restricts TBEV by degrading NS5.\n\nSo, putting this together, the processes involve both general and specific antiviral mechanisms. The general ones include things like interferons and pattern recognition, which activate broader immune responses. Specific factors like IFITM proteins interfere with viral entry by altering membrane properties, making it harder for the virus to fuse or enter. Others, like TRIM79a, target viral proteins directly for degradation, preventing replication. These mechanisms work together to block different stages of the viral life cycle, such as entry, fusion, and replication, thereby restricting infectivity.\n</think>\n\nThe processes described in the context restrict viral infectivity through a combination of **general cellular defense mechanisms** and **virus-specific countermeasures**. Here's how they work:\n\n1. **General Antiviral Systems**:  \n   - **Type 1 interferons (IFNs)** and **pattern recognition responses** activate broad antiviral states in cells, enhancing immune defenses and signaling to neighboring cells.  \n   - **Membrane rigidity and curvature** induced by IFITM proteins (e.g., forming a \"meshwork\" in the plasma membrane) disrupt viral fusion machinery (e.g., for influenza) and hinder endosomal membrane disruption required by nonenveloped viruses like reoviruses.  \n\n2. **Virus-Specific Restrictions**:  \n   - **TRIM proteins** (e.g.,",
      "retrieved_chunks": [
        "Title: The role of viral persistence in flavivirus biology\nPassage: When mammalian cell cultures are acutely infected with TBFV, a legion of general cellular defense and antiviral systems are triggered, as are specific factors designed to limit or restrict virus reproduction.",
        "Title: Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane\nPassage: These unavoidable processes are common to all enveloped viruses.",
        "It is perhaps unsurprising that the mammalian host has evolved multiple antiviral mechanisms whose role is to inhibit viral replicative processes that are associated with entry and exit , necessitating either the evolution of directly encoded countermeasures by the virus, or other mechanisms of resistance or avoidance. Furthermore, these mechanisms are often regulated by type 1 interferons and pattern recognition responses, linking these factors to the wider antiviral immune response.",
        "The evolutionary arms race between these countermeasures and species-specific\n\nTitle: Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane\nPassage: may prevent the effective viral envelope clustering that is required particularly for IAV fusion and the IFITM multiplexes could also form a \"meshwork\" within the outer leaflet of the membrane that not only decreases fluidity and imposes rigidity but induces an outward membrane curvature that opposes the forces exerted by the viral fusion machinery. These general mechanisms may account for the diversity of viruses inhibited, including nonenveloped viruses, such as reoviruses, that do not require fusion, but do need to disrupt the endosomal membrane to enter the cell .",
        "For example, the IFN-induced tripartite motif protein, TRIM79a, has been shown to restrict TBEV replication by degrading NS5 ."
      ],
      "computed_relevance": 0.7142857142857143,
      "computed_utilization": 0.8571428571428571,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.38095238095238093,
      "gt_utilization": 0.38095238095238093,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 13,
      "dataset_id": "378",
      "question": "What is the 5-year survival rate for colorectal cancer patients?",
      "ground_truth_answer": "The provided context does not contain information about the 5-year survival rate for colorectal cancer patients. Therefore, it is not possible to answer the question based on the given passages.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the 5-year survival rate for colorectal cancer patients. But looking at the provided context, all the passages are about research on severe ulcerative colitis (SUC) in China. The titles and passages mention things like colectomy rates, mortality rates, and follow-up periods, but none of them talk about colorectal cancer specifically. \n\nThe first passage mentions no cases of rectal dysplasia or cancer after a 3-year follow-up. The second and third passages discuss colectomy rates (7.7% vs. 17.9%) and mortality rates (0.8%). However, these are related to SUC patients, not colorectal cancer. The fourth passage just repeats the mortality rate.\n\nSince the question is about colorectal cancer survival rates, but the context is entirely about ulcerative colitis, there's no direct information provided that answers the question. The user might be conflating ulcerative colitis with colorectal cancer, but the data here doesn't address the 5-year survival rate for cancer patients. Therefore, the answer should state that the information isn't available in the provided context.\n</think>\n\nThe provided context discusses research on severe ulcerative colitis (SUC) in China, including colectomy rates, mortality rates, and follow-up outcomes. However, **no information is provided about the 5-year survival rate for colorectal cancer patients**. The passages focus on SUC management and complications (e.g., rectal dysplasia, colectomy rates) but do not address colorectal cancer survival statistics. Therefore, the answer cannot be determined from the given context.",
      "retrieved_chunks": [
        "Title: Chinese research into severe ulcerative colitis has increased in quantity and complexity\nPassage: no cases of rectal dysplasia and/or cancer was reported after a median 3-year follow-up.",
        "Title: Chinese research into severe ulcerative colitis has increased in quantity and complexity\nPassage: The colectomy rate in our study was found to be 7.7%, while the colectomy rate in hospitalized SUC patients reported by the West China Hospital is 17.9%, both are lower than the 20%-40% reported in United Kingdom . Title: Chinese research into severe ulcerative colitis has increased in quantity and complexity\nPassage: significantly increased.",
        "The colectomy rate and short-term mortality rate were 7.7% and 0.8% respectively.",
        "Title: Chinese research into severe ulcerative colitis has increased in quantity and complexity\nPassage: mortality rate were 7.7% and 0.8% respectively.",
        "The most commonly employed operation was total proctocolectomy with ileal pouch-anal anastomosis."
      ],
      "computed_relevance": 0.8333333333333334,
      "computed_utilization": 0.8333333333333334,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.0,
      "gt_utilization": 0.0,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 14,
      "dataset_id": "25",
      "question": "Which Human Coronavirus showed species specific clinical characteristics of its infection?",
      "ground_truth_answer": "HCoV\u2010HKU1 is the Human Coronavirus that showed species-specific clinical characteristics of its infection, specifically with a higher severity of gastrointestinal symptoms on the fourth day of illness.",
      "generated_response": "<think>\nOkay, let's see. The question is asking which human coronavirus showed species-specific clinical characteristics in the study mentioned. The context provided is from an abstract of a study titled \"Species-specific clinical characteristics of human coronavirus infection among otherwise healthy adolescents and adults.\"\n\nFirst, I need to recall what the passage says. The abstract mentions that human coronaviruses (HCoVs) are known to cause influenza-like illness (ILI). The study looked at four species: HCoV-OC43, HCoV-229E, HCoV-NL63, and HCoV-HKU1. The key part here is that they observed species-specific differences except for one. The passage states, \"We did not observe species-specific differences in the clinical characteristics of HCoV infection, with the exception of HCoV-HKU1, for which the severity of gastrointestinal symptoms trended higher on the fourth day of illness.\"\n\nSo, the answer should be HCoV-HKU1 because it's the only one mentioned as having a different clinical characteristic\u2014specifically, more severe gastrointestinal symptoms on day four. The other three didn't show such differences. The question is straightforward once I focus on the exception mentioned in the abstract. The other parts of the context like authors, DOI, and the 12% PCR-positive rate aren't relevant here. The main clue is in the exception part of the abstract.\n</think>\n\nThe Human Coronavirus that showed species-specific clinical characteristics of its infection is **HCoV-HKU1**. The study found that while most HCoV species (HCoV-OC43, HCoV-229E, HCoV-NL63) did not exhibit species-specific differences in clinical symptoms, HCoV-HKU1 was associated with a trend toward higher severity of gastrointestinal symptoms on the fourth day of illness. \n\n**Answer:** HCoV-HKU1.",
      "retrieved_chunks": [
        "Title: Species\u2010specific clinical characteristics of human coronavirus infection among otherwise healthy adolescents and adults\nPassage: Abstract: Human coronavirus is a known cause of influenza\u2010like illness .",
        "The distribution of species was as follows: HCoV\u2010OC43 , HCoV\u2010229E , HCoV\u2010NL63 , and HCoV\u2010HKU1 . We did not observe species\u2010specific differences in the clinical characteristics of HCoV infection, with the exception of HCoV\u2010HKU1, for which the severity of gastrointestinal symptoms trended higher on the fourth day of illness.",
        "Title: Species\u2010specific clinical characteristics of human coronavirus infection among otherwise healthy adolescents and adults\nPassage: Authors: Bouvier, Monique; Chen, Wei\u2010Ju; Arnold, John C.; Fairchok, Mary P.; Danaher, Patrick J.; Lalani, Tahaniyat; Malone, Leslie; Mor, Deepika; Ridor\u00e9, Michelande; Burgess, Timothy H.; Millar, Eugene V. Title: Species\u2010specific clinical characteristics of human coronavirus infection among otherwise healthy adolescents and adults\nPassage: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820427/\n\nTitle: Species\u2010specific clinical characteristics of human coronavirus infection among otherwise healthy adolescents and adults\nPassage: DOI: 10.1111/irv.12538",
        "In a multisite, observational, longitudinal study of ILI among otherwise healthy adolescents and adults, 12% of subjects were PCR\u2010positive for HCoV."
      ],
      "computed_relevance": 0.5,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4,
      "gt_utilization": 0.1,
      "gt_completeness": 0.25,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 15,
      "dataset_id": "1741",
      "question": "What has been demonstrated to  be  effective for prevention?",
      "ground_truth_answer": "Vaccines have been demonstrated to be effective for prevention, as well as household-based quarantine and isolation. Additionally, the use of face masks and hand hygiene has shown potential efficacy in reducing disease spread.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what has been demonstrated to be effective for prevention based on the provided context. Let me go through each passage carefully.\n\nFirst, the first context talks about non-pharmaceutical interventions like social distancing, school closures, and household quarantine. It mentions that these measures are likely somewhat effective but hard to sustain long-term. Then it references the eradication of smallpox through quarantine and isolation, which shows their effectiveness historically.\n\nThe second context is about vaccines being effective against infections, specifically mentioning EV71. It also describes a study where households received education on diet and masks. The face mask group got masks and training on their use. So here, masks and education are part of the intervention.\n\nThird context again discusses non-pharmaceutical interventions, specifically masks and hand hygiene. The study compared three interventions, but there's uncertainty about their efficacy. However, the study is proposed to assess their effectiveness, implying that previous evidence might be mixed or not conclusive.\n\nPutting this together, the first context mentions that household-based quarantine and isolation were effective, as seen in smallpox eradication. The second context shows that masks, when used with education, are part of an intervention. The third context is about the uncertainty but the study aims to assess masks and hand hygiene. \n\nThe answer should include what's been demonstrated. The smallpox example clearly shows quarantine and isolation worked. The study in the second context shows that masks and education were implemented, but the effectiveness isn't stated as proven yet. However, the first passage says that household quarantine is likely effective. The vaccines are mentioned as effective in general but not specifically demonstrated in the context's studies. \n\nSo the key points are household quarantine/isolation (from smallpox example) and maybe masks with education. But the third context says there's uncertainty about masks and hand hygiene. The answer should focus on what's been demonstrated. The smallpox example is a historical demonstration of effectiveness. The study in the second context implemented masks and education but the effectiveness isn't confirmed in the passage. The first passage says household measures are likely effective. So the answer would be household-based quarantine and isolation, as that's linked to smallpox eradication. Also, vaccines are mentioned as effective in general, but the context's own studies might not have demonstrated that. Wait, the second context's title is about vaccines for EV71, but the passage says vaccines are considered effective.",
      "retrieved_chunks": [
        "Title: Preliminary Findings of a Randomized Trial of Non-Pharmaceutical Interventions to Prevent Influenza Transmission in Households\nPassage: and targeted antiviral prophylaxis, other population-level social distancing measures such as school and workplace closures and travel restrictions are likely to be somewhat effective in reducing influenza transmission in the community , but implementation on a prolonged basis and with repeated waves of the pandemic could be difficult. Household-based quarantine and isolation will likely be effective in mitigating the impact of a pandemic .",
        "In fact, their effectiveness in the prevention of infectious diseases could be clearly observed in the eradication of smallpox, declared officially in 1976 by WHO, just two centuries after Edward Jenner showed the prevention of smallpox infection by inoculating cowpox into a person .",
        "Title: Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines\nPassage: Vaccines have always been considered as one of the most effective preventions against various types of infections, ranging from bacterial to viral infections.",
        "In the control arm, households received education about the importance of a healthy diet and lifestyle, both in terms of illness prevention and symptom alleviation . Households in the face mask arm received the control intervention plus education about the potential efficacy of masks in reducing disease spread to household contacts if all parties wear masks, distribution of a box of 50 surgical masks for each household member , and demonstration of proper face-mask wearing and hygienic disposal. Index subjects and all household contacts were taught to wear masks as often as possible at home\n\nTitle: Preliminary Findings of a Randomized Trial of Non-Pharmaceutical Interventions to Prevent Influenza Transmission in Households\nPassage: through intensive counselling, and demonstration of proper wearing of masks or hand washing.",
        "There is however considerable uncertainty about the efficacy of some non-pharmaceutical interventions at the personal level including face masks and hand hygiene. Our proposed study, to assess the efficacy of masks and hand-hygiene for influenza control,\n\nTitle: Preliminary Findings of a Randomized Trial of Non-Pharmaceutical Interventions to Prevent Influenza Transmission in Households\nPassage: Our study compared three interventions."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.2222222222222222,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.5333333333333333,
      "gt_utilization": 0.4666666666666667,
      "gt_completeness": 0.875,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 16,
      "dataset_id": "944",
      "question": "What does LAIV rely on?",
      "ground_truth_answer": "LAIV relies on antigenic match and the HA and NA antigens are replaced on the same schedule as the TIV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What does LAIV rely on?\" based on the provided context. I need to look through the passages given to find the answer.\n\nFirst, I'll recall what LAIV is. From the context, LAIV stands for Live-Attenuated Influenza Vaccine. The passages mention that LAIV is administered as a nasal spray and uses attenuated viruses. \n\nLooking at the first passage under \"Current and Novel Approaches in Influenza Management,\" there's a sentence that says: \"While LAIV relies on antigenic match and the HA and NA antigens are replaced on the same schedule as the TIV...\" So here, it directly states that LAIV relies on antigenic match. \n\nI should check if there's any other part of the context that might add to this. The other passages talk about LAIV's effectiveness in children, mucosal immunity, and safety, but the key part here is the antigenic match. The HA (hemagglutinin) and NA (neuraminidase) antigens are the surface proteins of the influenza virus that the vaccine targets. Since the vaccine needs to match these antigens to be effective, the answer should be that LAIV relies on antigenic match. \n\nI don't see any other factors mentioned in the context that LAIV relies on. The other parts discuss administration method, immune responses, and safety, but the direct answer comes from the part about antigenic match and the HA/NA antigens. So the answer should be that LAIV relies on antigenic match, specifically of the HA and NA antigens.\n</think>\n\nAnswer: LAIV relies on antigenic match, specifically with the HA (hemagglutinin) and NA (neuraminidase) antigens, which are updated on the same schedule as the trivalent inactivated vaccine (TIV).",
      "retrieved_chunks": [
        "A typical setback to the use of the LAIV\n\nTitle: Virus-Vectored Influenza Virus Vaccines\nPassage: February and then manufacturers begin production, taking at least six months to produce the millions of vaccine doses required for the fall .",
        "Title: Current and Novel Approaches in Influenza Management\nPassage: LAIV viruses in the nasopharynx elicit immune response that epitomizes a natural influenza infection.",
        "LAIV is not recommended for all populations; however, it is generally considered to be as effective as inactivated vaccines and may be more efficacious in children . While LAIV relies on antigenic match and the HA and NA antigens are replaced on the same schedule as the TIV , there is some suggestion that LAIV may\n\nTitle: Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens\nPassage: decade and it has been reported to protect young individuals better than IIV . Importantly, recent studies showed that LAIV can pre-sensitize the population and, subsequently, synergistically boost the efficacy of IIV . It should be noted that the use of LAIV in poultry requires strict safety standards due to concerns about the possibility that wild type strains may circulate in domestic poultry without apparent clinical symptoms, undergo genetic reassortment with the vaccine virus, and produce novel virulent strains . An ideal poultry LAIV should not be able to revert to wild type virus or undergo reassortment with field strains.",
        "For this reason, LAIV has shown some superiority over the IIV in terms of the induction of mucosal immunity via secreted immunoglobulin A . Use of the LAIV has proven to be safe in children and immunocompromised persons . The most spelt-out advantage is the \"non-invasive\" capacity of the attenuated viruses and this had made it suitable to use for all categories of vaccines, although LAIVs are not recommended for people with underlying chronic medical conditions .",
        "LAIV is administered as a nasal spray and contains the same three or four influenza virus strains as inactivated vaccines but on an attenuated vaccine backbone . LAIV are temperature-sensitive and cold-adapted so they do not replicate effectively at core body temperature, but replicate in the mucosa of the nasopharynx . LAIV immunization induces serum antibody responses, mucosal antibody responses , and T cell responses. While robust serum antibody and nasal wash antibody responses are associated with protection from infection, other immune responses, such as"
      ],
      "computed_relevance": 0.07142857142857142,
      "computed_utilization": 0.07142857142857142,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.13043478260869565,
      "gt_utilization": 0.043478260869565216,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 17,
      "dataset_id": "1009",
      "question": "What have the studies on NP shown for the protection against influenza challege?",
      "ground_truth_answer": "The studies on NP have shown that NP-specific CD8 T-cell responses may be directly correlated to protection against homologous influenza virus infection, and that mucosal vaccination with rAd/NP can confer complete protection against lethal homologous virus challenge. Additionally, protection against heterosubtypic influenza virus infection may also be correlated to NP-specific CTL response.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what studies on NP (nucleoprotein) have shown regarding protection against influenza challenge. I need to go through the provided context and extract relevant information.\n\nFirst, looking at the first context: It mentions that NP-specific CTL (cytotoxic T lymphocyte) responses may be directly correlated with protection against homologous influenza virus infection. Also, protection against heterosubtypic infection (different subtypes) might be linked to NP-specific CD8 T cells since their levels increased in surviving mice. So NP's role in both same and different subtype protections is highlighted here.\n\nNext, the second title talks about a surveillance study. The passage says that protective mechanisms in animal models include antibodies to NP and M2. However, NP is highly conserved, but sometimes antibodies against pH1N1 NP don't recognize seasonal viruses. This suggests that while NP is conserved, there might be some variability in antibody recognition between different strains.\n\nThe third context is about mucosal vaccination with rAd/NP. The study shows that immunization with rAd/NP provides complete protection against lethal homologous challenges and some cross-protection against heterologous H1N1 or H3N2. They investigated if this cross-protection correlates with NP-specific CD8 T-cell responses. The passage mentions that NP has a conserved CD8 T-cell epitope. They analyzed CD8 T cells using tetramer staining after challenge. Also, it's noted that rAd/NP might induce long-lasting innate immunity working with other immune responses. However, even with protection, virus replication continued up to day 5, indicating that while protection is there, it might not fully prevent replication, just disease severity.\n\nPutting this together, the key points are: NP-specific CD8 T cells are important for both homologous and heterosubtypic protection. The studies show that inducing these T cells through vaccination (like rAd/NP) can confer protection. Also, while antibodies to NP exist, their effectiveness might vary between strains. The rAd/NP vaccine seems to offer strong protection, possibly through CD8 T cells and innate immunity, but doesn't stop replication entirely. The user's answer should summarize these findings, emphasizing the role of NP-specific T cells in protection against both same and different subtypes, and the effectiveness of vaccines targeting NP.\n</think>\n\nThe studies on NP (nucleoprotein) have demonstrated",
      "retrieved_chunks": [
        "route, indicating that NP-specific CTL response may be directly correlated to protection against homologous influenza virus infection. Moreover, protection against heterosubtypic influenza virus infection may also be correlated to NP-specific CTL response as NP-specific blood CD8 T lymphocyte levels considerably increased in mice that survived the lethal challenge with heterosubtypic\n\nTitle: Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic\nPassage: detect similar correlations of T-cell reactivity with outcomes was that we had too few infected donors. Protective mechanisms in animal models include antibodies to influenza NP and M2. Although NP is highly conserved, occasional antibodies recognize pH1N1 NP but not NP from seasonal viruses .",
        "Title: Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection\nPassage: Complete protection offered by i.n. immunization of rAd/NP during heterologous H1N1 or heterosubtypic H3N2 virus challenge rendered us to investigate whether the observed cross-protection correlates with the magnitude NP-specific CD8 T-cell responses, given that influenza NP contains a conserved immunodominant CD8 T-cell epitope as indicated previously. In order to determine the possible presence of such correlation, blood lymphocytes of mice challenged with 10 LD 50 dose of influenza A/Philippines were analyzed by K d /NP 147-155 -tetramer staining from day 0 to day 12 post-challenge.",
        "route\n\nTitle: Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection\nPassage: In our present study, we demonstrated that rAd/NP immunization increases the frequency of NP-specific CD8 T cells recruited to the lungs of i.n.",
        "It is probable that rAd/NP may induce long-lasting innate immunity that contributes complementarily with other specific immune arms to the control of the disease by uncharacterized mechanisms .",
        "immunization of rAd/NP can confer complete protection against the lethal homologous virus challenge while allowing competent virus replication to perpetuate even to day 5 post-challenge."
      ],
      "computed_relevance": 0.3,
      "computed_utilization": 0.3,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.30434782608695654,
      "gt_utilization": 0.21739130434782608,
      "gt_completeness": 0.7142857142857143,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 18,
      "dataset_id": "640",
      "question": "What do ANDV-infected hamsters fitted with physiologic monitoring devices exhibit?",
      "ground_truth_answer": "Diminished pulse pressures, tachycardia, and hypotension that closely mimic the shock experienced by patients who succumb to HCPS.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what ANDV-infected hamsters with physiologic monitoring devices exhibit. I need to look through the provided context to find the relevant information.\n\nFirst, I'll scan through each passage. The first context mentions that these hamsters show diminished pulse pressures, tachycardia, and hypotension. It also says these symptoms mimic the shock seen in HCPS patients. \n\nAnother part of the context talks about high viral titers in hamsters, but that's more about the virus levels. The liver enzymes part says that even though human patients have elevated hepatic enzymes, the hamsters don't show that. The lung tissue sections mention inflammation and other pathologies, but the question is specifically about the physiologic monitoring devices.\n\nSo the key part here is the first passage under the title about depletion of alveolar macrophages. The relevant sentence is: \"ANDV-infected hamsters fitted with physiologic monitoring devices exhibited diminished pulse pressures, tachycardia, and hypotension that appear to closely mimic the shock that is believed to be the proximate cause of demise in patients who succumb to HCPS.\"\n\nTherefore, the answer should list those three physiological changes: diminished pulse pressures, tachycardia, and hypotension. Also, it's important to note that these mimic shock similar to HCPS patients. I need to make sure I include all three and maybe mention the shock part as well.\n</think>\n\nANDV-infected hamsters fitted with physiologic monitoring devices exhibit **diminished pulse pressures, tachycardia, and hypotension**. These physiological changes closely mimic the shock observed in patients with hantavirus cardiopulmonary syndrome (HCPS), which is considered a proximate cause of death in severe cases of the disease.",
      "retrieved_chunks": [
        "Title: Depletion of Alveolar Macrophages Does Not Prevent Hantavirus Disease Pathogenesis in Golden Syrian Hamsters\nPassage: progresses. At later times after infection, similar levels of viral genome and/or infectious virus were found in the lung of all hamsters, supporting the argument that AM contribute more substantially to the immune response against ANDV early after infection but less so at later times once ANDV is primarily replicating in endothelial cells.",
        "ANDV-infected hamsters fitted with physiologic monitoring devices exhibited diminished pulse pressures, tachycardia, and hypotension that appear to closely mimic the shock that is believed to be the proximate cause of demise in patients who succumb to HCPS . Title: Hantaviruses in the Americas and Their Role as Emerging Pathogens\nPassage: Compared to the human disease, ANDV-infected hamsters exhibit exceptionally high titers of live ANDV in their tissues, with much of the viral replication occurring in hepatocytes, which are spared in the human disease. Titers of live ANDV in some cases exceed 10 8 /g, whereas hantavirus isolates from human tissues have been notoriously difficult to obtain.",
        "Title: Depletion of Alveolar Macrophages Does Not Prevent Hantavirus Disease Pathogenesis in Golden Syrian Hamsters\nPassage: Serial sections of lung tissue from these groups further revealed the presence of ANDV antigen colocalized to CD31-positive endothelial cells in both capillaries and larger vessels . Regardless of treatment, no differences were observed in the pathogenesis of HPS-like disease in ANDV-infected hamsters. Hamsters in all groups exhibited signs of mild to moderate inflam- mation, interstitial pneumonia, alveolar fibrin deposition, and edema characteristic of ANDV infection.",
        "Despite the universal occurrence of mildly-elevated hepatic enzymes in patients with HCPS, hepatic enzymes do not appear to be present at elevated levels in the blood of diseased hamsters even immediately before death .",
        "Title: Hantaviruses in the Americas and Their Role as Emerging Pathogens\nPassage: abundantly in the microvascular endothelium."
      ],
      "computed_relevance": 0.1,
      "computed_utilization": 0.1,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.07142857142857142,
      "gt_utilization": 0.07142857142857142,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 19,
      "dataset_id": "1629",
      "question": "Why is the Spanish Influenza virus the Mother of the modern influenza viruses?",
      "ground_truth_answer": "The Spanish Influenza virus is considered the Mother of all modern influenza viruses due to its initial genetic characterization, the origin and evolution of its hemagglutinin gene, characterization of its neuraminidase gene, and characterization of its matrix gene. This extensive research and understanding of the genetic makeup of the virus has provided crucial insights into the development and evolution of influenza viruses, making it a significant and influential virus in the history of influenza pandemics.",
      "generated_response": "<think>\nOkay, let's see. The user is asking why the Spanish Influenza virus is called the Mother of all modern influenza viruses. The context provided includes several titles and passages about the 1918 Spanish flu, specifically mentioning the matrix gene, hemagglutinin gene, neuraminidase gene, and initial genetic characterization.\n\nFirst, I need to recall what the term \"Mother of all pandemics\" refers to. The 1918 flu was a major pandemic with high mortality. But the question is about why it's the mother of modern influenza viruses. That probably relates to its genetic makeup influencing subsequent strains.\n\nLooking at the context, the passages talk about the characterization of the matrix, hemagglutinin, and neuraminidase genes. These are key components of the influenza virus. The hemagglutinin (HA) and neuraminidase (NA) are surface proteins that determine the virus's ability to infect cells and spread. The matrix gene is also important for the virus's structure.\n\nThe answer likely involves the genetic legacy of the 1918 virus. If the 1918 virus's genes have been found in modern strains, that would explain its role as a progenitor. For example, if modern influenza viruses have evolved from the 1918 strain through mutations or reassortment, then the 1918 virus is a key ancestor. The studies mentioned in the context probably show that the 1918 virus's genes are similar to those in current strains, indicating a direct lineage.\n\nAlso, the term \"Mother\" might imply that it's a common ancestor or that its genetic components are foundational in the evolution of later influenza viruses. The fact that they characterized the matrix, HA, and NA genes suggests that these genes have been conserved or have evolved from the 1918 version, contributing to the genetic makeup of modern viruses.\n\nI should check if the answer is in the provided context. The user mentioned the authors Reid et al. 2000, which is a study on the 1918 flu. Their work likely showed that the 1918 virus's genes are related to later strains. The answer would be that the 1918 virus's genetic components are present in modern influenza viruses, making it a progenitor. So, the 1918 virus is the mother because its genetic material",
      "retrieved_chunks": [
        "Title: 1918 Influenza: the Mother of All Pandemics\nPassage: Characterization of the 1918 \u201cSpanish\u201d influenza virus matrix gene",
        "Origin and evolution of the 1918 \u201cSpanish\u201d influenza virus hemagglutinin gene. Title: 1918 Influenza: the Mother of All Pandemics\nPassage: Characterization of the 1918 \u201cSpanish\u201d influenza virus neuraminidase gene.",
        "Title: 1918 Influenza: the Mother of All Pandemics\nPassage: Initial genetic characterization of the 1918 \u201cSpanish\u201d influenza virus. Title: 1918 Influenza: the Mother of All Pandemics\nPassage: 12.",
        "Reid AH, Fanning TG, Hultin JV, Taubenberger JK.",
        "Proc Natl Acad Sci U S A 2000;97:6785\u201390."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.5714285714285714,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4,
      "gt_utilization": 0.4,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 20,
      "dataset_id": "962",
      "question": "What is  the result of rAd5 trials?",
      "ground_truth_answer": "The provided context does not contain the specific result of rAd5 trials. The information given pertains to methods used in the study, such as statistical analysis, luciferase activity assays, PCR methods for creating recombinant constructs, transfection of cells, and verification of expressed target proteins. It does not mention the specific results of rAd5 trials.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the result of rAd5 trials. First, I need to check the provided context for any mention of rAd5. The context includes three passages, all with the same title about polyethylenimine's anti-radiation effect. \n\nLooking at the first passage: It talks about F2 and F3 using PCR methods resulting in Fa and Fb fragments. There's no mention of rAd5 here.\n\nThe second passage says the assays were repeated three times independently. Still no rAd5.\n\nThird passage mentions data expressed as mean \u00b1 SD and BCA Protein Assay kit. Also, linear regressions calculated with a statistical package. Again, no rAd5 mentioned.\n\nSince none of the provided passages refer to rAd5 trials, there's no information to answer the question. The answer should state that the context doesn't provide results for rAd5 trials.\n</think>\n\nThe provided context does not mention any trials or results related to \"rAd5.\" The passages focus on PCR methods, protein assays, and statistical analyses in the study of polyethylenimine's anti-radiation effects, but there is no information about \"rAd5\" trials. \n\nAnswer: The context does not provide information about the results of rAd5 trials.",
      "retrieved_chunks": [
        "Title: Anti-radiation damage effect of polyethylenimine as a toll-like receptor 5 targeted agonist\nPassage: F2 and F3 using PCR methods, respectively, resulting in Fa and Fb fragments.",
        "The assays were repeated three times independently.",
        "Title: Anti-radiation damage effect of polyethylenimine as a toll-like receptor 5 targeted agonist\nPassage: Data are expressed as mean \u00b1 SD .",
        "Title: Anti-radiation damage effect of polyethylenimine as a toll-like receptor 5 targeted agonist\nPassage: determined using BCA Protein Assay kit .",
        "Linear regressions were calculated using a statistical computer package, Number Cruncher Statistical Systems ."
      ],
      "computed_relevance": 0.0,
      "computed_utilization": 1.0,
      "computed_completeness": 0.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.0,
      "gt_utilization": 0.42857142857142855,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 21,
      "dataset_id": "152",
      "question": "What is the structure of the CD40 Ligand?",
      "ground_truth_answer": "The CD40 Ligand is a type II membrane glycoprotein with a sandwiched extracellular structure composed of a \u03b2-sheet, \u03b1-helix loop, and a \u03b2-sheet, allowing for trimerization. It is a member of the TNF superfamily and can form hetero-trimeric complexes.",
      "generated_response": "<think>\nOkay, let's tackle this question about the structure of the CD40 Ligand (CD40L) based on the provided context. First, I need to go through each passage carefully to extract relevant information.\n\nStarting with the first passage: It mentions \"hetero-trimeric complexes\" and that the ligand forms trimerization for receptor binding. The term \"trimeric\" suggests that the structure involves three subunits. Also, it says that the ligand binds to the receptor along three clefts formed by neighboring monomers in the trimer. So, trimerization is a key structural feature here.\n\nThe second and third passages (which are duplicates) provide more details. They state that CD40L is a type II membrane glycoprotein with a molecular weight of 32-39 kDa. It's part of the TNF superfamily. The structure is described as a \"sandwiched extracellular structure composed of a \u03b2-sheet, \u03b1-helix loop, and a \u03b2-sheet.\" This layered structure allows for trimerization, which is a common feature in the TNF family. The trimerization is important for receptor binding, as mentioned before.\n\nThe fourth passage again talks about hetero-trimeric complexes and receptor binding via three clefts. The fifth and sixth passages (also duplicates) mention that seven conserved residues form the trimer interface in the TNF domain, and six conserved receptor binding sites are mapped in the crCD40L sequence. This implies that the trimer interface and receptor binding sites are conserved, which is crucial for the ligand's function.\n\nPutting this all together: CD40L has a structure that includes a trimeric arrangement. Each monomer has a \u03b2-sheet, \u03b1-helix loop, and another \u03b2-sheet. The trimerization is essential for binding to the receptor, as the three clefts between the monomers interact with the receptor. The conserved residues in the trimer interface and receptor binding sites further support the structural importance of the trimeric form.\n\nSo, the answer should mention the trimeric structure, the components of each monomer (\u03b2-sheets and \u03b1-helix loop), and how the trimerization facilitates receptor binding through the clefts. Also, noting its membership in the TNF superfamily is relevant.\n</think>\n\nThe CD40 Ligand (CD40L) has a",
      "retrieved_chunks": [
        "Title: Identification and characterisation of the CD40-ligand of Sigmodon hispidus\nPassage: hetero-trimeric complexes and bind one elongated receptor molecule along each of three clefts formed by neighboring monomers of the trimer and ligand trimerization is for receptor binding .",
        "Title: Identification and characterisation of the CD40-ligand of Sigmodon hispidus\nPassage: CD40L plays a critical role in orchestrating immune responses against pathogens. Depending on the post-translational modification, the murine CD40L is a 32-39 kDa type II membrane glycoprotein that was initially identified as a surface marker exclusive to activated CD4 + T cells . It is a member of the TNF superfamily consisting of a sandwiched extracellular structure composed of a \u03b2-sheet, \u03b1-helix loop, and a \u03b2-sheet, allowing for the trimerization of CD40L, an additional feature of the TNF family of ligands . Since its initial discovery, CD40L has been shown to be not only expressed on CD4+ T cells, but\n\nTitle: Identification and characterisation of the CD40-ligand of Sigmodon hispidus\nPassage: CD40L plays a critical role in orchestrating immune responses against pathogens. Depending on the post-translational modification, the murine CD40L is a 32-39 kDa type II membrane glycoprotein that was initially identified as a surface marker exclusive to activated CD4 + T cells . It is a member of the TNF superfamily consisting of a sandwiched extracellular structure composed of a \u03b2-sheet, \u03b1-helix loop, and a \u03b2-sheet, allowing for the trimerization of CD40L, an additional feature of the TNF family of ligands . Since its initial discovery, CD40L has been shown to be not only expressed on CD4+ T cells, but\n\nTitle: Identification and characterisation of the CD40-ligand of Sigmodon hispidus\nPassage: hetero-trimeric complexes and bind one elongated receptor molecule along each of three clefts formed by neighboring monomers of the trimer and ligand trimerization is for receptor binding .",
        "All seven known conserved residues that constitute the trimer interface on the conserved TNF domain , were mapped to the putative crCD40L protein sequence. Additionally, all six known conserved receptor binding sites on the conserved TNF domain , were mapped to the crCD40L protein sequence.",
        "All seven known conserved residues that constitute the trimer interface on the conserved TNF domain , were mapped to the putative crCD40L protein sequence. Additionally, all six known conserved receptor binding sites on the conserved TNF domain , were mapped to the crCD40L protein sequence."
      ],
      "computed_relevance": 0.16666666666666666,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.3333333333333333,
      "gt_utilization": 0.16666666666666666,
      "gt_completeness": 0.5,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 22,
      "dataset_id": "1241",
      "question": "What is the basic reproduction number (R 0)?",
      "ground_truth_answer": "The basic reproduction number (R 0) is a widely used epidemiological measurement that represents the average number of secondary infections generated by a single primary case in a fully susceptible population. If R 0 > 1, then the disease can invade an otherwise susceptible population and persist, whereas if R 0 < 1, the disease cannot successfully invade and will die out. It is used to measure the transmission potential of a given population and is important for assessing the effectiveness of different intervention strategies in controlling the spread of diseases.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking for the definition of the basic reproduction number, R0. I need to look through the provided contexts to gather the key points.\n\nFirst, the first context mentions that R0 is the most widely used measure in epidemiology for transmission potential. It says that if R0 is greater than 1, the disease can spread, and if less than 1, it dies out. The definition here is the number of secondary infections from a primary case in a fully susceptible population.\n\nThe second context also talks about R0 as the average number of infections each case causes. It emphasizes the importance of estimating R0 for assessing interventions. They mention that R is the effective number which includes control measures, but R0 is the basic one without any controls.\n\nThird context reiterates that R0 is the average secondary cases from a primary case in a fully susceptible population. It also notes that R0 is used to determine immunization coverage thresholds. The fourth context adds that R0 being above 1 means the infection can spread, below 1 it dies out. Also, the note about the subscript 0 implying a fully susceptible population and no control measures.\n\nPutting this all together, the answer should define R0 as the average number of secondary infections produced by one case in a completely susceptible population with no interventions. Also, mention the threshold of 1 for spread vs. dying out. Need to make sure to include that R0 doesn't account for any control measures and is a baseline measure. Check if all contexts agree on the definition. Yes, they all align on these points. Avoid mentioning R (effective reproduction number) unless necessary, since the question is specifically about R0. Make the answer concise but cover all key aspects from the contexts.\n</think>\n\nThe basic reproduction number (R\u2080) is a fundamental concept in epidemiology that quantifies the transmission potential of an infectious disease. It is defined as the **average number of secondary infections** generated by a single primary case in a **fully susceptible population** with **no control measures** in place. \n\nKey points from the context:\n1. **Threshold behavior**: If R\u2080 > 1, the disease can spread and persist; if R\u2080 < 1, the disease will eventually die out.\n2. **Purpose**: R\u2080 is critical for assessing intervention strategies, determining immunization thresholds, and understanding disease dynamics.\n3. **Assumptions**: The subscript \"",
      "retrieved_chunks": [
        "Title: The Failure of R (0)\nPassage: The basic reproductive ratio-also known as the basic reproductive number, the basic reproduction number, the control reproduction number, or R 0 -is one of the foremost concepts in epidemiology . R 0 is the most widely used epidemiological measurement of the transmission potential in a given population . It is a measure of initial disease spread, such that if R 0 > 1, then the disease can invade an otherwise susceptible population and hence persist, whereas if R 0 < 1, the disease cannot successfully invade and will die out. The concept is defined as the number of secondary infections\n\nTitle: Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus\nPassage: Secondly, the R0, the basic reproduction number, is correctly described as the average number of infections each case causes.",
        "For this reason, estimating the basic reproduction number is paramount for assessing the effectiveness of different intervention strategies.",
        "R is the effectiive number and can include the impact of control measures.",
        "Title: Correcting the Actual Reproduction Number: A Simple Method to Estimate R(0) from Early Epidemic Growth Data\nPassage: The basic reproduction number, R 0 , of an infectious disease is the average number of secondary cases generated by a single primary case in a fully susceptible population . R 0 is the most widely used epidemiological measurement of the transmission potential in a given population. Statistical estimation of R 0 has been performed for various infectious diseases , aiming towards understanding the dynamics of transmission and evolution, and designing effective public health OPEN ACCESS intervention strategies. In particular, R 0 has been used for determining the minimum coverage of immunization, because the threshold condition to prevent a major\n\nTitle: Early real-time estimation of the basic reproduction number of emerging or reemerging infectious diseases in a community with heterogeneous contact pattern: Using data from Hong Kong 2009 H1N1 Pandemic Influenza as an illustrative example\nPassage: totally susceptible population . When R 0 is greater than one, there is a likelihood that the infection will to continue to spread; however if R 0 is less than one, then the infection will eventually die out.",
        "But it lacks two key ideas: 1) the 0 after the R implies the native state, which is a fully susceptible population and without any control measures."
      ],
      "computed_relevance": 0.6666666666666666,
      "computed_utilization": 0.5833333333333334,
      "computed_completeness": 0.875,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.4444444444444444,
      "gt_completeness": 0.8888888888888888,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 23,
      "dataset_id": "1533",
      "question": "What is a Hantavirus?",
      "ground_truth_answer": "A Hantavirus is a virus that is primarily transmitted by rodents through their urine, feces, and saliva, as well as the aerosols produced by them. It can cause severe pathologies in humans, such as hemorrhagic fever with renal syndrome and hantavirus cardiopulmonary syndrome.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is a Hantavirus?\" I need to base my answer on the provided context.\n\nFirst, I'll go through each of the given passages to gather relevant information. \n\nFrom the first context, I see that Hantavirus infections like Hantan and Seoul viruses cause hemorrhagic fever with renal syndrome, mainly affecting the kidneys in Asia. \n\nThe second passage mentions that Hantaviruses are zoonotic pathogens spread worldwide except Antarctica. They're transmitted mainly through rodent excreta aerosols, not through bites usually. It also notes increased infection rates in China and Europe, and that they cause two severe diseases: HFRS and HCPS.\n\nAnother part says they belong to the Bunyaviridae family but are exceptions because they're transmitted directly via aerosols without arthropod vectors. Only rodent-borne ones cause human diseases, even though other hosts like insectivores and bats have been found to carry them. They have a tri-segmented RNA genome.\n\nThe vaccines passage adds that outbreaks are linked to rodent population cycles and climate changes. The Americas passage reiterates the transmission method through aerosols from rodent waste.\n\nPutting this together, Hantavirus is a zoonotic RNA virus transmitted via rodent excreta, causing severe diseases in humans. They're part of Bunyaviridae, have a tri-segmented genome, and are found globally except Antarctica. The main diseases are HFRS and HCPS. Rodents are the primary hosts, and transmission isn't via arthropods. Recent outbreaks are tied to rodent population dynamics and climate.\n\nI need to make sure I include all key points: definition, transmission, hosts, diseases caused, genome structure, and factors affecting outbreaks. Avoid mentioning Antarctica since the first context says they're distributed worldwide except there. Also, note that while other animals carry them, only rodents transmit to humans. Make sure the answer is concise but covers all essential aspects.\n</think>\n\nHantavirus is a zoonotic RNA virus belonging to the Bunyaviridae family, primarily transmitted to humans through inhalation of aerosols contaminated with excreta (urine, feces, saliva) of infected rodents, though rare cases of transmission via bites occur. These viruses are distributed globally except in Antarctica and are known to cause two severe human diseases: **hemorrhagic fever with renal",
      "retrieved_chunks": [
        "In Asia, hantavirus infection by Hantan virus and Seoul virus targets mainly the human kidney and causes hemorrhagic fever with renal syndrome . In\n\nTitle: Complete Genome and Phylogeny of Puumala Hantavirus Isolates Circulating in France\nPassage: Hantaviruses are emerging zoonotic pathogens distributed worldwide except in Antarctica .",
        "Title: Vaccines and Therapeutics Against Hantaviruses\nPassage: Hantavirus is a virus transmitted mainly by rodent animals, mainly through urine, feces, and saliva and the aerosols produced by them, but rarely by the bites of infected animals . In recent years, the infection rate of hantavirus has increased in China and Europe . Hantavirus disease has turned out to be a newly identified but not a \"new\" disease in Germany .",
        "There is a long history of human co-existence with rodents, raising questions about the apparent recent increases in hantavirus-related illnesses, especially HCPS.",
        "They may cause two severe pathologies in humans: hemorrhagic fever with renal syndrome and hantavirus cardiopulmonary syndrome .",
        "Viruses of the genus Hantavirus are exceptions within the Bunyaviridae family, in being directly transmitted via aerosols ofsmall mammals excreta with no role for arthropod vectors . Although a growing diversity of hantaviruses has been discovered over the last decade in insectivores and bats , up to now, only rodent-borne hantaviruses have been shown at the origin of human diseases. Hantaviruses are small, enveloped viruses, possessing a tri-segmented RNA genome of\n\nTitle: Vaccines and Therapeutics Against Hantaviruses\nPassage: In recent years, the repeated outbreak of hantavirus disease has caused a serious threat to human health. The spread of hantavirus from natural hosts to humans is a natural ecological process; however, the outbreak of hantavirus is driven by striped field mouse population cycle dynamics and seasonal climate change . Title: Hantaviruses in the Americas and Their Role as Emerging Pathogens\nPassage: The main mechanism by which humans acquire hantavirus infection is by exposure to aerosols of contaminated rodent feces, urine, and saliva ."
      ],
      "computed_relevance": 0.5,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.65,
      "gt_utilization": 0.25,
      "gt_completeness": 0.38461538461538464,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 24,
      "dataset_id": "1031",
      "question": "How long is the protein Alpha-tubulin?",
      "ground_truth_answer": "The provided context doesn't contain information specifically about the length of the protein Alpha-tubulin. Therefore, it is not possible to determine the length of the protein Alpha-tubulin from the given passages.",
      "generated_response": "<think>\nOkay, let's see. The user is asking how long the protein Alpha-tubulin is. I need to look through the provided context to find any information related to the length of Alpha-tubulin.\n\nLooking at the first passage, it mentions PCR conditions but nothing about protein length. The second one talks about COPI protein and centrifugation, not relevant. The third passage is about proteasome inhibition and mentions a tubulin polymerization assay. Then there's a sentence about variations in protein length and mass, but it's not specific to Alpha-tubulin. The fourth passage describes a lysis buffer used to separate polymerized and soluble tubulin. \n\nWait, the third passage says: \"These findings suggest a tendency of recurrent duplications and/or insertions, as well as deletions evidenced by variations in the length and mass of protein ranging between approximately 25% and 4.62 fold, respectively.\" But this is about variations, not the actual length. \n\nThe fourth passage mentions the lysis buffer but again no specific length. The tubulin polymerization assay might involve Alpha-tubulin, but the context doesn't state its length. None of the passages directly mention the length of Alpha-tubulin. The user might be expecting a numerical answer, like in amino acids or molecular weight. Since the provided context doesn't have that info, maybe the answer is that it's not provided here. But I need to check again. \n\nWait, maybe the third passage's mention of variations in length and mass refers to Alpha-tubulin? But the passage is about proteasome inhibition in multiple myeloma cells. The tubulin polymerization assay is part of that. However, the variations mentioned are between 25% and 4.62 fold, but that's a range, not the actual length. Since there's no specific number given for Alpha-tubulin's length in any of the passages, the answer would be that the information isn't provided in the context.\n</think>\n\nThe provided context does not specify the exact length of the Alpha-tubulin protein. While the passages discuss tubulin-related experiments (e.g., polymerization assays, protein variations), they do not mention the specific length (e.g., in amino acids or molecular weight) of Alpha-tubulin. The reference to \"variations in the length and mass of protein\" in the third passage describes general experimental observations but does not pertain",
      "retrieved_chunks": [
        "Title: Small Glutamine-Rich Tetratricopeptide Repeat-Containing Protein Alpha (SGTA) Ablation Limits Offspring Viability and Growth in Mice\nPassage: of 92 \u00b0C for 1 min, 58 \u00b0C for 1 min and 72 \u00b0C for 2 min; followed by final elongation at 72 \u00b0C for 10 min.",
        "Title: Alpha-COPI Coatomer Protein Is Required for Rough Endoplasmic Reticulum Whorl Formation in Mosquito Midgut Epithelial Cells\nPassage: at 10000 rpm for 10 min at 4uC.",
        "Title: Quantitative Phosphoproteomics of Proteasome Inhibition in Multiple Myeloma Cells\nPassage: Tubulin polymerization assay was performed essentially as previously described .",
        "These findings suggest a tendency of recurrent duplications and/ or insertions, as well as deletions evidenced by variations in the length and mass of protein ranging between approximately 25% and 4.62 fold, respectively.",
        "To separate polymerized from soluble tubulin, the cells were all incubated at 37uC for 5 min in the dark in hypotonic lysis buffer containing 5 mM paclitaxel, 10 mM Trichostatin-A , 1 mM MgCl2, 2 mM EGTA, 0.5% Nonidet P-40, 2 mM phenylmethylsulfonyl fluoride, 200 units/ml aprotinin, 100 mg/ml soybean trypsin inhibitor, 5.0 mM e-amino caproic acid, 1 mM benzamidine, and 20 mM Tris-HCl, pH 6.8, vortexed vigorously and centrifuged at ,15,000 g at 22uC for\n\nTitle: Tollip or Not Tollip: What Are the Evolving Questions behind It?"
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.0,
      "gt_utilization": 0.0,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 25,
      "dataset_id": "721",
      "question": "What is the most common cause of viral gastroenteritis in children?",
      "ground_truth_answer": "The most common cause of viral gastroenteritis in children is rotavirus infection.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking for the most common cause of viral gastroenteritis in children. I need to look through the provided context to find the answer.\n\nFirst, I'll scan through each passage. The first context mentions astrovirus as an important cause, but the second passage under the title \"Viruses Causing Gastroenteritis...\" says that rotavirus is the most common cause among children. It also states that rotavirus accounts for about two million hospitalizations and a significant number of deaths in young children each year. Another part of the context even mentions that nearly all children have had a rotavirus infection by age five. \n\nWait, there's also a mention of astrovirus causing about 10% of sporadic diarrhea cases. But the key point here is that the question is about the most common cause. The passage clearly states that rotavirus is the most common, followed by astrovirus. The other viruses like norovirus are more associated with epidemics and adults. So the answer should be rotavirus.\n</think>\n\nThe most common cause of viral gastroenteritis in children is **rotavirus**. The context explicitly states that rotavirus is the leading cause, accounting for approximately two million hospitalizations and 350,000 to 600,000 deaths in young children annually. Additionally, nearly all children experience at least one rotavirus infection by age five, underscoring its prevalence. While astrovirus and norovirus are also mentioned as contributors, rotavirus is highlighted as the primary viral agent for this condition in children.",
      "retrieved_chunks": [
        "Astrovirus has been found by several studies to be an important cause of acute gastroenteritis in young children; a prevalence study in the United Kingdom found that over 70% of five year-olds had antibodies to the virus . Astrovirus has also been cited as an important cause of gastroenteritis in elderly populations . Title: Viruses Causing Gastroenteritis: The Known, The New and Those Beyond\nPassage: Text: The gastrointestinal tract is a vulnerable organ for infections as there is constant contact with the outside, mainly via the oral route. Inflammation of the stomach and the intestines can cause nausea, vomiting and diarrhea.",
        "Title: Viruses Causing Gastroenteritis: The Known, The New and Those Beyond\nPassage: Rotavirus infection is the most common cause of viral gastroenteritis among children; however, parents of infected children also often become ill and as a result rotavirus is the second most common cause of gastroenteritis in adults . Studies in human volunteers have shown that infection with rotavirus causes diarrhea, results in shedding of the virus and a rise in antibody anti-virus titer after infection . Additionally, astroviruses infections are common, accounting for about 10% of all sporadic diarrhea cases . Astrovirus has been isolated from diseased people, filtrated and administered to healthy individuals after which in some of the volunteers\n\nTitle: Incubation periods of viral gastroenteritis: a systematic review\nPassage: Caliciviruses, in particular noroviruses, are the most important cause of epidemic, non-bacterial gastroenteritis worldwide, affect both adults and children, and account for 40 to 50% of all foodborne gastroenteritis in the United States . Title: Incubation periods of viral gastroenteritis: a systematic review\nPassage: Acute viral gastroenteritis is an important and often unappreciated cause of morbidity and mortality worldwide.",
        "While bacterial and parasitic gastrointestinal infections are declining as a result of proper disposal of sewage and safe drinking water, viral gastroenteritis is not declining in developing",
        "Gastroenteritis is responsible for two to three million deaths each year, making it one of the most common causes of mortality .",
        "Nearly all children have experienced at least one rotavirus infection by age five. Rotavirus accounts for approximately two million hospitalizations and between 350,000 and 600,000 deaths in young children each year ."
      ],
      "computed_relevance": 0.15384615384615385,
      "computed_utilization": 0.23076923076923078,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.15789473684210525,
      "gt_utilization": 0.15789473684210525,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 26,
      "dataset_id": "517",
      "question": "What is Reunion Island?",
      "ground_truth_answer": "Reunion Island is a French overseas department located in the southwestern Indian Ocean, between Madagascar and Mauritius. It has a population of 850,000 and benefits from a healthcare system similar to mainland France.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Reunion Island?\" and they provided several contexts from different studies.\n\nFirst, I need to look through the passages to gather all the relevant information. The first context mentions that Reunion Island is a French overseas department in the southwestern Indian Ocean, 700 km east of Madagascar and 200 km southwest of Mauritius. Another passage refers to it as a French overseas territory with 850,000 inhabitants, located between Madagascar and Mauritius in the Indian Ocean. So, it's a French territory, which is important.\n\nThe second context talks about influenza activity during the austral winter and the vaccination campaigns starting in April. This gives a bit of info on their healthcare system and how it's similar to France's. Also, there's mention of direct flights to France despite the 9,300 km distance. The healthcare system is managed by the French Institute for Public Health Surveillance, similar to mainland France.\n\nAnother part mentions that during the pH1N1/2009 pandemic, the virus became predominant quickly, peaked in week 35, and ended by week 38. The healthcare system wasn't overwhelmed, which is a detail about their response to the pandemic.\n\nPutting this all together, Reunion Island is a French territory in the Indian Ocean, with a population of around 850,000. It's located between Madagascar and Mauritius. The healthcare system is similar to France's, and they have a surveillance system in place. The island has experienced influenza outbreaks, like the 2009 pandemic, but managed it without overwhelming their healthcare.\n\nI need to make sure the answer includes the location, status as a French territory, population, and maybe a bit about healthcare. Also, check if there's any other key info. The answer should be concise but cover all the main points from the contexts provided.\n</think>\n\nReunion Island is a French overseas territory located in the southern hemisphere, specifically in the Indian Ocean between Madagascar and Mauritius. It has a population of approximately 850,000 inhabitants and operates under a healthcare system similar to that of mainland France, with epidemiological surveillance managed by the French Institute for Public Health Surveillance. The island experiences seasonal influenza activity, with vaccination campaigns typically starting in April to align with austral winter conditions. Notably, during the 2009",
      "retrieved_chunks": [
        "Title: Pandemic Influenza Due to pH1N1/2009 Virus: Estimation of Infection Burden in Reunion Island through a Prospective Serosurvey, Austral Winter 2009\nPassage: Reunion Island is a French overseas department located in the southwestern Indian Ocean, 700 km east of Madagascar and 200 km southwest of Mauritius.",
        "Title: Etiology of Influenza-Like Illnesses from Sentinel Network Practitioners in R\u00e9union Island, 2011-2012\nPassage: R\u00e9union Island, a French overseas territory with 850,000 inhabitants, is located in the southern hemisphere between Madagascar and Mauritius in the Indian Ocean .",
        "Influenza activity generally increases during austral winter, corresponding to summer in Europe . Since 2011, influenza vaccination campaign in Reunion Island starts in April and the vaccine used corresponds to World Health Organization recommendations for the southern\n\nTitle: Etiology of Influenza-Like Illnesses from Sentinel Network Practitioners in R\u00e9union Island, 2011-2012\nPassage: Despite the distance of 9,300 km between R\u00e9union and France, the island is directly connected to Europe with four daily flights to France.",
        "The island benefits from a healthcare system similar to mainland France and epidemiological surveillance has been developed by the regional office of the French Institute for Public Health Surveillance , based on the surveillance system of mainland France .",
        "pH1N1/2009v became the predominant circulating influenza virus within four weeks of its first detection, its activity peaked during week 35 and ended at week 38 . Contrary to initial fears, the health care system was not overwhelmed, as morbidity and mortality rates were lower\n\nTitle: Pandemic Influenza Due to pH1N1/2009 Virus: Estimation of Infection Burden in Reunion Island through a Prospective Serosurvey, Austral Winter 2009\nPassage: the population of Reunion Island and a Chi2 test was used to analyse differences in age, sex and geographic location."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.7142857142857143,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.16666666666666666,
      "gt_utilization": 0.16666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 27,
      "dataset_id": "729",
      "question": "What changes do viruses make to be unrecognizable to previously neutralizing antibodies?",
      "ground_truth_answer": "Viruses can make changes such as accumulation of point mutations on immunodominant regions, glycosylation of functionally pivotal residues, or association with host serum components in order to be unrecognizable to previously neutralizing antibodies.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what changes viruses make to become unrecognizable to previously neutralizing antibodies. I need to look through the provided context to find the answer.\n\nFirst, looking at the first passage titled \"Neutralization Interfering Antibodies...\" It mentions that hypervariable viruses use several mechanisms. The most studied is the accumulation of point mutations in immunodominant regions of surface proteins. These mutations make the proteins unrecognizable by existing neutralizing antibodies. That's a key point.\n\nAnother part of the same passage talks about other escape mechanisms. They mention glycosylation of functionally important residues and association with host serum components to mask them. So glycosylation and masking with host components are other methods.\n\nThe second passage about EV71 vaccines says that viral proteins being folded differently affects epitope exposure. Different subgenogroups have varying exposure of neutralizing epitopes. So structural changes in protein folding could be another way.\n\nThe third passage about Coxsackievirus B3 discusses GAGs as receptors, but that might not directly relate to antibody recognition. The last passage about CoVs just mentions genome organization similarity, which isn't relevant here.\n\nPutting it all together, the main changes are point mutations in surface proteins, glycosylation of key residues, association with host serum to mask, and structural folding differences. The answer should list these mechanisms. The user wants the answer based on the context provided, so I need to make sure I'm not adding external knowledge. The first passage's point mutations and glycosylation are definitely the primary answers. The EV71 part adds protein folding as another factor. So the answer should include these three: point mutations, glycosylation, and structural changes in protein folding.\n</think>\n\nViruses make several changes to become unrecognizable to previously neutralizing antibodies. The most studied mechanism is the **accumulation of point mutations** in immunodominant regions of surface proteins, which alters their structure and prevents recognition by existing antibodies. Additionally, viruses may employ **glycosylation** of functionally critical residues or **mask these regions** by associating with host serum components. Structural differences in viral protein folding (e.g., among subgenogroups) can also affect the exposure of neutralizing epitopes, further evading antibody detection. These adaptations collectively reduce the effectiveness of humoral immune responses.",
      "retrieved_chunks": [
        "This, hence, would lead to the differences in the amount of universal neutralizing antibodies produced, translating to the different neutralizing capacity observed. Title: Neutralization Interfering Antibodies: A \u201cNovel\u201d Example of Humoral Immune Dysfunction Facilitating Viral Escape?",
        "Title: Neutralization Interfering Antibodies: A \u201cNovel\u201d Example of Humoral Immune Dysfunction Facilitating Viral Escape? Passage: Text: Hypervariable viruses adopt several mechanisms to cope with the host humoral immune response.",
        "The most studied mechanism is the accumulation of point mutations on immunodominant regions of surface proteins, making them no longer recognizable by previously generated neutralizing antibodies . Other escape mechanisms involving surface proteins include glycosylation of functionally pivotal residues or their association with host serum components in order to mask them from the immune system . Other known escape mechanisms are a sort of protected route of virus spreading, such as cell-to-cell transmission ; the molecular mimicry between viral proteins and host self-antigens or the viral-induced\n\nTitle: Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines\nPassage: With the viral proteins being folded differently, the degree of exposure of these neutralizing epitopes is different among the subgenogroups.",
        "Title: Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3\nPassage: Many viruses attach to cells by binding HS or other GAGs . For some viruses, GAGs are bona fide receptors. Other viruses have nonglycan proteinaceous receptors, but binding to GAGs can enhance attachment. GAGs most commonly interact with viral particles via positively charged amino acids such as lysine or arginine .",
        "Passage: The basic genome organization and replicative cycle is similar for all CoVs."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.10526315789473684,
      "gt_completeness": 0.5,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 28,
      "dataset_id": "1686",
      "question": "What strains were included in  this study?",
      "ground_truth_answer": "The strains included in this study were Detrick 1, Detrick 2, 1013, NRS-356, and the first seven BG strains listed in Table 1.",
      "generated_response": "<think>\nOkay, let's see. The user is asking what strains were included in this study. The context provided mentions \"the six test strains\" in part B. The passage also talks about the NRS-356 variant and the 1942 strain. Wait, the question is about the strains included.\n\nThe first part of the context says \"the strains sequenced for this study.\" Then part B refers to \"each of the six test strains as compared to the 1942 strain.\" So the 1942 strain is one, and there are six test strains. But the NRS-356 variant is mentioned as possibly being from Camp Detrick and returned to UW. Is NRS-356 one of the test strains?\n\nThe question is asking for all the strains included. The answer should include the 1942 strain and the six test strains. But the NRS-356 variant is mentioned as a variant in the study. Wait, maybe the six test strains include NRS-356? The passage says \"the NRS-356 variant in this study,\" so perhaps NRS-356 is one of the six test strains. The 1942 strain is the reference. So total strains would be the 1942 strain plus the six test strains, which include NRS-356. But the answer should list them as per the context. The context doesn't name the other five test strains, just mentions NRS-356. So the answer would be the 1942 strain and the six test strains, with NRS-356 being one of them. But the user wants the answer based on the provided context. Since the context doesn't list all six test strains by name, only NRS-356 is mentioned. So the answer should state that the study included the 1942 strain and six test strains, one of which is NRS-356. The other five are not specified here.\n</think>\n\nThe study included the 1942 strain and six test strains. One of the test strains is explicitly mentioned as the **NRS-356 variant**, while the identities of the remaining five test strains are not specified in the provided context.",
      "retrieved_chunks": [
        "globigii, a Historical Biowarfare Simulant\nPassage: the strains sequenced for this study.",
        "B) Most significant phenotypes for each of the six test strains as compared to the 1942 strain.",
        "Given the lack of original records, it is unclear whether the NRS-356 variant in this study might have passed through Camp Detrick and been returned to the University of Wisconsin.",
        "Two biological replicates of the experiment were conducted for each strain.",
        "Five representative viewing fields were counted from each strain for each experiment."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.4,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2222222222222222,
      "gt_utilization": 0.1111111111111111,
      "gt_completeness": 0.5,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 29,
      "dataset_id": "331",
      "question": "Which patients were excluded from the study?",
      "ground_truth_answer": "Patients excluded from the study were those who were unwilling or unable to give consent, under 18 yrs of age, pregnant, with advanced directive to withhold or withdraw life-sustaining treatment, admitted for palliative care only, and not eligible for enrolment. Additionally, studies in homogeneous PICU populations reporting diagnosis-related outcome in particular but not intensive care treatment, and studies evaluating mortality only, were also excluded.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking which patients were excluded from the study. The context provided includes multiple passages from different studies. I need to carefully read each one to identify the exclusion criteria mentioned.\n\nFirst, looking at the first passage about the GenOSept cohort study on community-acquired pneumonia in European ICUs. The exclusion criteria listed here are: patients or their legal representatives unwilling or unable to give consent, patients under 18 years old, pregnant patients, those with advanced directives to withhold life-sustaining treatment, and those admitted for palliative care only. That's a clear list from the first study.\n\nThen there's another passage titled \"Outcome of paediatric intensive care survivors.\" The exclusion here is about studies that focused on homogeneous PICU populations reporting diagnosis-related outcomes but not intensive care treatment, and studies that evaluated mortality only. However, this seems to be about excluding certain types of studies rather than patient criteria. The question is about patients excluded from the study, so maybe this part isn't relevant unless the user is referring to the same study. Wait, the user's question is about the GenOSept cohort study, given the titles provided. The second exclusion about microbiological protocols not being standardized is a limitation, not an exclusion criterion for patients.\n\nAnother passage mentions \"were not eligible for enrolment\" but doesn't specify the criteria. However, since the first passage clearly lists the exclusion criteria for the GenOSept study, that's the main source. The other passages might be from different studies, so I should focus on the first one. The answer should include the specific patient exclusions from the GenOSept study. Let me make sure I didn't miss any other exclusions there. The first passage's exclusion criteria are the key points here.\n</think>\n\nThe patients excluded from the GenOSept cohort study on community-acquired pneumonia in European intensive care units were:  \n1. Patients or their legal representatives unwilling or unable to provide consent.  \n2. Patients under 18 years of age.  \n3. Pregnant patients.  \n4. Patients with advanced directives to withhold or withdraw life-sustaining treatment.  \n5. Patients admitted for palliative care only.  \n\nThese criteria were explicitly stated in the study's exclusion guidelines. Other passages in the context refer to different studies or methodological limitations (e.g., non-standardized microbiological protocols, selection bias) and do not pertain to patient exclusion criteria for the",
      "retrieved_chunks": [
        "Title: Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort\nPassage: This study has two important limitations.",
        "Firstly participating centres were at liberty to decide which patients they would enrol; subjects were not, therefore, enrolled consecutively, thereby introducing a potential for selection bias. Also there was considerable variation in the number of patients recruited in each country and some centres contributed only small numbers of patients.",
        "Title: Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort\nPassage: Exclusion criteria were as follows: patient or legal representative unwilling or unable to give consent; patient under 18 yrs of age; patient pregnant; advanced directive to withhold or withdraw life-sustaining treatment or admitted for palliative care only . Title: Outcome of paediatric intensive care survivors\nPassage: Excluded were: studies in homogeneous PICU populations reporting diagnosis-related outcome in particular but not intensive care treatment as such, and studies evaluating mortality only.",
        "Secondly, microbiological protocols were not standardised.",
        "Title: Genetic diversity and molecular epidemiology of human rhinoviruses in South Africa\nPassage: were not eligible for enrolment."
      ],
      "computed_relevance": 0.14285714285714285,
      "computed_utilization": 0.42857142857142855,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.15384615384615385,
      "gt_utilization": 0.15384615384615385,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 30,
      "dataset_id": "1287",
      "question": "In addition to oral swabs, which tests detected the presence of 2019-nCOV virus?",
      "ground_truth_answer": "In addition to oral swabs, blood and anal swabs were used to detect the presence of 2019-nCoV virus.",
      "generated_response": "<think>\nOkay, let's see. The question is asking which tests, in addition to oral swabs, detected the presence of 2019-nCoV virus. I need to look through the provided context to find the answer.\n\nFirst, the context mentions that a shift from oral positive to anal swab positive was observed during late infection. So anal swabs are one. Then, in the first investigation, they tested blood, oral swabs, and anal swabs. They found viral RNA in anal swabs and blood. Wait, there's a title that says \"Detectable 2019-nCoV viral RNA in blood is a strong indicator...\" which suggests blood tests (qPCR) detected the virus. Also, they mention viral RNA in anal swabs. The passage also says they didn't collect stool samples but believe virus RNA exists there because of anal swab results. However, the question is about tests that detected the virus, so stool isn't mentioned as a test they did. Also, they mention viral antibodies in patients, so serological tests (IgM and IgG) are another method. But the question is about detecting the presence of the virus itself, not antibodies. So the direct detection methods would be anal swabs and blood tests (qPCR). The answer should include anal swabs and blood tests. Let me check again. The passage says they collected blood, oral, and anal swabs for qPCR. They found viral RNA in anal swabs and blood. So the answer is anal swabs and blood tests. Also, the context says they didn't collect sputum or bronchoalveolar lavage fluid, so those aren't part of the answer. The serological tests detect antibodies, not the virus directly. So the answer should be anal swabs and blood tests.\n</think>\n\nThe presence of 2019-nCoV virus was detected in **anal swabs** and **blood** (via qPCR) in addition to oral swabs. The study found viral RNA in anal swabs during late infection and detectable viral RNA in blood, which correlated with clinical severity. While serological tests (IgM and IgG) were recommended to confirm infection, they detect antibodies rather than the virus directly. Stool and respiratory samples (e.g., sputum, bronchoalveolar lavage fluid) were not collected in this study. \n\n**Answer:** Anal sw",
      "retrieved_chunks": [
        "A possible shift from oral positive during early infection to anal swab positive during late infection can be observed. This observation implied that we cannot discharge a patient purely based on oral swabs negative, who may still shed the virus by oral-fecal route. Above all, we strongly suggest using viral IgM and IgG serological test to confirm an infection, considering the unreliable results from oral swabs detection.",
        "Title: Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes\nPassage: Like SARS-CoV, 2019-nCoV induced pneumonia through respiratory tract by clinical observation. Therefore, the presence of viral antigen in oral swabs was used as detection standard for 2019-nCoV. Similarly, two times of oral swabs negative in a 24-h interval was considered as viral clearance by patients officially. Title: Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes\nPassage: In the first investigation, we aimed to test whether viral positive can be found in anal swab and blood as well as oral swabs. We conducted a molecular investigation to patients in Wuhan pulmonary hospital, who were detected as oral swabs positive for 2019-nCoV upon admission. We collected blood, oral swabs and anal swabs for 2019-nCoV qPCR test using previously established method . Title: Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity\nPassage: Unfortunately, in our study, we did not collect stool samples from patients and did not pursue viral RNA in the stool. But we believe the existence of virus RNA in the stool samples from these patients because that a large amount of viral RNA was detected in anal swabs and that viral RNA had also been detected in a case reported from the United States .",
        "Also, we didn't collect sputum and bronchoalveolar lavage fluid for virus detection because that the dry coughing characteristic of patients infected with 2019-nCoV prevents producing enough amount of sputum and that bronchoalveolar lavage fluid\n\nTitle: Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes\nPassage: through routine surveillance, and thus pose a threat to other people. In contrast, we found viral antibodies in near all patients, indicating serology should be considered for 2019-nCoV epidemiology."
      ],
      "computed_relevance": 0.46153846153846156,
      "computed_utilization": 0.46153846153846156,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.3333333333333333,
      "gt_utilization": 0.2777777777777778,
      "gt_completeness": 0.8333333333333334,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 31,
      "dataset_id": "543",
      "question": "How many people were affected as of Feb. 10, 2020?",
      "ground_truth_answer": "The given pieces of context do not provide information on the number of people affected as of Feb. 10, 2020. Therefore, we cannot answer the question based on the provided context. We would need additional information to determine the number of people affected as of that specific date.",
      "generated_response": "<think>\nOkay, let's see. The user is asking how many people were affected as of February 10, 2020. The context provided includes several passages from a document titled \"Estimating the number of infections and the impact of non-\" which probably refers to non-pharmaceutical interventions. \n\nLooking at the passages, the first one mentions that interventions in 11 countries averted 59,000 deaths up to March 31. The other passages talk about specific measures like banning gatherings of more than 5 people starting October 3, 2020, and school closures ordered on March 14, 2020. There's also a mention of no in-person teaching until April 4, 2020.\n\nThe question is about February 10, 2020. The earliest date mentioned in the context is October 3, 2020, which is after February 10. The other dates are in March 2020. Since the user is asking about February 10, which is before any of the dates provided in the context, there's no information given about interventions or affected people prior to March 2020. The 59,000 deaths averted up to March 31 would be after February 10, but that's about deaths averted, not the number of people affected at that time.\n\nThe answer probably is that there's no data provided in the context for February 10, 2020. The user might be expecting a number, but since the earliest measures are in March, the answer would be that the context doesn't include information from that date.\n</think>\n\nThe provided context does not include any data or estimates related to the number of people affected as of February 10, 2020. The earliest interventions mentioned in the context (e.g., school closures, gathering bans) occurred in March 2020, and the death averted estimate (59,000) covers up to March 31, 2020. No specific information is available for February 10, 2020, in the given passages. \n\nAnswer: The context does not provide information on the number of people affected as of February 10, 2020.",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: estimate that interventions across all 11 countries will have averted 59,000 deaths up to 31 March\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Banning of gatherings of more than 5 people.21 10/3/2020\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: ordered No in person teaching until 4th of April.52 14/3/2020\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: ordered Nationwide school closures.23 14/3/2020"
      ],
      "computed_relevance": 0.0,
      "computed_utilization": 1.0,
      "computed_completeness": 0.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.0,
      "gt_utilization": 0.0,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 32,
      "dataset_id": "1069",
      "question": "How many genotypes of CHIKV have been isilated?",
      "ground_truth_answer": "Three genotypes of CHIKV have been isolated: Asian, East/Central/South African, and West African.",
      "generated_response": "<think>\nOkay, let's see. The question is asking how many genotypes of CHIKV have been isolated. I need to look through the provided context to find the answer.\n\nFirst, in the first passage under the first context, it says, \"CHIKV has been isolated into three genotypes based on phylogenetic studies.\" That seems like a direct answer. Then later, in the same context, there's a mention of the Asian genotype and the West and East African genotypes diverging. Wait, the exact wording is: \"the Asian genotype of CHIKV emerged between 50 and 310 y ago, and the West and East African genotypes diverged between 100 and 840 y ago.\" So that's three genotypes: Asian, West African, and East African. But the first sentence mentions three genotypes, so that matches. \n\nLooking at the second passage, the title is about genome-wide analysis of codon usage in Chikungunya viruses. The passage mentions that they analyzed 141 isolates, but the key part here is the third passage's title and content. The third passage's title is \"Chikungunya Virus Fidelity Variants...\" and in the passage, it says, \"These genotypes, based on the gene sequences of an Envelope protein, are Asian, East/Central/South African, and West African.\" So here, they list three genotypes again: Asian, East/Central/South African, and West African. \n\nWait, the first context mentions three genotypes, and the third passage also lists three. So combining that information, the answer should be three. The user is asking how many genotypes have been isolated, and the context clearly states three different genotypes. The answer is three.\n</think>\n\nThe context states that CHIKV has been isolated into three genotypes based on phylogenetic studies and gene sequences of the Envelope protein. These genotypes are explicitly listed as **Asian**, **East/Central/South African**, and **West African**. \n\n**Answer:** Three genotypes of CHIKV have been isolated.",
      "retrieved_chunks": [
        "Passage: CHIKV has been isolated into three genotypes based on phylogenetic studies.",
        "Comparing mutant spectra of CHIKV isolates from ankles by specific nucleotide substitution frequencies, the only significant differences from the WT were greater frequencies of A\u03feC and G\u03feU substitutions in LoFi CHIKV populations .",
        "estimate that the Asian genotype of CHIKV emerged between 50 and 310 y ago, and the West and East African genotypes diverged between 100 and 840 y ago . Since then, CHIKV has come a long way, with several mutations incorporated, and has continued to wreak epidemics in several regions. Recent activities of CHIKV include the Indian epidemic in 2005-2006, which was\n\nTitle: Genome-Wide Analysis of Codon Usage and Influencing Factors in Chikungunya Viruses\nPassage: The complete genome sequences of 141 CHIKV isolates were obtained from the National Center for Biotechnology GenBank database . The accession numbers and other detailed information of the selected CHIKVs' genomes, such as isolation date, isolation place, host and genome size were also retrieved . Title: Chikungunya Virus Fidelity Variants Exhibit Differential Attenuation and Population Diversity in Cell Culture and Adult Mice\nPassage: preinoculation.",
        "Adult mouse viremia titers were determined by qRT-PCR of CHIKV RNA in whole blood.",
        "These genotypes, based on the gene sequences of an Envelope protein , are Asian, East/Central/ South African, and West African ."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.2222222222222222,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.09523809523809523,
      "gt_utilization": 0.09523809523809523,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 33,
      "dataset_id": "740",
      "question": "What is the regularity of the virion major coat protein lattice useful for?",
      "ground_truth_answer": "The regularity of the virion major coat protein lattice is useful for the development of an ELISA for testing specific antibodies of clinical pig serum, and it is a valuable tool to monitor the prevalence of the PCV3 virus.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the regularity of the virion major coat protein lattice and its usefulness. From the context provided, I need to figure out what the regularity refers to and how it's applied.\n\nFirst, the context mentions that PCV3's capsid protein can self-assemble into virus-like particles (VLPs), similar to PCV2. The passage talks about the application of these VLPs in detecting antibodies. The key points here are self-assembly into VLPs and their use in antibody detection.\n\nThe question is about the \"regularity of the virion major coat protein lattice.\" The term \"regularity\" here probably refers to the structured, repeating arrangement of the coat proteins in the viral particle. In viruses, the capsid proteins arrange in a regular, symmetrical pattern to form the viral structure. This regularity is important because it allows the proteins to self-assemble correctly into the virus-like particles without genetic material.\n\nLooking at the context, the VLPs are made of structural proteins (like the Cap protein from ORF2 in PCV3) that self-assemble. The regular lattice structure would be essential for the proper formation of these VLPs. Since VLPs are used in the ELISA test mentioned, their regular structure ensures consistency and effectiveness in binding antibodies, making the test specific and sensitive.\n\nSo, the regularity of the coat protein lattice is useful for the self-assembly into VLPs, which in turn are used for applications like antibody detection. The structured arrangement allows the proteins to come together correctly, forming particles that mimic the real virus but lack genetic material, making them safe for use in diagnostics.\n</think>\n\nThe regularity of the virion major coat protein lattice is useful for **self-assembly into virus-like particles (VLPs)**. This structural organization allows recombinant capsid proteins (such as the immunogenic Cap protein of PCV3) to form stable, uniform VLPs without genetic material. These VLPs retain the antigenic properties of the native virus, enabling their application in **antibody detection** (e.g., in ELISA assays) and serving as tools for studying viral morphology, prevalence, and immune responses. The lattice's consistency ensures reproducibility and specificity in diagnostic and research applications. \n\n**Answer:** The regularity of the virion major coat protein lattice is useful for self-assembly into",
      "retrieved_chunks": [
        "In recent years, the technology of expressing capsid protein\n\nTitle: Self-assembly into virus\u2013like particles of the recombinant capsid protein of porcine circovirus type 3 and its application on antibodies detection\nPassage: of PCV2 and self-assembly into virus-like particles has advanced, and can be used in multiple recombinant protein expression systems including baculovirus, yeast and E.",
        "Whether the idea of forming recombinant Cap into VLPs is equally applicable to PCV3 is the main purpose in our research. Title: Self-assembly into virus\u2013like particles of the recombinant capsid protein of porcine circovirus type 3 and its application on antibodies detection\nPassage: In conclusion, this is the first report of the ability of PCV3 VLPs to self-assemble which were successfully expressed in E.",
        "Similar to PCV2, there are two major open reading frames , ORF1 and ORF2, in PCV3 genome. ORF2 encode the immunogenic Cap which is the sole structural protein of the viral coat .",
        "Title: Self-assembly into virus\u2013like particles of the recombinant capsid protein of porcine circovirus type 3 and its application on antibodies detection\nPassage: of factors including storage conditions as well as the process design also influence the characteristics of VLPs . 10 nm particles can be used as a preliminary evaluation standard before the real virus morphology of PCV3 is discovered. Title: Self-assembly into virus\u2013like particles of the recombinant capsid protein of porcine circovirus type 3 and its application on antibodies detection\nPassage: VLPs, composed of viral structural proteins without genetic materials, are self-assembled macromolecules.",
        "The VLP ELISA was highly specific, sensitive and reproducible, it is a valuable tool to monitor the prevalence of the PCV3 virus. The invention of virus-like particles will play a significant role in providing a new tool for the study of PCV3."
      ],
      "computed_relevance": 0.3,
      "computed_utilization": 0.3,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.3157894736842105,
      "gt_utilization": 0.10526315789473684,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 34,
      "dataset_id": "1077",
      "question": "What are exhibited in the two phases?",
      "ground_truth_answer": "The RNA is exhibited in the bottom, complex-enriched phase in one of the two phases.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What are exhibited in the two phases?\" based on the provided context. Let me start by reviewing the context carefully.\n\nFirst, the title mentions \"Rapid RNA Exchange in Aqueous Two-Phase System and Coacervate Droplets.\" The passages describe experiments involving RNA labeled with 5\u2032-6-FAM, coacervate samples, and changes in phase separation with salt concentration. \n\nLooking at the first passage: it says that coacervate samples with RNA are in a two-phase system where RNA is in the bottom, complex-enriched phase. The second passage talks about increasing salt concentrations disrupting charge interactions between pLys and ATP, leading the system to become a one-phase system again. The third passage mentions imaging done with FIJI, but that's probably less relevant here.\n\nThe key here is understanding what the two phases are. The first passage explicitly states that the system separates into two phases with RNA in the bottom phase. The second passage mentions that at higher salt concentrations, the system tends to become one phase. So, the two phases are likely the complex-enriched phase (where RNA is concentrated) and the other phase, which might be the aqueous phase without the complexes. \n\nThe question is asking what is exhibited in the two phases. The answer should be the RNA in the complex-enriched phase and the other components in the aqueous phase. But the context specifically mentions RNA being in the bottom phase. The first passage says \"the system clearly separates into two phases with the RNA in the bottom, complex-enriched phase.\" So the two phases are the complex-enriched phase (containing RNA) and the other phase. \n\nWait, the answer might be that the two phases are the complex-enriched phase (with RNA) and the bulk aqueous solution. The second passage also mentions \"complex-enriched droplets in bulk aqueous solution,\" which supports that. So the two phases are the complex-enriched phase (containing RNA) and the aqueous phase. Therefore, the two phases exhibit the RNA in the complex-enriched phase and the other components in the aqueous phase. \n\nBut the question is phrased as \"What are exhibited in the two phases?\" So the answer should be the RNA in the complex-enriched phase and the other phase. The first passage says RNA is in the bottom",
      "retrieved_chunks": [
        "Title: Rapid RNA Exchange in Aqueous Two-Phase System and Coacervate Droplets\nPassage: to be:\n\nTitle: Rapid RNA Exchange in Aqueous Two-Phase System and Coacervate Droplets\nPassage: coacervate samples with 5 \u00b5M 5\u2032-6-FAM-labeled RNA 15-mer at room temperature in 100 mM Tris-Cl pH 8. On the left, the system clearly separates into two phases with the RNA in the bottom, complex-enriched phase.",
        "At increasing salt concentrations, the charge interactions between the pLys and ATP are disrupted and the system starts to tend towards a one-phase system again.",
        "Title: Rapid RNA Exchange in Aqueous Two-Phase System and Coacervate Droplets\nPassage: the corners with Valap, and evaporation was allowed to occur through the edges over several hours.",
        "On the right, the system is composed of small, dispersed complex-enriched droplets in bulk aqueous solution and resulted in a turbid solution.",
        "Title: Rapid RNA Exchange in Aqueous Two-Phase System and Coacervate Droplets\nPassage: All imaging visualization, analysis, calculations, and production of movies were performed using FIJI ."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.3333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.13333333333333333,
      "gt_utilization": 0.06666666666666667,
      "gt_completeness": 0.5,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 35,
      "dataset_id": "1649",
      "question": "Which virus samples  from the 1918 swine flu pandemic have been identified?",
      "ground_truth_answer": "The H1N1 virus samples from the 1918 swine flu pandemic have been identified.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking which virus samples from the 1918 swine flu pandemic have been identified. I need to look through the provided context to find the relevant information.\n\nFirst, looking at the first passage: It mentions that the low uracil content of the 1918 virus doesn't rule out a pandemic virus circulating in pigs before humans. Then there's a part about Richard Shope isolating the first influenza virus from pigs in 1931. Then two years later, the H1N1 virus was isolated from humans. Also, it says that sera from humans infected with the 1918 virus could neutralize the swine virus. \n\nAnother passage talks about the simultaneous outbreaks in humans and pigs in 1918, suggesting human-to-swine transmission was more likely. Then there's a part about sequence data from the earliest human samples of 1918 H1N1 viruses indicating they have avian-like segments. Also, a reconstructed 1918 virus from Alaskan permafrost showed avian origins.\n\nSo the key points here are that the 1918 pandemic virus (H1N1) was later found in pigs, and they could neutralize each other. The samples identified would be the H1N1 virus from humans and the swine virus. But the question is specifically about the 1918 swine flu pandemic samples. The passage mentions that the H1N1 was isolated from humans in 1933 (two years after Shope's 1931 swine isolation). However, the actual 1918 samples from swine might not have been directly isolated until later. The sera from 1918 humans neutralizing the swine virus suggests that the swine virus is related to the 1918 human virus. Also, the reconstructed virus from Alaskan permafrost is the 1918 human virus, which has avian origins. \n\nSo the answer would be that the H1N1 virus samples from the 1918 pandemic have been identified, both in humans and in swine. The swine virus was isolated later (1931), but it's related to the 1918 human virus. The key sample is the H1N1 from humans, and the swine virus that's",
      "retrieved_chunks": [
        "The low uracil content of the 1918 virus does not preclude the possibility that a pandemic virus circulated in pigs briefly before transmitting to humans, but it\n\nTitle: Origins of the 1918 Pandemic: Revisiting the Swine \u201cMixing Vessel\u201d Hypothesis\nPassage: coincidence if not suggesting a close relation between the two conditions\" . Confirmation that influenza was circulating in US swine was achieved in 1931 when Richard Shope isolated the first influenza virus from pigs .",
        "Two years later, the H1N1 virus was isolated from humans . It was later demonstrated that sera from humans infected with the 1918 pandemic virus could neutralize the swine virus . Title: 1918 Influenza: the Mother of All Pandemics\nPassage: Because the only 1918 pandemic Virus samples we have\n\nTitle: Origins of the 1918 Pandemic: Revisiting the Swine \u201cMixing Vessel\u201d Hypothesis\nPassage: The simultaneous outbreaks of influenza in humans and pigs during the 1918 pandemic naturally raised questions about whether the virus had transmitted from pigs to humans, or humans to pigs. At the time, Koen noted that the flu outbreaks appeared to represent a novel disease in pigs, whereas humans had a long history of influenza pandemics, which suggested that humanto-swine transmission was more likely.",
        "Title: Origins of the 1918 Pandemic: Revisiting the Swine \u201cMixing Vessel\u201d Hypothesis\nPassage: The low availability of sequence data from influenza viruses circulating in humans, swine, or birds at the time of the 1918, 1957, or 1968 pandemics makes it difficult to conclusively rule out a role for swine.",
        "However, the sequence data available from the earliest human samples of 1918 H1N1 viruses, 1957 H2N2 viruses, and 1968 H3N2 viruses indicate that all 3 pandemic viruses have segments almost entirely avianlike in their nucleotide composition .",
        "Almost a century later, the reconstruction of a 1918 virus from human tissues preserved in Alaskan permafrost and autopsy blocks indicated that the virus's genes appeared to have avian origins ."
      ],
      "computed_relevance": 0.4444444444444444,
      "computed_utilization": 0.6666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.3125,
      "gt_utilization": 0.1875,
      "gt_completeness": 0.6,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 36,
      "dataset_id": "1449",
      "question": "What are both IFV and RSV infections shown to do?",
      "ground_truth_answer": "Both IFV and RSV infections are shown to trigger cytokine responses and affect immune responses.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what both IFV and RSV infections are shown to do, based on the provided context. First, I need to recall what the context says about these viruses.\n\nLooking at the passages, there's a lot about RSV and its interaction with RLRs (RIG-I-like receptors), TLR3, and cytokine responses. The titles mention Leukemia inhibitory factor (LIF) protecting the lung during RSV infection. There's also mention of cytokines like MIF, LIF, etc., being expressed during RSV. The context also talks about RSV inducing RLRs and the regulation through RIG-I and MDA5. \n\nNow, the question is about both IFV and RSV. Wait, the context doesn't mention IFV (Influenza Virus) directly. The only mention of IFV might be in the part where it says \"the decrease in type I IFN by prior vaccination may reduce its potential adverse effect of increasing the susceptibility to secondary bacterial infections.\" But that's in the context of RSV. Also, there's a line about the generalizability being limited by the lack of a model for influenza and RSV superinfection. \n\nSo, the context is mainly about RSV. The user is asking about both IFV and RSV. Since the context doesn't discuss IFV's specific mechanisms, maybe the answer is about something they both do. The only common point might be related to the immune response pathways. The passage mentions that RLRs and Trif signaling pathways are important in RSV. If IFV also uses similar pathways, maybe that's the answer. \n\nWait, the question is \"What are both IFV and RSV infections shown to do?\" The context doesn't explicitly state what IFV does. However, in the last paragraph, there's a mention of influenza and RSV superinfection, implying that both viruses can co-infect. But the context's main focus is RSV. The answer might be inferred from the part where it says \"the decrease in type I IFN by prior vaccination may reduce its potential adverse effect of increasing the susceptibility to secondary bacterial infections.\" This suggests that both viruses might cause increased susceptibility to secondary infections when type I IFN is reduced. However, the context doesn't directly state that both IFV and RSV do this. Alternatively, maybe they both induce R",
      "retrieved_chunks": [
        "as compared to challenge with RSV .",
        "Title: Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection\nPassage: which may allow RSV to induce RLRs. Our study observed early cytokine responses following RSV infection and identified a pronounced RIG-I response, which could be lost over time following NS1 or NS2 binding to RIG-I/ MDA5 as reported by others . Also, RSV induction of TLR3 is regulated by RIG-I-dependent IFN-\u03b2 secretions from infected epithelial cells, which is mediated by both IFN response-stimulated element and signal transducer and activator of transcription sites in its proximal promoter . Therefore there are multiple levels of RLRs regulation in RSV infections that can both trigger RLRs responses or subsequently adapt to block RLR-mediated\n\nTitle: Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection\nPassage: To our knowledge, these findings represent the first evidence that MIF, LIF, CTAK/CCL27, SDF-1\u03b1/CXCL12, SCGF-\u03b2 and SCF are expressed during an RSV infection and LIF signaling is critical to prevent lung damage. Others and we demonstrate that a spectrum of cytokines is released to counter RSV infection 34 ] but further analysis is required to determine the role of these immune responses in RSV pathology. The results of this study demonstrate that RLRs and Trif signaling pathways play major roles in the immune response to RSV infection for both inflammation induction and resolution.",
        "when compared to the levels observed following RSV challenge .",
        "For instance, the decrease in type I IFN by prior vaccination may reduce its potential adverse effect of increasing the susceptibility to secondary bacterial infections .",
        "The generalizability of these findings are limited, however, by the lack of a relevant animal model for influenza and RSV superinfection."
      ],
      "computed_relevance": 0.1,
      "computed_utilization": 1.0,
      "computed_completeness": 0.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.47619047619047616,
      "gt_utilization": 0.2857142857142857,
      "gt_completeness": 0.6,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 37,
      "dataset_id": "303",
      "question": "What statistical tests were used to compare categorical variables?",
      "ground_truth_answer": "The statistical tests used to compare categorical variables were the Chi-square test and the Fisher exact test.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking which statistical tests were used to compare categorical variables based on the provided context.\n\nFirst, I need to look through the context given. The context mentions that Chi-square tests were used to compare frequencies of demographic and other categorical variables across three waves. Then, in the passage, it says that for categorical data, the Chi-square test was used to compare distributions. Additionally, it mentions that Chi-squared analysis and Fisher exact test were used for categorical variables with powder contamination.\n\nSo, putting this together, the main tests mentioned for categorical variables are the Chi-square test and the Fisher exact test. The Chi-square is mentioned in both the context and the passage, and the Fisher exact test is specifically noted in the passage when dealing with powder contamination. The question is about categorical variables in general, so both tests should be included in the answer. The other tests like t-tests and Wilcoxon are for continuous variables, so they can be ignored here. The answer should list Chi-square and Fisher exact tests.\n</think>\n\nThe statistical tests used to compare categorical variables were the **Chi-square test** and the **Fisher exact test**. The Chi-square test was applied for general comparisons of categorical data, while the Fisher exact test was specifically used for categorical variables related to powder contamination.",
      "retrieved_chunks": [
        "Chi-square tests were used to compare frequencies of demographic and other categorical variables for the three waves.",
        "We used t tests to compare continuous variables.",
        "Non-parametric tests, including the Wilcoxon and Kruskal Wallis tests were used to compare continuous variables such as age and time between illness onset and other dates of interest.",
        "Title: A method of processing nasopharyngeal swabs to enable multiple testing\nPassage: For categorical data we used the Chi-square test to compare distributions.",
        "Chi-squared analysis and Fisher exact test were used to compare categorical variables with powder contamination."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.6,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.19047619047619047,
      "gt_utilization": 0.19047619047619047,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 38,
      "dataset_id": "834",
      "question": "What is the the primary means for diagnosing the new virus strain?",
      "ground_truth_answer": "The primary means for diagnosing the new virus strain is real time RT-PCR (reverse transcriptase-polymerase chain reaction).",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the primary means for diagnosing the new virus strain, which I assume is 2019-nCoV based on the first context. Let me look through the provided passages to find the answer.\n\nIn the first context, the title mentions \"Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.\" The passage states, \"With the emergence of 2019-nCoV, real time RT-PCR remains the primary means for diagnosing the new virus strain...\" So that's a direct statement. \n\nLooking at the other contexts about influenza, they also mention real-time RT-PCR as a reliable method, especially comparing it to other tests like viral culture or antigen tests. But the question specifically refers to the \"new virus strain,\" which in the contexts is 2019-nCoV. The first passage clearly says real time RT-PCR is the primary method for that. \n\nI need to make sure there's no conflicting information. The other passages about influenza support RT-PCR as a primary method but are about different viruses. The answer should be real time RT-PCR. Let me check again. Yes, the first passage explicitly states that for 2019-nCoV, real time RT-PCR is the primary means. The other contexts back up RT-PCR's effectiveness but aren't about the coronavirus. So the answer is real time RT-PCR.\n</think>\n\nThe primary means for diagnosing the new virus strain (2019-nCoV) is **real-time reverse transcriptase-polymerase chain reaction (RT-PCR)**. This is explicitly stated in the first context, which highlights that \"real time RT-PCR remains the primary means for diagnosing the new virus strain\" among available diagnostic platforms. The other contexts further corroborate the reliability and specificity of RT-PCR for viral detection, though they focus on influenza viruses. For 2019-nCoV, the passage directly links RT-PCR to its role as the primary diagnostic method. \n\n**Answer:** Real-time RT-PCR is the primary means for diagnosing the new virus strain.",
      "retrieved_chunks": [
        "Title: Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review\nPassage: With the emergence of 2019-nCoV, real time RT-PCR remains the primary means for diagnosing the new virus strain among the many diagnostic platforms available ; Table S3 ). Among the 16 diagnostics studies selected, one study discussed the use of RT-PCR in diagnosing patients with 2019-nCoV . The period and type of specimen collected for RT-PCR play an important role in the diagnosis of 2019-nCoV.",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: The real-time reverse transcriptase-polymerase chain reaction Swine Flu Panel for detection of pandemic H1N1 influenza, developed by the Centers for Disease Control and Prevention and distributed to many laboratories in US and worldwide, is a reliable and timely method of diagnosing the pandemic strain . The viral culture, while the gold standard in influenza diagnostics, takes several days before the results are known . The direct fluorescent antigen influenza test was recently reported to have a sensitivity of 93% compared with the rRT-PCR , but the test requires considerable technical expertise in addition to a fluorescent microscope.",
        "It was found that the respiratory specimens were positive for the virus while serum was negative in the early period. It has also suggested that in the early days of illness, patients have high levels\n\nTitle: Diagnosis of influenza viruses with special reference to novel H1N1 2009 influenza virus\nPassage: A number of different laboratory diagnostic tests can be used for detecting the presence of novel H1N1 infl uenza virus in respiratory specimens, including direct antigen detection tests, virus isolation in cell culture, or detection of infl uenza-specifi c RNA by real-time reverse transcriptasepolymerase chain reaction . Title: Diagnosis of influenza viruses with special reference to novel H1N1 2009 influenza virus\nPassage: of infl uenza virus genome have advantages over other methods and provide sensitive, highly specifi c and rapid diagnosis. The realtime RT-PCR should be the method of choice and both in-house developed and CDC-developed real-time PCR assays can be used for the specifi c detection of novel H1N1 2009 infl uenza virus.",
        "The commonly used"
      ],
      "computed_relevance": 0.09090909090909091,
      "computed_utilization": 0.09090909090909091,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.1875,
      "gt_utilization": 0.125,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 39,
      "dataset_id": "848",
      "question": "What was the performance of the vaccine candidates?",
      "ground_truth_answer": "The vaccine candidates demonstrated acceptable safety profiles and induced immune responses in a significant percentage of participants, with some variability in response rates and durability depending on the vaccine and dosage. Some participants also experienced side effects such as fever and arthritis after vaccination.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the performance of the vaccine candidates based on the provided context. Let me go through each passage carefully.\n\nFirst, the first passage mentions that all candidate vaccines for EVD (Ebola Virus Disease) that went into Phase I studies after the 2013-2016 outbreak had acceptable safety profiles. The next step was to look at the magnitude and characteristics of the immune response they induced. So, safety was good, and then they focused on immunity.\n\nThe second passage talks about a trial where 100% of the high-dose group developed antibody responses against the Zaire glycoprotein, while 90% in another group (maybe lower dose?) had responses. Also, the immunity was maintained in 79% up to week 60. That suggests the vaccine induced strong and lasting immunity, especially at higher doses.\n\nThe third passage mentions that 22% of participants had fever after vaccination, which is higher than the 8% with another vaccine (ChAd3). Fever is a concern because Ebola itself causes fever, so a vaccine causing fever might complicate diagnosis during an outbreak. So, while the vaccines are safe and induce good immunity, the fever side effect is a consideration.\n\nPutting this together, the performance of the vaccine candidates was good in terms of safety and immune response. High-dose groups showed strong antibody responses, and immunity lasted. However, there was a higher incidence of fever compared to another vaccine, which is a drawback when considering use in outbreaks where fever is a symptom. The answer should highlight both the positive aspects (safety, immune response) and the concern (fever).\n</think>\n\nThe performance of the Ebola virus disease (EVD) vaccine candidates, based on the provided context, can be summarized as follows:  \n\n1. **Safety**: All candidates demonstrated **acceptable safety profiles** in Phase I trials, with no major safety concerns reported.  \n2. **Immune Response**:  \n   - **High-dose groups** showed robust immune responses, with **100% of participants developing antibody responses** against the Zaire glycoprotein (a key viral component). Lower-dose groups had slightly lower but still strong responses (e.g., 90%).  \n   - Immunity was **sustained over time**, with 79% of participants maintaining responses up to week 60 post-vaccination.",
      "retrieved_chunks": [
        "Passage: In summary, all of the candidate vaccines for EVD that progressed to Phase I studies in response to the 2013-2016 outbreak demonstrated acceptable safety profiles; therefore, describing the magnitude and characteristics of vaccine-induced immunity was the next scientific aim.",
        "Title: Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review\nPassage: doses, respectively, and was maintained in 79% participants up to study end at week 60.",
        "In the same trial, 100% of volunteers in the high dose group developed antibody responses against the vaccine strain of Zaire glycoprotein , while only 90% developed responses\n\nTitle: A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?",
        "Passage: 22% of participants across the six trials had documented fever after vaccination, significantly higher than the 8% observed after vaccination with ChAd3 ). Although both vaccines have been evaluated across a range of doses, post-immunization fever levels are an important consideration for a vaccine that may be deployed in an outbreak of a highly febrile illness, such as EVD.",
        "Title: A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?"
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4,
      "gt_utilization": 0.3333333333333333,
      "gt_completeness": 0.8333333333333334,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 40,
      "dataset_id": "903",
      "question": "How does NLRP3 detect RNA viral infection?",
      "ground_truth_answer": "NLRP3 detects RNA viral infection via recognition of viral RNA, disturbances in intracellular ionic concentrations including K+ efflux and Ca2+ influx, and activation by viroporins encoded by RNA viruses. Additionally, RNA cleavage products generated by RNase L and the proton-selective M2 ion channel in the acidic trans-Golgi network can also activate the NLRP3 inflammasome.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how NLRP3 detects RNA viral infection. I need to look through the provided context to find the relevant information.\n\nFirst, the context mentions that NLRP3 is involved in detecting influenza virus. The initial studies suggested that NLRP3 detects viral RNA, but now it's clear that multiple sources contribute to signal 2. Signal 2 depends on the viral M2 protein. The sources include things like ionic imbalance in the trans-Golgi pH, potassium efflux through the P2X7 receptor, and ATP-gated channels. \n\nAnother part of the context talks about different models for NLRP3 activation by RNA viruses. One model says viral RNA or RNA cleavage products from RNase L activate NLRP3 via DHX33. Another model mentions viroporins activating NLRP3. For influenza, the M2 ion channel in the trans-Golgi network activates NLRP3. \n\nAlso, there's mention of two steps in NLRP3-mediated IL-1b and IL-18 production: enhancing transcription of pro-IL-1b and NLRP3, and then activating the inflammasome. \n\nPutting this together, NLRP3 detection of RNA viruses seems to involve multiple mechanisms. The initial detection might be through viral RNA via TLR7, but for NLRP3 specifically, it's more about the M2 protein causing ionic imbalances and potassium efflux. Additionally, viroporins like M2 from influenza directly activate NLRP3. So the answer should include both the M2 protein's role in signal 2 (like pH changes and potassium efflux) and the viroporin activation model.\n</think>\n\nNLRP3 detects RNA viral infection through multiple mechanisms. Initially, viral RNA is recognized by TLR7, activating NF-\u03baB to enhance transcription of pro-IL-1\u03b2 and NLRP3. For signal 2, the influenza virus's M2 protein\u2014a viroporin\u2014plays a central role. It disrupts the trans-Golgi pH balance and induces potassium efflux via the P2X7 receptor, both of which activate the NLRP3 inflammasome. Additionally, viroporins like M2 directly trigger NLRP3, while RNA cleavage products from RNase L may engage the hel",
      "retrieved_chunks": [
        "Signal 1 is initiated by the detection of viral RNA by TLR7, which activates NF-kB. Although initial studies showed that NLRP3 detects influenza virus via recognition of viral RNA , it is now clear that many sources contribute to signal 2 either in combination or alone, and all depend on the newly synthesized viral M2 protein. These include, ionic imbalance of the trans-Golgi pH, potassium efflux through the P2X7 receptor, an ATP-gated\n\nTitle: Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome\nPassage: The innate immune systems utilizes pattern recognition receptors to detect pathogen-associated molecular patterns .",
        "Second, cathepsin B and L, which are specific lysosomal cysteine proteases, are though to play a\n\nTitle: Innate Immune Sensing and Response to Influenza\nPassage: Studies have shown that NLRP3 , NLRC2 , and NLRX1 are the NLRs responding to influenza virus . Whereas NLRP3 inflammasome induces the secretion of mature IL-1b/IL-18, NLRC2/NOD2, and NLRX1 signals the production of type I IFNs in response to influenza virus. Title: Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome\nPassage: Thus far, several models have been proposed to explain NLRP3 inflammasome activation by RNA viruses. First, viral RNA or RNA cleavage products generated by RNase L activate the NLRP3 inflammasome via the DExD/H-box helicase, DHX33 . Second, viroporins encoded by RNA viruses activates the NLRP3 inflammasome . In the case of influenza virus, the proton-selective M2 ion channel in the acidic trans-Golgi network activates the NLRP3 inflammasome .",
        "Four models describing activation of the NLRP3 inflammasome have been proposed thus far .",
        "Title: Innate Immune Sensing and Response to Influenza\nPassage: Influenza virus-induced NLRP3-mediated IL-1b and IL-18 production involve two steps that include, enhancing the transcription of genes encoding pro-IL-1b and pro-IL-18 and NLRP3 and activating NLRP3 inflammasome .",
        "Nod-like receptor family, pyrin domain-containing 3 is activated by a wide variety of stimuli, including virus infection ."
      ],
      "computed_relevance": 0.16666666666666666,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.42857142857142855,
      "gt_utilization": 0.3333333333333333,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 41,
      "dataset_id": "1121",
      "question": "What is  an example of anti-viral defense in bats?",
      "ground_truth_answer": "One example of an anti-viral defense in bats is the interferon pathway, which is perpetually switched on in some bat species, helping to keep viral infections in check.",
      "generated_response": "<think>\nOkay, let's see. The user is asking for an example of an anti-viral defense in bats based on the provided context.\n\nFirst, I need to look through the passages given. The first passage mentions that some bats have an antiviral immune response called the interferon pathway that's perpetually switched on. It also says that in most other mammals, this would cause harmful inflammation, but bats have adapted anti-inflammatory traits. \n\nAnother part of the context talks about host receptor sequence incompatibilities and constitutive expression of IFN-\u03b1. The experiments used bat cells from two species with different interferon pathway activations. \n\nSo, the key points here are the interferon pathway being constantly active and other mechanisms like receptor incompatibilities. The question is asking for an example, so the most direct answer would be the interferon pathway. The passage explicitly states that as an example. Also, the constitutive expression of IFN-\u03b1 is another example mentioned. \n\nI need to make sure I'm not missing any other examples. The context also mentions loss of certain genes that promote inflammation as an adaptation, but that's more about their anti-inflammatory traits rather than the antiviral defense itself. The main antiviral defenses are the interferon pathway and receptor incompatibilities. \n\nSince the question is asking for an example, either of those would work. The first example given in the passage is the interferon pathway being perpetually on. That's probably the best answer here. The answer should be concise, so stating the interferon pathway as an example would be correct.\n</think>\n\nAn example of an antiviral defense in bats is the **constitutive activation of the interferon pathway**, which is perpetually switched on in some bat species. This hyper-vigilant immune response helps limit viral load by promoting antiviral defenses. Additionally, bats exhibit **species-specific mechanisms** such as host receptor sequence incompatibilities for certain viruses and the constitutive expression of the antiviral cytokine IFN-\u03b1. These adaptations allow bats to control viral infections while avoiding harmful inflammation through evolved anti-inflammatory traits.",
      "retrieved_chunks": [
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: Bats have a suite of antiviral defenses that keep the amount of virus in check. For example, some bats have an antiviral immune response called the interferon pathway perpetually switched on. In most other mammals, having such a hyper-vigilant immune response would cause harmful inflammation. Bats, however, have adapted anti-inflammatory traits that protect them from such harm, include the loss of certain genes that normally promote inflammation. However, no one has previously explored how these unique antiviral defenses of bats impact the viruses themselves.",
        "In some bat cells, the\n\nTitle: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: countered by the virus spreading more quickly from cell to cell. This suggests that bat immune defenses may drive the evolution of faster transmitting viruses, and while bats are well protected from the harmful effects of their own prolific viruses, other creatures like humans are not.",
        "The experiments and model helped reveal that the bats' defenses may have a potential downside for other animals, including humans. In both bat species, the strongest antiviral responses were\n\nTitle: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: Recent research advances are beginning to shed light on the molecular mechanisms by which bats avoid pathology from these otherwise virulent pathogens . Bats leverage a suite of species-specific mechanisms to limit viral load, which include host receptor sequence incompatibilities for some bat-virus combinations and constitutive expression of the antiviral cytokine, IFN-a, for others .",
        "have studied this exact question using bat cells grown in the laboratory. Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: The experiments made use of cells from one bat species -the black flying fox -in which the interferon pathway is always on, and another -the Egyptian fruit bat -in which this pathway is only activated during an infection. The bat cells were infected with three different viruses, and then Brook et al.",
        "Typically, the presence of viral RNA or DNA in the cytoplasm of mammalian cells will induce secretion of type I interferon proteins , which promote expression and translation of interferon-stimulated genes in neighboring cells and render them effectively antiviral ."
      ],
      "computed_relevance": 0.14285714285714285,
      "computed_utilization": 0.21428571428571427,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.35,
      "gt_utilization": 0.1,
      "gt_completeness": 0.2857142857142857,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 42,
      "dataset_id": "269",
      "question": "What are associated with cancer, diabetes, inflammatory disease, and osteoporosis?",
      "ground_truth_answer": "Obesity, inflammation, stress, and diet are associated with cancer, diabetes, inflammatory disease, and osteoporosis.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what factors are associated with cancer, diabetes, inflammatory disease, and osteoporosis based on the provided context. Let me go through the context again to make sure I don't miss anything.\n\nFirst, the context is from a study titled \"T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders.\" The passages mention several risk factors and their interactions with genes related to T2DM complications. The key factors listed are obesity, inflammation, stress, and diet. \n\nLooking at the first passage, it states that obesity and inflammation play major roles in T2DM development and complications. The second passage breaks down different tissues: adipose tissue has obesity linked to nephropathy and atherosclerosis, while neuropathy and retinopathy are linked to stress and inflammation. Cardiovascular complications are tied to diet and inflammation. Another part mentions that hyperglycemic conditions lead to microvascular and macrovascular complications. The last passage emphasizes that the major risk factors are obesity, inflammation, stress, and diet, with obesity being the dominant one. It also notes that inflammation can lead to vascular calcification with atherosclerosis and mentions hepatokines involved in atherosclerosis.\n\nNow, the question is about what's associated with cancer, diabetes (T2DM), inflammatory disease, and osteoporosis. Wait, the original context is about T2DM complications, not directly about cancer or osteoporosis. But maybe the factors mentioned (obesity, inflammation, stress, diet) are the ones that link these conditions. The user might be expecting the answer to list these factors since they are mentioned as risk factors for T2DM complications, which could overlap with other diseases. However, the context doesn't explicitly mention cancer or osteoporosis. But the question is phrased as if these are associated with the factors discussed. \n\nWait, the user's question is a bit different. They are asking what is associated with those four conditions (cancer, diabetes, inflammatory disease, osteoporosis). The context talks about T2DM and its complications, and the risk factors there. But the answer needs to connect those factors to the four diseases mentioned. However, the context doesn't mention cancer or osteoporosis. So maybe the answer is that the factors like obesity, inflammation, stress, and diet are associated with these conditions? But the context only links them to T2DM",
      "retrieved_chunks": [
        "Title: T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders\nPassage: Thus it is apparent that obesity and inflammation play major role in the development of T2DM and its associated complications and therefore therapeutic regimens may be targeted towards ameliorating these effects.",
        "However, it is to be\n\nTitle: T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders\nPassage: In Adipose tissue, obesity topped the list with the number of DEG associated with nephropathy, atherosclerosis, whereas in neuropathy and retinopathy, stress and inflammation are at the top and in cardiovascular complication, diet and inflammation topped the list .",
        "Title: T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders\nPassage: Hyperglycaemic conditions in late stages of diabetic individuals include well known microvascular complications and macrovascular complications .",
        "It is evident that the complications arising from T2DM are also multifactorial and could be further governed by gene-environment interactions. Title: T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders\nPassage: Among the risk factors considered in this work, are obesity, inflammation, stress and diet and their interactions with the genes of T2DM associated complications. The major share of differentially expressed genes in T2DM patients as observed here is contributed by pancreas tissue followed by adipose and skeletal muscle tissues. Obesity is clearly a dominant risk factor interacting with the genes of T2DM complications followed by inflammation, diet and stress to variable extents.",
        "Inflammation could lead to vascular calcification in association with atherosclerosis 31 . Hepatokines such as Fibroblast growth factor 21, Fetuin A and selenoprotein P are also implicated in the development of atherosclerosis 32 ."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.5555555555555556,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.6470588235294118,
      "gt_utilization": 0.11764705882352941,
      "gt_completeness": 0.18181818181818182,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 43,
      "dataset_id": "191",
      "question": "What are the ages of the patients in this study?",
      "ground_truth_answer": "The ages of the patients in the study range from 10 months to 109 years old, with the median ages being 31 months, 53.2 years, 56.7 years, 36.7 years, and 61 years. The study also mentions a significant number of patients being in the age group of 21 to 40 years and a majority of cases occurring in patients aged 65 years and older.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the ages of the patients in the study mentioned in the provided context. First, I need to look at the context given.\n\nLooking at the first passage, the title is about acute kidney injury requiring dialysis. The passage states that the mean age was 36.7 \u00b114.5 years, with more than two-thirds between 21 to 40 years. Also, it mentions that the median age of patients with co-morbidities was higher than those without. But the question is about the ages in the study, so I need to focus on the numbers given here.\n\nThen there's another study on influenza cases from 2010-2015. The passage here says the median age was 31 months, with 19% under 3 months. However, the title mentions \"severe hospitalized cases of laboratory-confirmed influenza,\" so this is a different study. The user's question is about \"this study,\" but which one? The context includes two different studies. The first one is about AKI and dialysis, the second about influenza. The question is a bit ambiguous, but since the answer needs to be based on the provided context, I need to check which study's age data is being referred to.\n\nWait, the user's question is in the context of the first study mentioned? Let me check again. The first context's passage says \"The mean age of patients was 36.7 \u00b114.5 years, with more than two third being in the age group between 21 to 40 years.\" The second study's passage says \"The median age of the patients was 31 months...\" So the answer depends on which study the question refers to. The question is \"What are the ages of the patients in this study?\" but the context includes two studies. However, the first study's title is about acute kidney injury requiring dialysis, and the second is about influenza. The user might be referring to the first study since the first context is presented first. But the question isn't explicitly tied to a specific title. Wait, the user provided two different contexts here. Let me check the original problem again.\n\nWait, looking back, the user provided two different studies as part of the context. The first one is about AKI and dialysis, the second about influenza. The question is \"What",
      "retrieved_chunks": [
        "The median age of patients presenting co-morbidities was significantly higher than of those without .",
        "Title: Clinical profile and outcome of patients with acute kidney injury requiring dialysis\u2014an experience from a haemodialysis unit in a developing country\nPassage: The mean age of patients was 36.7 \u00b1 14.5 years, with more than two third being in the age group between 21 to 40 years.",
        "The majority of patients acquired AKI in the community.",
        "Title: Descriptive study of severe hospitalized cases of laboratory-confirmed influenza during five epidemic seasons (2010\u20132015)\nPassage: During the 2010-2015 seasons 1400 cases of SHCLCI were recorded, 462 required ICU admission and 167 died: 778 were male.",
        "The median age of the patients was 31 months , with 19% of the children having less than 3 months of age ."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.4,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2727272727272727,
      "gt_utilization": 0.22727272727272727,
      "gt_completeness": 0.8333333333333334,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 44,
      "dataset_id": "1610",
      "question": "What has this focus on mammalian defences and pathologies sidelined?",
      "ground_truth_answer": "The focus on mammalian defences and pathologies has sidelined the study of host-pathogen interactions in non-mammalian organisms, such as Drosophila, and the potential insights that could be gained from studying them.",
      "generated_response": "<think>\nOkay, let's see. The user is asking what the focus on mammalian defenses and pathologies has sidelined. I need to look through the provided contexts to find clues.\n\nFirst, looking at the first context about Marek disease as a model for human tumors. Then there's a mention of MHC Class I molecules and how studying them with evolutionary biology approaches uses wild outbred populations. The third context talks about pathogen proteomics in farm animals, specifically bovine mastitis. The fourth context mentions deconstructing host-pathogen interactions in Drosophila, noting that studying virulence factors is more challenging in intact mammals.\n\nPutting this together, the focus on mammals might have overshadowed studies in other models. The Drosophila context suggests that using simpler models like fruit flies could be beneficial but are perhaps neglected because the main focus is on mammals. Also, the MHC study mentions using wild populations, which might be a different approach than typical mammalian models. The proteomics in farm animals shows that non-mammalian or less complex models can provide insights. So the answer is likely that non-mammalian models or alternative models like Drosophila and evolutionary approaches have been sidelined in favor of mammalian studies.\n</think>\n\nThe focus on mammalian defenses and pathologies has sidelined the study of **non-mammalian models and alternative approaches**, such as evolutionary biology methods (e.g., wild outbred populations) and simpler systems like *Drosophila* for deconstructing host-pathogen interactions. These alternatives offer unique insights into cellular processes, pathogen mechanisms, and immune responses but are often overshadowed by the dominant emphasis on mammalian systems.",
      "retrieved_chunks": [
        "Title: Animal board invited review: advances in proteomics for animal and food sciences\nPassage: with a special focus on Marek disease , which is of particular interest as a model for human tumours .",
        "Title: Generalists and Specialists: A New View of How MHC Class I Molecules Fight Infectious Pathogens\nPassage: Finally, much can be learned from evolutionary biology approaches, including observation and simulation, typically with wild outbred populations.",
        "Finally, we highlight in Box 1 how studying the effect of toxins can shed light on basic cellular processes.",
        "Title: Animal board invited review: advances in proteomics for animal and food sciences\nPassage: Pathogen proteomics Proteomic technologies have also been used to provide novel approaches and insights into the pathogenic mechanisms of bacterial infection in farm animal diseases, which offer unique opportunities to study the proteome of bacterial pathogens during infection . A limited number of proteomic studies have focussed on pathogen responses during clinical intramammary infections discovered major membrane-associated proteins in bovine mastitis S.",
        "Title: Deconstructing host-pathogen interactions in Drosophila\nPassage: virulence factors, which is more challenging in intact mammals."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.42857142857142855,
      "gt_utilization": 0.42857142857142855,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 45,
      "dataset_id": "657",
      "question": "What happens when a recipient of a vaccine has immune response to the delivery vector?",
      "ground_truth_answer": "When a recipient of a vaccine has an immune response to the delivery vector, it can potentially result in a reduction in the subsequent immune response. This can be due to the induction of neutralizing antibodies, limiting the number of transduced cells and therefore limiting the overall immune response. Additionally, repeated immunization with the same vaccine and dose can counteract the negative impact of vector-specific immune responses by leading to higher priming of naive T cells against the delivered antigen. However, this may not always be practicable in real-world situations.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what happens when someone who has an immune response to the vaccine's delivery vector receives the vaccine. The context provided talks about pre-existing immunity against vaccine vectors and how it affects subsequent immune responses.\n\nFirst, I need to parse the key points from the context. The passage mentions that for viral vectors, cell-mediated immunity has a more pronounced impact, leading to a reduction in the subsequent immune response. This is because the first dose induces neutralizing antibodies, which then limit the number of transduced cells in subsequent doses. That makes sense because if the body already has antibodies against the vector, they might neutralize the vector before it can deliver the antigen, reducing the effectiveness of the vaccine.\n\nThen there's a part about repeated immunization with the same vaccine and dose. The context says that repeated vaccination can counter the negative impact by priming naive T cells more effectively. But it also notes that this might not be practical in real-world scenarios. So, even though repeated doses might help, in practice, people might not get multiple doses of the same vaccine.\n\nAnother example given is about Listeria vectors. The study mentioned that pre-existing immunity to the Listeria vector didn't diminish the immune response to the delivered antigen. Similarly, a study with Salmonella vectors showed that an anamnestic response (a quick, strong immune response due to prior exposure) to the vector's antigens occurs. However, another study indicated that exposure to the empty vector could completely eliminate immune responses to the delivered antigens. The context also emphasizes that the downregulation of immune responses depends on the dose and timing.\n\nPutting this together, the answer should address both the negative impact (reduced immune response due to pre-existing immunity neutralizing the vector) and possible exceptions where pre-existing immunity doesn't hinder the antigen response. Also, mention factors like dose, timing, and vector type influencing the outcome.\n\nI need to make sure the answer is concise but covers all these points. The user probably wants a clear explanation of the consequences of pre-existing immunity against the vector, including both the general negative effect and the exceptions where it doesn't matter. Also, note that repeated vaccination might help but isn't always feasible.\n</think>\n\nWhen a recipient has pre-existing immunity to the vaccine delivery vector, the immune system may rapidly neutralize the vector, reducing its ability to deliver the target antigen. This typically **diminishes the subsequent immune response to the",
      "retrieved_chunks": [
        "also demonstrated that the negative impact of vector-specific immune responses can also be countered by repeated immunization with the same vaccine and dose; this in effect leads to higher priming of naive T cells against the delivered antigen. Of course, such repeated vaccination may not be practicable in real-world situations. Title: Pre-existing immunity against vaccine vectors \u2013 friend or foe? Passage: For viral vectors, the impact of cell-mediated immunity was more pronounced, and as depicted in Table 2 , almost always resulted in a reduction in the subsequent immune response. Presumably this is because viruses will induce neutralizing antibody on the first dose, and in subsequent doses this antibody will limit the number of transduced cells, therefore limiting the responses.",
        "This will theoretically reduce the exposure of the heterologous antigen to the immune system, as the vector is rapidly cleared. Surprisingly, as will be seen in some of the examples given below, this can have results that differ depending on the magnitude of the response to the vectored antigen. Similarly, for virally vectored antigens, the existence of pre-existing immunity to the vector will restrict delivery of the virus into cells, thereby effectively reducing the dose of the vectored antigen.",
        "indicates that pre-existing immune responses against the Listeria vector do not diminish immune responses against the delivered heterologous antigen, and a similar study by Starks et al. also concluded that prior exposure of mice to the empty Listeria vector did not influence anti-cancer immune responses when a similar mutant was used as a carrier of a melanoma cancer antigen.",
        "Passage: as such, when a vaccination is delivered, an anamnestic response to the Salmonella antigens will be induced .",
        "indicated that exposure to the empty vector may completely abrogate immune responses against the delivered antigens . However, these studies also indicate that downregulation of antigenspecific immune responses is highly dependent on dose and time."
      ],
      "computed_relevance": 0.5384615384615384,
      "computed_utilization": 0.6153846153846154,
      "computed_completeness": 0.7142857142857143,
      "computed_adherence": 0.0,
      "gt_relevance": 0.7,
      "gt_utilization": 0.2,
      "gt_completeness": 0.2857142857142857,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 46,
      "dataset_id": "1752",
      "question": "Approximately how many people died during the 1918-1919 influenza pandemic?",
      "ground_truth_answer": "Between 21 and 25 million people died of influenza worldwide during the 1918-1919 influenza pandemic.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking approximately how many people died during the 1918-1919 influenza pandemic. I need to find the answer based on the provided context.\n\nLooking at the context, there are several passages mentioned. The first one mentions that during the 1918-1919 pandemic, between 21 and 25 million people died worldwide. Another passage titled \"Influenza, evolution, and the next pandemic\" states that the 1918 pandemic killed as many as 50-100 million people. Wait, there's a discrepancy here. The first number is 21-25 million, and the second is 50-100 million. Which one is correct?\n\nLet me check the other titles. The passage under \"Making Universal Influenza Vaccines...\" also mentions the 1918 virus killed an estimated 50-100 million. The title \"A year of terror...\" says 10% infected each year but doesn't mention deaths. The first context says 21-25 million. Hmm.\n\nWait, the user's question is specifically about the 1918-1919 pandemic. The first context says \"during the 1918-1919 influenza pandemic, between 21 and 25 million people died.\" But another passage says 50-100 million. Which is accurate? I need to reconcile this. \n\nI recall from general knowledge that the 1918 flu pandemic is often cited as causing around 50 million deaths, sometimes up to 100 million. The 21-25 million might be a lower estimate or perhaps a specific region? Wait, the first context says \"worldwide.\" Let me check again. The first passage says \"between 21 and 25 million people died of influenza worldwide.\" But the other sources in the context say 50-100 million. \n\nThis is conflicting. Which one is correct? The user's answer should be based on the provided context. Since the context includes both numbers, but the question is about the 1918-1919 pandemic, I need to see which part of the context refers to that exact period. The first passage says \"during the 191",
      "retrieved_chunks": [
        "For example, about 700,000 Germans died from malnutrition-related diseases in the years of 1914-1918. During the 1918-1919 influenza pandemic, between 21 and 25 million people died of influenza worldwide. Those people were killed both directly and indirectly by influenza virus infections.",
        "Title: It is Unlikely That Influenza Viruses Will Cause a Pandemic Again Like What Happened in 1918 and 1919\nPassage: deaths in the world in that period of time.",
        "Title: A year of terror and a century of reflection: perspectives on the great influenza pandemic of 1918\u20131919\nPassage: It is postulated that 10% of the worldwide population is infected by an influenza virus each year, resulting in a total economic burden of $87.1 billion USD . As a testament to the significant toll posed by influenza on public health and healthcare systems, the US Centers for Disease Control and Prevention estimated that from 2010 to 2015, influenza infections resulted in 9.23-35.6 million illnesses and 139,000-707,000 hospitalizations annually in the US alone . It has been suggested that children are likely the primary transmitters of influenza . Lethal influenza infections are primarily associated with high risk populations, including infants\n\nTitle: Influenza, evolution, and the next pandemic\nPassage: The 1918 influenza pandemic is remembered because it killed as many as 50-100 million people worldwide: an estimated 2.5% or more of the global population . Remarkably, the mortality rate was much higher in younger adults than it was in children, giving rise to the familiar W-shaped pandemic mortality curve . A similar mortality pattern has not been described for subsequent pandemics .",
        "Influenza virus could infect all members of a family, and this could result in no one left to feed the fires, and to prepare food for the whole\n\nTitle: Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic\nPassage: The novel 1918 pandemic virus killed an estimated 50-100 million people within the span of a year , which would equate, given the same degree of lethality, to as many as 400 million or more deaths today. Preventing a repeat of such an unimaginable disaster is a litmus test, and the ultimate standard, for any universal influenza vaccine.",
        "Many families were too poor to buy food and coal, and to afford health care expenses when their family members were ill."
      ],
      "computed_relevance": 0.15384615384615385,
      "computed_utilization": 0.15384615384615385,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.15789473684210525,
      "gt_utilization": 0.05263157894736842,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 47,
      "dataset_id": "438",
      "question": "What structural proteins are coded by Rotavirus?",
      "ground_truth_answer": "Rotavirus codes for four major structural proteins: VP4, VP6, VP7, and VP8*.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking which structural proteins are coded by the rotavirus. I need to look through the provided passages to find the answer.\n\nFirst, in the first passage titled \"Rotavirus Structural Proteins and dsRNA Are Required for the Human Primary Plasmacytoid Dendritic Cell IFN\u03b1 Response,\" it says that rotaviruses have a triple-layered protein capsid composed of four major structural proteins. Wait, but then in another passage from the same title, it mentions that the genome contains 11 segments encoding 12 proteins, with six structural and six non-structural. So there's a discrepancy here between four and six structural proteins. Hmm, maybe the first part refers to the major ones, and the second includes more?\n\nLooking at the fourth passage, which is part of the same title as the first one, it says that VP4 is a structural protein. Then in the third passage, \"The Eukaryotic Translation...\" it mentions VP4 as a spike protein, part of the structural proteins. Also, VP1-VP3 are mentioned as having high amino acid identities with group G rotavirus. Wait, VP1-VP3 are structural? The passage says that VP1-VP3 share high identities, and other structural proteins have lower. So maybe VP1, VP2, VP3, VP4, VP6 are structural? Because VP6 is mentioned in the classification based on VP6. Also, the second passage mentions six structural proteins related to group G rotavirus.\n\nPutting this together: The first passage mentions four major structural proteins (maybe VP2, VP3, VP4, VP6?), but another passage says there are six structural proteins. The third passage lists VP4 as structural, and mentions VP1-VP3 as structural (since they are compared in terms of identity). Also, VP6 is a structural protein because classification is based on VP6. So maybe the structural proteins are VP1, VP2, VP3, VP4, VP6, and another? The fourth passage also mentions VP7 as part of the triple-layered particles (TLPs) being necessary for infectivity. Wait, in the first passage, it says that VP4 and VP7 are required for cell binding. So VP7 must be a structural protein. So that's VP1, VP2, VP3, VP4, VP6, VP7.",
      "retrieved_chunks": [
        "The rotavirus genome\n\nTitle: Rotavirus Structural Proteins and dsRNA Are Required for the Human Primary Plasmacytoid Dendritic Cell IFN\u03b1 Response\nPassage: Rotaviruses are characterized by a triple-layered protein capsid composed of four major structural proteins.",
        "Although both triple-and doublelayered particles are generated during rotavirus replication, only TLPs are infectious, due to the requirements of VP4 and VP7 for cell binding, and trypsin cleavage of VP4 for viral entry and infectivity . Formation of noninfectious empty TLPs and DLPs, which lack the viral genome,\n\nTitle: The Viruses of Wild Pigeon Droppings\nPassage: The six structural proteins showed best hits by BLASTx to group G rotavirus, first described in chicken feces from Northern Ireland .",
        "Title: The Eukaryotic Translation Initiation Factor 4F Complex Restricts Rotavirus Infection via Regulating the Expression of IRF1 and IRF7\nPassage: The genome of rotavirus contains 11 segments encoding 12 proteins including six structural and six non-structural proteins . Among the structural proteins, as a spike protein, rotavirus VP4 plays an essential role in both viral entry and exit . VP4 was also demonstrated to be of importance in viral attachment and internalization , which is often used for the development of rotavirus vaccines . VP4 contains two subunits including a C-terminal subunit VP5* and a N-terminal subunit VP8*, and both VP5* and VP8* help virus entry by interacting with several putative partners and cell surface receptors .",
        "While VP1-VP3 shared 84%-94% aa-identities with group G rotavirus, other structural proteins showed lower aa-identities, ranging from 35% to 67% . Classification of rotavirus is based mainly on the inner capsid protein VP6 and according to ICTV definition the members of the same rotavirus species should share .60% nt-identity in VP6 region . The sequence of the VP6-encoding genome segment shared 68% nt-identity to group G rotavirus . Direct observation of VP6 alignment between HK18 and its closest\n\nTitle: Rotavirus Structural Proteins and dsRNA Are Required for the Human Primary Plasmacytoid Dendritic Cell IFN\u03b1 Response\nPassage: is also observed during infection.",
        "The nonstructural proteins are involved in viral replication, morphogenesis and assembly, but they are not expressed by nonreplicating virus and are not part of the infectious virion ."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.3333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.38095238095238093,
      "gt_utilization": 0.14285714285714285,
      "gt_completeness": 0.375,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 48,
      "dataset_id": "798",
      "question": "How many people did SARS-CoV infect?",
      "ground_truth_answer": "SARS-CoV infected 8098 reported cases and 774 deaths in 37 countries before the epidemic was controlled.",
      "generated_response": "<think>\nOkay, let's see. The user is asking how many people SARS-CoV infected. I need to look through the provided context to find the relevant information.\n\nFirst, looking at the first passage under the title \"Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus,\" it mentions that SARS-CoV caused 8098 reported cases and 774 deaths in 37 countries before the epidemic was controlled. That seems like the direct answer. \n\nBut wait, there's another passage that talks about SARS-CoV-Z with 7 to 43 million infections. Wait, is that a typo? The title says \"Estimating the number of infections and the impact of non-\" which might be cut off. But the passage mentions SARS-CoV-Z up to March 28th. However, SARS-CoV-Z isn't a real virus I'm aware of. Maybe that's a mistake in the context? Because SARS-CoV is the actual virus, and the numbers here are way higher. But the first passage clearly states 8098 cases for SARS-CoV. \n\nAlso, the other passage mentions 2798 confirmed 2019-nCoV cases, which is SARS-CoV-2, not SARS. So that's about the novel coronavirus, not SARS. \n\nThe user is specifically asking about SARS-CoV. The first passage gives 8098 reported cases. The second passage with the high numbers (7-43 million) refers to SARS-CoV-Z, which might be a typo or a different virus. Since the question is about SARS-CoV, the correct number is 8098. Also, later in the same first passage, it says that initial R0 was over 2 but later estimates were less than 1, which aligns with SARS-CoV's transmission. \n\nSo the answer should be 8098 reported cases. The other numbers are either for a different virus or a typo. The user might be confused if there's conflicting info, but the context clearly states 8098 for SARS-CoV.\n</think>\n\nThe SARS-CoV infected **8,098 reported cases** globally, as stated in the passage under the title *Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus*. This figure",
      "retrieved_chunks": [
        "Title: Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus\nPassage: SARS-CoV and MERS-CoV cause severe disease, but despite the initial R0 estimations of greater than 2.0 for SARS-CoV , and some large outbreaks, neither were as transmissible as initial concerns suggested. SARS-CoV caused 8098 reported cases and 774 deaths in 37 countries before the epidemic was controlled.",
        "Title: Estimating the number of infections and the impact of non-\nPassage: countries between 7 and 43 million individuals have been infected with SARS-CoV-Z up to 28th March,\n\nTitle: SARS to novel coronavirus \u2013 old lessons and new lessons\nPassage: According to the situation report published by the WHO on 28 January 2020 , a total of 2798 confirmed 2019-nCoV cases have been reported globally; of these, 2761 cases were from China, including Hong Kong , Macau and Taipei .",
        "Later estimates of R0 were less than 1, indicating that SARS-CoV may not have been capable of sustained transmission, especially in the setting of control measures.4",
        "There was no secondary transmission in the United States from the 8 imported cases, although\n\nTitle: Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus\nPassage: in Toronto, Canada, a single importation is thought to have led to about 400 cases and 44 deaths.",
        "Thirty-seven confirmed cases have been reported outside of China in eleven countries in Europe, North America, Australia and Asia; of these 37 exported cases, 36 had a travel history from China or an epidemiological link to a case from China. Of the confirmed cases in China, 461 have been reported as severely ill, with 80 deaths to date."
      ],
      "computed_relevance": 0.14285714285714285,
      "computed_utilization": 0.42857142857142855,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.06666666666666667,
      "gt_utilization": 0.06666666666666667,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 49,
      "dataset_id": "867",
      "question": "What was a characteristic of  SARS-CoV and MERS-CoV, specimens collected from the lower respiratory tract such as sputum and tracheal aspirates?",
      "ground_truth_answer": "The characteristic of SARS-CoV and MERS-CoV specimens collected from the lower respiratory tract, such as sputum and tracheal aspirates, was that they had higher and more prolonged levels of viral RNA compared to specimens collected from the upper respiratory tract.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about a characteristic of SARS-CoV and MERS-CoV when specimens are collected from the lower respiratory tract, like sputum and tracheal aspirates.\n\nFirst, I need to look at the provided context. The first paragraph mentions that for both SARS-CoV and MERS-CoV, lower respiratory tract specimens (sputum, tracheal aspirates) have higher and more prolonged levels of viral RNA due to the virus's tropism. Also, for MERS-CoV, severe cases have higher viral loads and longer shedding compared to mild cases. Upper respiratory specimens like nasopharyngeal swabs might have lower viral loads and higher false-negative risks.\n\nThe WHO passage recommends lower respiratory tract (LRT) sampling for MERS-CoV RT-rtPCR, especially if collection is delayed. LRT samples are better for isolating the virus, though culture success decreases with prolonged disease. Another study showed tracheal aspirates and BAL had the highest viral loads, followed by NPA and sputum. Higher viral loads correlate with better genome sequencing and culture success, and in NPA, they're linked to severe disease.\n\nThe question is specifically about SARS-CoV and MERS-CoV. The key point from the context is that lower respiratory specimens have higher and prolonged viral RNA levels. The answer should reflect that characteristic. The answer given in the example is \"higher and more prolonged levels of viral RNA because of the tropism of the virus,\" which matches the first part of the context. I need to confirm that this is the correct answer based on the provided info. The user wants the answer based on the context, so I should just restate that part accurately.\n</think>\n\nAnswer: Specimens collected from the lower respiratory tract such as sputum and tracheal aspirates have **higher and more prolonged levels of viral RNA because of the tropism of the virus**.",
      "retrieved_chunks": [
        "For SARS-CoV and MERS-CoV, specimens collected from the lower respiratory tract such as sputum and tracheal aspirates have higher and more prolonged levels of viral RNA because of the tropism of the virus. MERS-CoV viral loads are also higher for severe cases and have longer viral shedding compared to mild cases. Although upper respiratory tract specimens such as nasopharyngeal or oropharyngeal swabs can be used, they have potentially lower viral loads and may have higher risk of false-negatives among\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: The WHO recommends sampling from the LRT for MERS-CoV RT-rtPCR testing, especially when sample collection is delayed by a week or more after onset of symptoms. LRT samples are also best for attempting isolation of infectious virus, although the success of culture is reduced when disease persists .",
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: In the only study to examine the effect of sample type on molecular analysis, 64 nasopharyngeal aspirates , 30 tracheal aspirates, 13 sputa and three BAL were examined. The tracheal aspirates and BAL returned the highest viral load values followed by NPA and sputum. Unsurprisingly, higher viral loads generally paralleled whole genome sequencing and culture success and, in NPA testing, were significantly correlated with severe disease and death .",
        "Specimens were nasal swabs , throat swabs , nasal aspirates , tracheal aspirates , bronchoalveolar lavages , gargles , and sputum .",
        "Title: Molecular Analysis of Human Metapneumovirus Detected in Patients with Lower Respiratory Tract Infection in Upper Egypt\nPassage: In total, 520 patients were prospectively enrolled in this study.",
        "Recommended sample types include bronchoalveolar lavage , tracheal/tracheobronchial aspirate, pleural fluid and sputum ."
      ],
      "computed_relevance": 0.1,
      "computed_utilization": 0.1,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.17391304347826086,
      "gt_utilization": 0.043478260869565216,
      "gt_completeness": 0.25,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 50,
      "dataset_id": "1251",
      "question": "Which city has had has had more MERS cases than any other region of the KSA ?",
      "ground_truth_answer": "Riyadh has had more MERS cases than any other region of the KSA.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking which city in the Kingdom of Saudi Arabia (KSA) has had the most MERS cases. The context provided mentions that Riyadh is a nexus for camel and human travel and has had more MERS cases than any other region. Additionally, there's a passage about a hospital-based cluster in the Ar Riyad region, which includes Riyadh. The title of one of the studies also refers to the Riyadh Regional Laboratory.\n\nFirst, I need to confirm that \"Riyadh\" is the correct answer. The context explicitly states that Riyadh has had more cases than any other region. The other passages mention studies conducted in Riyadh and the South Korean outbreak, but the key point here is the direct statement about Riyadh's case numbers. The other regions aren't mentioned in the context, so there's no confusion there. The answer should be straightforward based on the given information.\n</think>\n\nThe city that has had more MERS cases than any other region of the KSA is **Riyadh**. The context explicitly states that Riyadh is a major hub for MERS cases and highlights its role as a nexus for travel and the presence of diverse MERS-CoV variants. Additionally, studies referenced in the passages focus on the Riyadh Regional Laboratory and hospital clusters in the Ar Riyad region, confirming its significance in the MERS epidemic. \n\n**Answer:** Riyadh.",
      "retrieved_chunks": [
        "Riyadh is a nexus for camel and human travel and has had more MERS cases than any other region of the KSA to date but also harbours a wide range of MERS-CoV variants .",
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: In the region of Ar Riyad, including the capital city of Riyadh, a hospital based cluster began, within a single hospital, from late June 2015 .",
        "However the South Korean outbreak originated from a single infected person, resulting in three to four generations of cases . Studies of this apparently recombinant viral variant did not find an increased evolutionary rate and no\n\nTitle: Demographic Variations of MERS-CoV Infection among Suspected and Confirmed Cases: An Epidemiological Analysis of Laboratory-Based Data from Riyadh Regional Laboratory\nPassage: Our study covered two main regions in Saudi Arabia and provides evidence that the MERS-CoV epidemic in these two regions has specific characteristics that might help future plans for prevention and management of such contagious diseases.",
        "Future studies should aim to confirm such findings in other regions in Saudi\n\nTitle: Demographic Variations of MERS-CoV Infection among Suspected and Confirmed Cases: An Epidemiological Analysis of Laboratory-Based Data from Riyadh Regional Laboratory\nPassage: Our data reported a higher prevalence of infection among Saudi nationals as compared with non-Saudi. Another study also showed similar results but with a much higher percentage among Saudis, which may be due to the fact that it included Saudis from all regions .",
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: been rare ."
      ],
      "computed_relevance": 0.14285714285714285,
      "computed_utilization": 0.14285714285714285,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.05555555555555555,
      "gt_utilization": 0.05555555555555555,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 51,
      "dataset_id": "1492",
      "question": "Which Western European country is estimated to have the lowest attack rate?",
      "ground_truth_answer": "Germany.",
      "generated_response": "<think>\nOkay, let's see. The user is asking which Western European country has the lowest estimated attack rate based on the provided context. The context has four passages, each mentioning different countries and their attack rates.\n\nFirst, I need to parse each passage. The first passage says the attack rate is highest in Spain, followed by Italy, and lowest in Germany. That's a clear statement. The second passage mentions Germany having one of the lowest attack rates at 0.7% with 600,000 infected. The third passage talks about Spain with an attack rate of 9.8%. The fourth mentions France at 3.0%.\n\nSo, putting this together: Spain is highest at 9.8%, France is 3.0%, and Germany is 0.7%. The first passage says Germany is the lowest, and the second passage confirms that with the 0.7% figure. The other countries mentioned are Italy (but no specific number given except that it's after Spain) and France. Since Germany's rate is 0.7%, which is lower than France's 3.0%, the answer should be Germany. I need to make sure there's no other country mentioned with a lower rate. The answer is Germany.\n</think>\n\nThe Western European country estimated to have the lowest attack rate is **Germany**, with an attack rate of 0.7%. This is explicitly stated in the context, which notes Germany as having \"one of the lowest attack rates\" and provides the specific percentage. Other mentioned countries include Spain (9.8%), France (3.0%), and Italy (implied to have a higher rate than Germany but no specific figure provided).",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: to date \u2014 the attack rate - is estimated to be highest in Spain followed by Italy and lowest in Germany\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: infected to date. Germany is estimated to have one of the lowest attack rates at 0.7% with 600,000\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: infected as of March 28th, giving an attack rate of 9.8% of the population . Spain\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: France 3.0%"
      ],
      "computed_relevance": 0.6666666666666666,
      "computed_utilization": 0.6666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.3333333333333333,
      "gt_utilization": 0.2222222222222222,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 52,
      "dataset_id": "1301",
      "question": "What was the focus of the study?",
      "ground_truth_answer": "The focus of the study was to investigate community responses to communication campaigns for influenza A (H1N1) and to provide evidence-based practical information to guide the development and delivery of key health messages for H1N1 and other health campaigns. The study specifically focused on the responses of different target groups, including M\u0101ori, Pacific Peoples, children, general population, and vulnerable people with chronic conditions, to the key health messages in the 2009 and 2010 H1N1 campaigns.",
      "generated_response": "<think>\nOkay, let's see. The user is asking what the focus of the study was. I need to look through the provided context to find the answer.\n\nFirst, looking at the titles, they all mention \"Community responses to communication campaigns for influenza A (H1N1): a focus group study.\" That seems important. The main focus is probably about how communities responded to these communication campaigns.\n\nIn the first passage, it says the analysis was done by a researcher not involved in the focus groups, and verified by facilitators. But that's more about the methodology. The second passage mentions the primary objective was to provide health authorities with evidence-based info for developing health messages, specifically for H1N1 and other campaigns. It also says they focused on community responses to key health messages in 2009 and 2010 H1N1 campaigns. \n\nAnother part mentions the study was part of a rapid response initiative using focus groups. They had eight groups with 7-13 participants each, targeting five groups: M\u0101ori, Pacific Peoples, children, general population, and vulnerable people with chronic conditions. \n\nSo putting it all together, the study's focus was on understanding how different community groups responded to the H1N1 communication campaigns. The goal was to help health authorities improve their messaging strategies. The answer should mention the community responses, the specific campaigns (2009-2010 H1N1), and the target groups they studied.\n</think>\n\nThe study focused on examining **community responses to key health messages in the 2009 and 2010 influenza A (H1N1) communication campaigns**. It aimed to provide health authorities with evidence-based insights to improve the development and delivery of health messages for H1N1 and other public health campaigns. The research specifically analyzed how different target populations\u2014such as M\u0101ori, Pacific Peoples, children, the general population, and vulnerable individuals with chronic conditions\u2014perceived and reacted to these communication efforts.",
      "retrieved_chunks": [
        "Title: Community responses to communication campaigns for influenza A (H1N1): a focus group study\nPassage: The analysis of the focus group data was undertaken by a single researcher who was neither present at the focus groups nor had read any preliminary findings.",
        "This work was verified by the focus group facilitators to ensure that any \"contextual richness\" had not been missed in the data.",
        "Title: Community responses to communication campaigns for influenza A (H1N1): a focus group study\nPassage: The primary objective of this study was to provide health authorities with evidence-based practical information to guide the development and delivery of key health messages for H1N1 and other health campaigns. The study focused on community responses to key health messages in the 2009 and 2010 H1N1 campaigns. Title: Community responses to communication campaigns for influenza A (H1N1): a focus group study\nPassage: The study was part of a rapid response initiative; therefore focus groups were selected as the most efficient means of data collection in the time available.",
        "The extracts used to illustrate the content of each theme are identified by codes which correspond to the focus group transcripts from which they were taken .",
        "Eight semi-structured focus groups were recruited between May and July 2010 comprising 7 to 13 participants each and lasting approximately 1 hour. Separate focus groups were conducted for each of the target groups with a total of 80 participants representative of five target populations groups identified in consultation with Ministry of Health staff: M\u0101ori, Pacific Peoples, children , general population, and vulnerable people with chronic conditions (defined as those who are eligible for subsidised\n\nTitle: Community responses to communication campaigns for influenza A (H1N1): a focus group study\nPassage: All focus group sessions were recorded and independently, professionally transcribed."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.375,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.29411764705882354,
      "gt_utilization": 0.17647058823529413,
      "gt_completeness": 0.6,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 53,
      "dataset_id": "171",
      "question": "What organ produces hepcidin?",
      "ground_truth_answer": "The liver and airway epithelial cells (AECs) produce hepcidin.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What organ produces hepcidin?\" and they want the answer based on the provided context.\n\nFirst, I need to go through the context given. The context includes several passages. Let me start by reading each one carefully.\n\nThe first context mentions that evidence suggests other cells may express hepcidin mRNA at lower levels than hepatocytes. It also says the biological significance of extra-hepatic production is uncertain. Then it talks about plasma hepcidin being filtered through glomeruli and excreted in urine in animals with normal kidney function. Also, some hepcidin is degraded along with ferritin. Factors increasing hepcidin production include increased bone marrow, anemia, iron accumulation, and inflammation.\n\nThen there's a title and passage about a study where hepcidin is bound to plasma alpha-2 macroglobulin. Another study mentions that hepcidin is expressed in AECs (airway epithelial cells) in response to interferon-\u03b3, and during polymicrobial sepsis, hepcidin levels in AECs increase. The study suggests that elevated hepcidin in the lungs might protect against lung injury in sepsis. When they knocked down hepcidin in AECs, lung injury worsened.\n\nAnother title and passage state that hepcidin is a \u03b2-defensin-like antimicrobial peptide mainly produced by the liver. It functions in iron regulation by binding to ferroportin, reducing iron export. It also restricts iron availability to microbes, aiding host defense. Additionally, it modulates inflammatory responses.\n\nThe third passage under the same title mentions that hepcidin is produced predominantly by hepatocytes.\n\nSo, putting this together: The main source of hepcidin is the liver, specifically hepatocytes. However, other cells (like AECs) can produce it at lower levels, but the primary organ is the liver. The question is about the organ that produces hepcidin, so even though other cells contribute, the main answer is the liver. The context says \"mainly produced by the liver\" and \"produced predominantly by hepatocytes,\" which are liver cells. Therefore, the answer should be the liver.\n</think>\n\nThe organ that produces hepcidin is the **liver**. The context explicitly states that hepcidin is \"mainly produced",
      "retrieved_chunks": [
        "Evidence suggests that other cells may express the hepcidin mRNA at a much lower level than the hepatocytes; the biological significance of the extra hepatic production of hepcidin remains uncertain. Plasma hepcidin is freely treated through glomeruli and in animals with normal kidney activity it quickly passes through the urine. In addition, a part of hepcidin is cleansed through degradation along with ferritin .",
        "Factors that cause hepcidin production are increased in bone marrow and anemia. Other factors that increase the production of hepcidin are iron accumulation and inflammation .",
        "Considering that\n\nTitle: Performance evaluation of antimicrobial peptide ll-37 and hepcidin and \u03b2-defensin-2 secreted by mesenchymal stem cells\nPassage: Hepcidin is bound to plasma alpha-2 macroglobulin .",
        "A recent study reported that hepcidin is expressed in AECs in response to interferon-\u03b3 . In the current study, an increased hepcidin level in AECs was observed during polymicrobial sepsis. Because the lung is the first vital organ that is adversely affected at the onset of sepsis , the elevated expression of hepcidin may protect the mice against lung injury. To support this hypothesis, knockdown of hepcidin in AECs exacerbated sepsisinduced lung injury .",
        "Title: Silencing airway epithelial cell-derived hepcidin exacerbates sepsis-induced acute lung injury\nPassage: Hepcidin is a \u03b2-defensin-like antimicrobial peptide that is mainly produced by the liver. Hepcidin not only shows antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and yeasts, but also functions as a principal iron regulatory hormone . Hepcidin binds to the iron export protein ferroportin and induces its internalization and degradation, which leads to decreased cellular iron export and increased intracellular iron retention . Because iron is an essential nutrient for all organisms, hepcidin also restricts the iron available to invading microbes, thereby enhancing the host defense against pathogens . Furthermore, hepcidin can modulate the lipopolysaccharide -induced acute inflammatory response via\n\nTitle: Silencing airway epithelial cell-derived hepcidin exacerbates sepsis-induced acute lung injury\nPassage: Hepcidin is produced predominantly by hepatocytes."
      ],
      "computed_relevance": 0.13333333333333333,
      "computed_utilization": 0.13333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.15384615384615385,
      "gt_utilization": 0.15384615384615385,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 54,
      "dataset_id": "737",
      "question": "What makes phage display technology useful for other applications?",
      "ground_truth_answer": "The unique physicochemical properties of the phage, in combination with modular display of peptides and proteins with known binding specificity, have spawned novel materials with diverse applications. Additionally, the unusual biophysical properties of filamentous phage can be exploited in the study of structures of other macromolecules, such as partially ordering DNA, RNA, proteins, and other biomolecules for measurement of dipolar coupling interactions in NMR spectroscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what makes phage display technology useful for other applications. The context provided is from a paper titled \"Beyond phage display...\" which discusses non-traditional uses of filamentous bacteriophages.\n\nFirst, I need to recall what phage display is. From what I remember, phage display is a technique where peptides or proteins are displayed on the surface of bacteriophages. This is typically used for selecting molecules with specific binding properties, like antibodies. But the question is about other applications beyond the traditional use.\n\nLooking at the provided passages, there are a few key points. The first passage mentions that phage display mimics the immune system's somatic evolution strategy for improving binding. However, other systems like yeast display have advantages for affinity maturation. But the question is about why phage display is useful for other applications, so maybe the answer lies elsewhere in the context.\n\nThe third and fourth passages talk about the unique physicochemical properties of the phage. They mention that combining these properties with modular display of peptides and proteins allows for novel materials with diverse applications. Also, the unusual biophysical properties can be used to study other macromolecules. Specifically, magnetic alignment of high-concentration phage can partially order DNA, RNA, proteins, etc., for NMR spectroscopy measurements of dipolar couplings.\n\nSo, the answer should highlight the unique physicochemical and biophysical properties of filamentous phage. These properties enable applications beyond just display, such as creating novel materials and aiding in structural studies of biomolecules through techniques like NMR. The modular display allows for specific binding, which is useful in making new materials. Additionally, their ability to align biomolecules magnetically helps in structural analysis.\n\nI need to make sure I'm not missing any other points. The first part also mentions that phage display can be used for affinity maturation, but other systems are better. However, the question is about other applications, so focusing on the non-traditional uses is key. The answer should mention the unique properties and how they enable vaccine carriers, therapeutic biologics, bioconjugation scaffolds, and structural studies. The NMR part is a specific example of how their properties are exploited beyond display.\n\nSo putting it all together: The unique physicochemical and biophysical properties of filamentous bacteriophages, combined with their ability to display modular peptides/proteins,",
      "retrieved_chunks": [
        "Title: Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold\nPassage: of improved or altered binding, roughly mimicking the somatic evolution strategy of the immune system . However, other in vitro display systems, such as yeast display, have important advantages over the filamentous phage for affinity maturation , and regardless of the display method, selection of \"improved\" variants can be slow and cumbersome.",
        "Title: Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold\nPassage: of improved or altered binding, roughly mimicking the somatic evolution strategy of the immune system . However, other in vitro display systems, such as yeast display, have important advantages over the filamentous phage for affinity maturation , and regardless of the display method, selection of \"improved\" variants can be slow and cumbersome.",
        "Title: Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold\nPassage: Thus, the unique physicochemical properties of the phage, in combination with modular display of peptides and proteins with known binding specificity, have spawned wholly novel materials with diverse applications. It is worth noting that the unusual biophysical properties of the filamentous phage can also be exploited in the study of structures of other macromolecules. Magnetic alignment of high-concentration filamentous phage in solution can partially order DNA, RNA, proteins, and other biomolecules for measurement of dipolar coupling interactions in NMR spectroscopy.",
        "Title: Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold\nPassage: Thus, the unique physicochemical properties of the phage, in combination with modular display of peptides and proteins with known binding specificity, have spawned wholly novel materials with diverse applications. It is worth noting that the unusual biophysical properties of the filamentous phage can also be exploited in the study of structures of other macromolecules. Magnetic alignment of high-concentration filamentous phage in solution can partially order DNA, RNA, proteins, and other biomolecules for measurement of dipolar coupling interactions in NMR spectroscopy.",
        "Iterative methods have been developed to combine computationally designed mutations and circumvent the screening of combinatorial libraries, but these have had limited success to date."
      ],
      "computed_relevance": 0.5454545454545454,
      "computed_utilization": 0.9090909090909091,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.75,
      "gt_utilization": 0.375,
      "gt_completeness": 0.5,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 55,
      "dataset_id": "1468",
      "question": "What is the structure of Hantaan virus?",
      "ground_truth_answer": "The structure of Hantaan virus is spherical or ovoid, composed of 20-30% fat, >50% protein, 7% carbohydrates, and 2% RNA. The genome comprises three negative sense, single-stranded RNAs that consist of the small, medium, and large segments encoding the nucleoprotein, envelope glycoproteins, and viral RNA-dependent RNA polymerase, respectively. The outer membrane of Hantaan virus is composed of Gn and Gc glycoproteins.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the structure of the Hantaan virus. I need to look through the provided context to find relevant information.\n\nFirst, I remember that the context mentions the diameter of hantavirus particles is 80-210 nm and they are spherical or ovoid. That's a basic structural detail. Then, the outer membrane is composed of Gn and Gc glycoproteins. These glycoproteins help the virus recognize and enter host cells. \n\nThe crystal structure of HTNV Gn (which is part of Hantaan virus) is similar to PUUV Gn, indicating conservation among hantaviruses. Also, the genome structure is mentioned: three negative-sense RNA segments (small, medium, large) encoding nucleoprotein, glycoprotein precursor (Gn and Gc), and RNA polymerase. \n\nPutting this together, the structure includes the outer glycoproteins, the shape, and the genome composition. I should mention the envelope glycoproteins, the shape, and the three RNA segments. Need to make sure I don't miss any key components from the context.\n</think>\n\nThe structure of the Hantaan virus includes a spherical or ovoid shape with a diameter of 80\u2013210 nm. Its outer membrane is composed of envelope glycoproteins **Gn** and **Gc**, which mediate host cell recognition and entry. The viral genome consists of three negative-sense, single-stranded RNA segments:  \n1. **Small (S) segment**: Encodes the nucleoprotein (NP) and a small non-structural protein.  \n2. **Medium (M) segment**: Encodes the glycoprotein precursor, which is processed into Gn and Gc.  \n3. **Large (L) segment**: Encodes the RNA-dependent RNA polymerase.  \n\nThe glycoprotein structure (e.g., HTNV Gn) is conserved across hantaviruses, as evidenced by similarities with PUUV Gn.",
      "retrieved_chunks": [
        "Title: Vaccines and Therapeutics Against Hantaviruses\nPassage: The diameter of hantavirus particles is 80-US210 nm, and the structure is spherical or ovoid.",
        "The outer membrane of hantavirus is composed of Gn and Gc\n\nTitle: Vaccines and Therapeutics Against Hantaviruses\nPassage: glycoprotein, which mediates the recognition of and entry into host cells. The crystal structure of HTNV Gn is very similar to that of PUUV Gn, which confirms that hantavirus Gn is conserved in hantavirus . Title: Complete Genome and Phylogeny of Puumala Hantavirus Isolates Circulating in France\nPassage: negative polarity: S segment codes for the nucleocapsid protein and a small non-structural s protein in several viral species; M segment for the glycoprotein precursor of the envelope glycoproteins Gn and Gc; and L segment for the RNA-dependent RNA polymerase . Each hantavirus is predominantly associated with one or a few distinct mammal species and this stable virus-host association underscore the importance of host-related factors for understanding current distribution, evolution and epidemiology and mechanisms of emergence. Title: Novel Identified HLA-A*0201-Restricted Hantaan Virus Glycoprotein Cytotoxic T-Cell Epitopes Could Effectively Induce Protective Responses in HLA-A2.1/K(b) Transgenic Mice May Associate with the Severity of Hemorrhagic Fever with Renal Syndrome\nPassage: Hantaan virus antigens in the supernatants of the tissue samples of Tg mice were detected by sandwich ELISA.",
        "The anti-HTNV NP mAb 1A8 was prepared in the Department of Microbiology of our university.",
        "The genome comprises three negative sense, single-stranded RNAs that consist the small , medium , and large segments that encode the nucleoprotein , envelope glycoproteins , and viral RNA-dependent RNA polymerase , respectively .",
        "Then, add 100 \u00b5L detecting antibody to each well and incubate"
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.3333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.3,
      "gt_utilization": 0.3,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 56,
      "dataset_id": "1628",
      "question": "Are the modern day Influenza viruses related to the 1918 Spanish Influenza virus?",
      "ground_truth_answer": "Based on the given context, it is suggested that modern day Influenza viruses may be related to the 1918 Spanish Influenza virus. The passages mention the origin and evolution of the 1918 influenza virus, and also discuss the possibility of a 1918-like virus circulating in Europe and North America in the 19th century. Furthermore, there is a question posed about whether a 1918-like pandemic could appear again, indicating a potential relation between the 1918 virus and modern day Influenza viruses.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking if modern-day influenza viruses are related to the 1918 Spanish Influenza virus. I need to base my answer on the provided context.\n\nLooking at the context, there are several passages mentioned. The first one talks about the origin and evolution of the 1918 virus's hemagglutinin gene. Hemagglutinin is a key surface protein in influenza viruses, so that's probably important. The second passage mentions that a 1918-like virus might have circulated in Europe and North America in the late 19th century. The third one is about whether the same virus caused the 1918 pandemic, and the fourth is a reference to a study by Reid et al.\n\nSo, the key points here are about the genetic lineage and possible circulation of similar viruses before 1918. The fact that the 1918 virus's hemagglutinin gene is discussed suggests that modern viruses might have evolved from it. Also, if a similar virus was around in the late 1800s, that implies a lineage. The study by Reid et al. probably contributes to understanding the evolution.\n\nBut wait, the user is asking about modern viruses. The context doesn't explicitly mention modern times, but if the 1918 virus has descendants or if its genetic material is found in current strains, that would be a yes. However, the provided passages don't directly state that modern viruses are related. They talk about the 1918 virus's origin and possible earlier circulation. Maybe the answer is that they are related through evolution, but the context doesn't confirm a direct link to today's viruses. Hmm, need to be careful here. The answer should be based strictly on the given context. Since the context mentions the origin and evolution of the 1918 virus's gene, and possible circulation in the late 1800s, it suggests that the 1918 virus evolved from earlier strains. But whether modern viruses are related would depend on if they are descendants of that lineage. The context doesn't explicitly say, but if the 1918 virus is part of a lineage that continued, then modern viruses might be related. However, without explicit mention of modern times in the context, maybe the answer is that they are related through evolutionary history, but the context",
      "retrieved_chunks": [
        "Title: 1918 Influenza: the Mother of All Pandemics\nPassage: Could a 1918-like Pandemic Appear Again?",
        "Origin and evolution of the 1918 \u201cSpanish\u201d influenza virus hemagglutinin gene. Title: The 1918 Influenza Pandemic: Looking Back, Looking Forward\nPassage: finding, and it will be important for future work to reconcile the well-accepted idea that a 1918-like virus may have circulated in Europe and North America in the second half of the 19th century, with the notion that Madrid would have escaped this virus. Title: 1918 Influenza: the Mother of All Pandemics\nPassage: by the Same Virus?",
        "Title: 1918 Influenza: the Mother of All Pandemics\nPassage: 12.",
        "Reid AH, Fanning TG, Hultin JV, Taubenberger JK.",
        "If So, How and Why?"
      ],
      "computed_relevance": 0.42857142857142855,
      "computed_utilization": 0.42857142857142855,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 57,
      "dataset_id": "1239",
      "question": "What is the transmission of MERS-CoV is defined as?",
      "ground_truth_answer": "The transmission of MERS-CoV is defined as sporadic, intra-familial, often healthcare associated, inefficient, and requiring close and prolonged contact.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is the transmission of MERS-CoV is defined as?\" and they want the answer based on the provided context.\n\nFirst, I need to look through the passages given. Let me scan each one. \n\nThe first passage mentions the WHO case definition for probable cases, but that's about diagnosis, not transmission. The second passage says, \"transmission of MERS-CoV is defined as sporadic, intra-familial, often healthcare associated, inefficient and requiring close and prolonged contact.\" That seems like the key part. \n\nAnother part in the same passage mentions a study where 14 out of 280 contacts were positive, and the general transmission rate is around 3%. The third passage talks about contact definitions but doesn't add much. The fourth passage reinforces that transmission is inefficient and mostly in healthcare settings with poor infection control. \n\nSo putting it all together, the answer should include that transmission is sporadic, intra-familial, healthcare-associated, inefficient, and requires close and prolonged contact. The user probably wants the exact terms used in the context. Let me make sure there's no other info conflicting. The answer is directly stated in the second passage, so I can confidently use that.\n</think>\n\nThe transmission of MERS-CoV is defined as **sporadic, intra-familial, often healthcare-associated, inefficient, and requiring close and prolonged contact**. This is explicitly stated in the second passage, which emphasizes that transmission occurs under these specific conditions, with limited spread even in outbreaks (e.g., a 3% general transmission rate observed in studies). Healthcare settings with poor infection control have been particularly significant in facilitating transmission.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: The first WHO case definition defined probable cases of MERS based on the presence of febrile illness, cough and requirement for hospitalization with suspicion of lower respiratory tract involvement.",
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: MERS-CoV was found and characterized because of its apparent association with severe, and therefore more obvious, illness in humans; we were the canaries in the coal mine. Sero-assays and prospective cohort studies have yet to determine the extent to which milder or asymptomatic cases contribute to MERS-CoV transmission chains. However, transmission of MERS-CoV is defined as sporadic , intra-familial, often healthcare associated, inefficient and requiring close and prolonged contact In a household study, 14 of 280 contacts of 26 MERS-CoV positive index patients were RNA or antibody positive; the rate of general transmission, even in outbreaks is around 3 %\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: of \"contact\" during these interviews has been defined for one study . Despite this lack of clarity, the WHO consider that evidence linking MERS-CoV transmission between DCs to humans is irrefutable .",
        "From July 2013, the revised WHO case definition included the importance of seeking out and understanding the role of asymptomatic cases and from June 2014, the WHO definition more\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: It became apparent early on that MERS-CoV spread relatively ineffectively from human-to-human. Despite ongoing and possibly seasonal introduction of virus to the human population via infected DCs and perhaps other animals yet to be identified, the vast majority of MERS-CoV transmission has occurred from infected to uninfected humans in close and prolonged contact through circumstances created by poor infection control in health care settings. This opportunistic virus has had its greatest impact on those with underlying diseases and such vulnerable people, sometimes suffering multiple comorbidities, have been most often associated with hospitals, creating a perfect storm of exposure, transmission and",
        "If strictly adhered to, only the severe syndrome would be subject to laboratory testing, which was the paradigm early on .",
        "It also included roles for contact with a probable or confirmed case or for travel or residence within the Arabian Peninsula."
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.3,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.25,
      "gt_utilization": 0.0625,
      "gt_completeness": 0.25,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 58,
      "dataset_id": "495",
      "question": "What is carageenan?",
      "ground_truth_answer": "Carrageenan is a high molecular weight sulfated polymer derived from red seaweed that has been extensively used in food, cosmetic and pharmaceutical industry and is generally recognized as safe by the FDA. It has three main forms: kappa, iota, and lambda, which differ in their degree of sulfation, solubility, and gelling properties.",
      "generated_response": "<think>\nOkay, let's see. The user is asking \"What is carrageenan?\" based on the provided context. First, I need to look through the context to find relevant information.\n\nThe context starts by mentioning that the Ca\u00b2+ ion is yellow green, but that might not be directly related. Then it says carrageenan is a high molecular weight sulfated polymer from red seaweed, used in food, cosmetics, and pharmaceuticals, and is FDA-approved as safe. There are three main types: kappa, iota, and lambda. The passage also talks about a study using kappa and iota carrageenan, confirming their identity and purity via NMR, and mixing them into a solution. The title mentions carrageenan's antiviral effect, specifically with influenza A virus when used with zanamivir.\n\nSo, putting this together, the answer should define carrageenan as a sulfated polymer from red seaweed, used in various industries, with three main types. Also, mention its antiviral mechanism by interfering with viral attachment. The example with the study can be included to show application. Need to make sure not to include irrelevant details like the Ca\u00b2+ color unless necessary. The answer should be concise but cover all key points from the context.\n</think>\n\nCarrageenan is a high molecular weight sulfated polymer derived from red seaweed, commonly used in food, cosmetic, and pharmaceutical industries. It is generally recognized as safe by the FDA and exists in three main forms: kappa, iota, and lambda. Its antiviral mechanism involves interfering with viral attachment, preventing viral entry into host cells. The context also highlights its synergistic antiviral activity against influenza A virus when combined with zanamivir, as demonstrated in a murine model study.",
      "retrieved_chunks": [
        "The Ca 2+ ion is colored yellow green.",
        "Carrageenan is a high molecular weight sulfated polymer derived from red seaweed that has been extensively used in food, cosmetic and pharmaceutical industry and is generally recognized as safe by the FDA ). Three main forms of carrageenans are commercially used: kappa, iota and lambda.",
        "Molecular cartoon drawn with Chimera.",
        "The antiviral mechanism of carrageenan is based on the interference with viral attachment; as a consequence, viral entry is\n\nTitle: The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model\nPassage: Kappa-carrageenan and iota-carrageenan were purchased from FMC Biopolymers . The identity, purity of carrageenan subtypes and the molecular weight was confirmed by NMR analysis as described elsewhere and the presence of lambda-carrageenan was below the detection limit of 3%.",
        "For further testing the stock solution was diluted to a mixture containing 1.2 mg/ml iota-carrageenan and 0.4 mg/ml kappa-carrageenan ."
      ],
      "computed_relevance": 0.42857142857142855,
      "computed_utilization": 0.7142857142857143,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2631578947368421,
      "gt_utilization": 0.15789473684210525,
      "gt_completeness": 0.6,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 59,
      "dataset_id": "1740",
      "question": "What is an effective public health hygiene?",
      "ground_truth_answer": "An effective public health hygiene is hand hygiene, which includes handwashing, safe cough practices, and social distancing to prevent the spread of respiratory viruses such as SARS-CoV-2. It has been shown to be a highly effective intervention in reducing the impact of COVID-19 and other respiratory infections.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is an effective public health hygiene?\" and they provided several contexts. I need to go through each passage and extract relevant information.\n\nFirst, the first context talks about responding to COVID-19 in humanitarian crises. It mentions that respiratory hygiene is effective, including hand hygiene, safe coughing, and social distancing. So hand hygiene is definitely a key point here.\n\nThe second context is about H1N1 in Hong Kong. It says that self-efficacy in prevention affects hand hygiene more than social distancing. Also, distributing soap increases handwashing by over 30%. So hand hygiene is emphasized again, and the role of education and trust in messages is mentioned.\n\nThird context is about Korea's national handwashing projects. It states that education in public facilities reduces infection risk and that role models like healthcare workers encourage hand hygiene. Institutional support is important here.\n\nFourth context is a focus group study on H1N1. Participants remembered hygiene measures like handwashing and sanitizer use. Some groups translated that into action.\n\nPutting this all together, the common theme is hand hygiene. All the contexts highlight handwashing as effective. Also, education and distribution of resources like soap are important. Social distancing is mentioned but less emphasized compared to hand hygiene. Safe coughing and staying home are additional measures. The answer should focus on hand hygiene as the primary effective method, supported by education, soap distribution, and role models. Also, maybe mention that while social distancing is part of it, hand hygiene is more impactful based on the studies.\n</think>\n\nAn effective public health hygiene measure is **hand hygiene**, which includes regular handwashing with soap and the use of hand sanitizers. This is supported by evidence across multiple contexts:  \n1. **Hand hygiene** is highlighted as a critical intervention for preventing respiratory virus transmission (e.g., SARS-CoV-2, H1N1), with soap distribution in humanitarian settings increasing handwashing by over 30%.  \n2. **Education and self-efficacy** play a key role in promoting hand hygiene, particularly when health messages emphasize individuals' ability to protect themselves.  \n3. **Institutional support**, such as hygiene education in schools, hospitals, and public facilities, reduces infection risks and reinforces behaviors through role models (e.g., healthcare workers).  \n4. While **social distancing** is also mentioned, studies suggest hand hygiene is more consistently adopted and influenced",
      "retrieved_chunks": [
        "Title: Responding to the COVID-19 pandemic in complex humanitarian crises\nPassage: To mitigate the impact of COVID-19 on crisesaffected populations, governments and agencies will implement the familiar, global evidence-based approaches for combatting respiratory viruses. Respiratory hygiene is a highly effective public health intervention, supported by evidence demonstrating that the spread of respiratory viruses, such as SARS-CoV-2, can be prevented by hand hygiene, safe cough practice, and social distancing .",
        "Title: Situational Awareness and Health Protective Responses to Pandemic Influenza A (H1N1) in Hong Kong: A Cross-Sectional Study\nPassage: Self-efficacy in preventing A/H1N1 influences hand hygiene but has little influence on social distancing. Formal health education messages that focus on enhancing the public's sense of their ability to protect themselves by adopting hygiene practices would seem to be the most effective to improve hand hygiene, but where the practice is already established, high levels of trust in these messages are not likely to significantly increase hand hygiene.",
        "Hand hygiene is a readily implemented behavior: the distribution of soap to households in humanitarian settings has been shown to increase handwashing by over 30% . Furthermore, hand hygiene is an avenue of agency for protecting one's own health, consistent with the\n\nTitle: Handwashing with soap and national handwashing projects in Korea: focus on the National Handwashing Survey, 2006-2014\nPassage: Hand hygiene education in public facilities such as schools and kindergartens resulted in reduced risk of infection, and hand hygiene compliance in hospital settings reduced the incidence of in-hospital infections and, thus, reduced demand for hospital resources . Worldwide, handwashing and hand hygiene education programs have high priority in public health programs, in which role models such as healthcare workers and community members encourage hand hygiene. Institutional support for funded studies and interventions should be a top-priority agenda item in order to improve hand hygiene behaviors .",
        "Title: Community responses to communication campaigns for influenza A (H1N1): a focus group study\nPassage: Recall of key health messages was varied, however most participants were aware of hygiene self-efficacy measures such as hand washing, sanitiser use, covering of coughs and sneezes, and staying at home.",
        "This was particularly strong in one of the Pacific Peoples groups and for many appeared to be translated into action."
      ],
      "computed_relevance": 0.6,
      "computed_utilization": 0.6,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4666666666666667,
      "gt_utilization": 0.2,
      "gt_completeness": 0.42857142857142855,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 60,
      "dataset_id": "1255",
      "question": "What would  aid accurate calculation of a case fatality ratio?",
      "ground_truth_answer": "The accurate calculation of a case fatality ratio would be aided by considering the probability of dying from the disease and accounting for biases in data reporting.",
      "generated_response": "<think>\nOkay, let's see. The user is asking what would aid in accurately calculating the case fatality ratio (CFR). The context provided mentions that using D/N (deaths over notified cases) underestimates the true CFR. The passage explains that this is because the integral part of the equation is less than 1, which suggests that there's some delay or underreporting in the data.\n\nSo, the key issue here is that if you just take the number of deaths divided by the number of reported cases, you might get an underestimate. Why? Because not all cases have been reported yet, especially in an emerging epidemic. People who are infected might not have shown symptoms or died yet, so the denominator (N) is too small. \n\nThe passage also mentions that the underestimation is due to the integral part of the equation being less than 1. That integral probably represents the proportion of cases that have been followed up long enough to know the outcome. If you don't account for the time it takes for deaths to occur after infection, you'll miss some deaths that haven't been recorded yet. \n\nSo, to get a more accurate CFR, you need to adjust for the time lag between infection and death. The answer might involve using a more sophisticated model that accounts for the distribution of times from infection to death. The context mentions \"a distribution of times\" in relation to the infection-fatality ratio. That suggests that knowing how long it takes from infection to death helps in adjusting the CFR calculation. \n\nAnother point is that the crude estimator D/N is biased because of underreporting or delayed reporting. Therefore, accurate calculation would require adjusting for these biases. The passage refers to \"remedies\" for these biases, which might include using statistical methods that account for the reporting delays or using more comprehensive data that includes all cases, not just the reported ones. \n\nSo, putting it all together, the answer should mention adjusting for the time between infection and death, using a distribution of times, and possibly accounting for underreporting or delayed reporting. The key is that the standard D/N ratio is too simplistic and underestimates the true CFR because it doesn't consider that some cases haven't resulted in death yet or aren't reported. Therefore, using a model that incorporates the time distribution from infection to death would help in getting a more accurate CFR.\n</think>\n\nTo accurately calculate the case fatality ratio (CFR), it is essential to account for",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: to the infection fatality ratio. Title: Estimation in emerging epidemics: biases and remedies\nPassage: Another useful application of the above result is to countbased estimation of the case fatality rate .",
        "In this case, p represents the probability of dying from the disease.",
        "It is well known that a crude estimator of the type D/N, D denoting number of dead individuals and N number of notified individuals in , will underestimate the 'true' CFR. In theory, disregarding biased reporting, the underestimation is reflected in the integral part of equation , which is always less than 1, where h\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: influence the rate of death and hence the estimated number of true underlying cases. Title: Estimating the number of infections and the impact of non-\nPassage: 19 infection-fatality-ratio ifr 9 together with a distribution oftimes",
        "The problem has been treated by many authors under many different assumptions of data availability )."
      ],
      "computed_relevance": 0.5714285714285714,
      "computed_utilization": 0.42857142857142855,
      "computed_completeness": 0.5,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5833333333333334,
      "gt_utilization": 0.3333333333333333,
      "gt_completeness": 0.5714285714285714,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 61,
      "dataset_id": "1718",
      "question": "Why might we underestimate the spread of COVID19?",
      "ground_truth_answer": "The spread of COVID-19 might be underestimated due to the inaccuracies in describing the geographic spread of the virus, as well as the high level of uncertainty and bias in estimating the number of infections and the impact of non-social distancing interventions. Additionally, data quality and availability impose limitations on modeling analysis, which could also contribute to underestimating the spread of COVID-19.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking why we might underestimate the spread of COVID-19. I need to look at the provided context to find relevant information.\n\nFirst, looking at the first context about the 2009 influenza pandemic, it mentions that geographic spread might be inaccurately described by raw commuting data. That suggests that using certain data (like commuting fluxes) might not capture the real spread accurately. Maybe similar issues apply to COVID-19.\n\nThen, the next contexts are about estimating infections and the impact of non-... Well, the passages mention that data gives a systematically biased view of trends and that there's a high level of uncertainty. Also, they talk about social distancing as an intervention. The conclusion is that data quality and availability limit modeling, and other factors might influence infection rates besides human behavior.\n\nPutting this together, underestimating the spread could be due to relying on incomplete or biased data. For example, if they use commuting data that doesn't account for all movements, or if testing isn't widespread, leading to underreported cases. Also, behavioral changes like social distancing might reduce transmission, but if models don't account for these changes properly, they might not capture the true spread. Additionally, other factors not considered in the models could be affecting the spread, leading to underestimation.\n\nSo the answer should mention data limitations (quality, availability, biases), reliance on certain data types (like commuting fluxes which might not be accurate), and unaccounted factors influencing transmission.\n</think>\n\nThe spread of COVID-19 might be underestimated due to limitations in data quality and availability, which can lead to systematically biased trends and high uncertainty in modeling. For example, relying on raw commuting data or incomplete case reports may inaccurately represent transmission dynamics. Additionally, human behavioral adaptations (e.g., social distancing) and unaccounted factors influencing the force of infection could further distort estimates, as models may fail to capture these variables adequately.",
      "retrieved_chunks": [
        "Title: Detecting a Surprisingly Low Transmission Distance in the Early Phase of the 2009 Influenza Pandemic\nPassage: Our results support the idea already presented by Birrell et al. 53 that the geographic spread of influenza might be inaccurately described by raw commuting fluxes.",
        "First, concerning the initial seeding of the infection, we compute the region-specific probability of importing cases by using data on the\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: gives a systematically biased view of trends. Title: Estimating the number of infections and the impact of non-\nPassage: with a high level of uncertainty. Title: Estimating the number of infections and the impact of non-\nPassage: Social distancing encouraged: As one of the first interventions against the spread of the COVID-19",
        "Clearly, data quality and availability impose several limitations on our modeling analysis.",
        "However, although our results point in the direction of a human behavioral adaptation to the pandemic threat, they are far from conclusive.",
        "In fact, other factors could have been responsible for the changes in the force of infection that we measured."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.5833333333333334,
      "gt_utilization": 0.3333333333333333,
      "gt_completeness": 0.5714285714285714,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 62,
      "dataset_id": "658",
      "question": "What is the effect of host immune response to the delivery vector on the efficacy of vaccination?",
      "ground_truth_answer": "The effect of host immune response to the delivery vector on the efficacy of vaccination varies. Some studies indicate that pre-existing immunity to the delivery vector may decrease immune responses against the delivered antigens, particularly impacting humoral responses and CD8+ responses. However, repeated immunization with the same vaccine and dose may counteract the negative impact and lead to higher priming of naive T cells against the delivered antigen. Additionally, controlling pre-host evolution of the vaccine vector may be a feasible way to limit within-host evolution and minimize the loss of immunity from vaccine evolution. For viral vectors, cell-mediated immunity may have a more pronounced impact, often resulting in a reduction in subsequent immune response, especially with common viral vectors like Ad which many people have immunological memory against.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the effect of the host's immune response to the delivery vector on vaccination efficacy. I need to look through the provided context to find relevant information.\n\nFirst, the context mentions that pre-host evolution (which I think refers to pre-existing immunity against the vector) can impact the host's immune response. The passage says that exposure to an empty vector might completely abrogate immune responses against the delivered antigens. That means if the host already has immunity to the vector, the vaccine might not work as well because the immune system is attacking the vector instead of the antigen.\n\nAnother part says that for viral vectors, cell-mediated immunity has a more pronounced effect, leading to reduced subsequent immune responses. The reason given is that the first dose induces neutralizing antibodies, which then limit the number of transduced cells in subsequent doses. So, if someone has pre-existing immunity to the vector, the vaccine's effectiveness is diminished because the body neutralizes the vector before it can deliver the antigen.\n\nHowever, there's also a note that repeated immunization with the same vaccine can counteract this negative impact. Repeating the vaccination might prime naive T cells better against the antigen. But the context also mentions that repeated vaccination might not be practical in real-world scenarios. So, while there's a way to mitigate the issue, it's not always feasible.\n\nPutting this together, the host's immune response to the vector can reduce vaccine efficacy by neutralizing the vector, thus limiting antigen delivery. But strategies like repeated dosing might help overcome this, though they have limitations.\n</think>\n\nThe host immune response to the delivery vector can significantly reduce the efficacy of vaccination. Pre-existing immunity against the vector (e.g., from prior exposure to viral vectors) may **abrogate immune responses against the delivered antigens**, as the host's immune system targets the vector itself rather than the antigen. For viral vectors, this manifests as **neutralizing antibodies** from the first dose limiting transduced cells in subsequent doses, thereby diminishing antigen-specific immune responses. However, repeated immunization with the same vaccine and dose can partially counteract this by enhancing priming of naive T cells against the antigen. Despite this, repeated vaccination may not be practical in real-world settings, making pre-existing immunity a critical challenge for vector-based vaccines.",
      "retrieved_chunks": [
        "also demonstrated that the negative impact of vector-specific immune responses can also be countered by repeated immunization with the same vaccine and dose; this in effect leads to higher priming of naive T cells against the delivered antigen. Of course, such repeated vaccination may not be practicable in real-world situations.",
        "Title: Recombinant vector vaccine evolution\nPassage: The effect of any 'pre-host' evolution on the host immune response is potentially as important as the effect of within-host evolution.",
        "indicated that exposure to the empty vector may completely abrogate immune responses against the delivered antigens . However, these studies also indicate that downregulation of antigenspecific immune responses is highly dependent on dose and time.",
        "Title: Pre-existing immunity against vaccine vectors \u2013 friend or foe? Passage: For viral vectors, the impact of cell-mediated immunity was more pronounced, and as depicted in Table 2 , almost always resulted in a reduction in the subsequent immune response. Presumably this is because viruses will induce neutralizing antibody on the first dose, and in subsequent doses this antibody will limit the number of transduced cells, therefore limiting the responses.",
        "An important difference between the two realms is that pre-host evolution may be more easily mitigated than is within-host evolution. That is, controlling pre-host evolution may be a feasible way to limit within-host evolution and to limit the loss of immunity from vaccine evolution. Title: Pre-existing immunity against vaccine vectors \u2013 friend or foe?"
      ],
      "computed_relevance": 0.18181818181818182,
      "computed_utilization": 0.36363636363636365,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5882352941176471,
      "gt_utilization": 0.47058823529411764,
      "gt_completeness": 0.7,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 63,
      "dataset_id": "1612",
      "question": "What is another  case in point?",
      "ground_truth_answer": "Another case in point is the use of case examples as training material for public health nurses based on real cases that have come to the attention of the RKI in the quality control process.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking for another case in point, which means they want an example similar to the ones mentioned in the context. The context talks about case examples used in a study assessing the reliability of case definitions for public health surveillance. These examples were created from real cases and included facsimile excerpts from sources like laboratory reports, physician forms, and patient interview protocols.\n\nSo, another case in point would be another example of a case definition or scenario used in the study. The context mentions that the case examples were based on real cases from the RKI's quality control process and hotline. The study compared different formats of case definitions\u2014narrative descriptions versus explicit checklists. The case examples were presented to participants, and 220 out of 396 found them realistic.\n\nTo answer the question, I need to think of another instance where case definitions were used in a similar way. Maybe another disease's case definition that uses a checklist format versus a narrative one. For example, the IfSG case definitions mentioned in the context were implemented for diseases notifiable in specific states. Another example could be a different disease where the case definition was revised from a narrative to a checklist format, and then tested for reliability using a Round-Robin method. Alternatively, another source of case examples, like a different type of medical documentation (e.g., hospital discharge summaries or electronic health records) could be another case in point. The key is to provide a specific example that fits within the study's methodology and purpose.\n</think>\n\nAnother case in point could be the use of **checklist-style case definitions for measles surveillance** compared to narrative descriptions. For instance, public health departments might evaluate whether a checklist format (e.g., \"fever + rash + contact with a known case\") improves inter-rater reliability among healthcare workers compared to a narrative description of the clinical picture (e.g., \"a patient presenting with high fever, erythematous rash, and recent exposure to an infected individual\"). This aligns with the study\u2019s focus on comparing explicit criteria versus narrative formats to assess reliability in public health surveillance.",
      "retrieved_chunks": [
        "The clinical classification was considered correct if the part regarding the clinical picture was classified according to the gold standard, regardless whether other parts of the case definition were correctly classified or not. This analysis was done to compare case definitions with narrative description of the clinical pic-ture to case definitions with a more explicit check-list format of clinical criteria, that was implemented for diseases additionally notifiable in specific states and for the new IfSG case definitions.",
        "The case examples were created based on real cases that have come to the attention of the RKI in the quality control process and in the information service hotline that the RKI is offering to the health departments.",
        "With respect to the case examples presented to the participants, 220 of 396 respondents stated that the case examples were realistic.",
        "Title: Reliability of case definitions for public health surveillance assessed by Round-Robin test methodology\nPassage: To specifically assess the effect of different styles in formulating case definitions, a fourth outcome variable was used.",
        "Title: Reliability of case definitions for public health surveillance assessed by Round-Robin test methodology\nPassage: The case example book, which resulted from this study, constitutes a detailed feed back for the participants of the study and is now being used as training material for public health nurses. Title: Reliability of case definitions for public health surveillance assessed by Round-Robin test methodology\nPassage: The case examples consisted in facsimile excerpts of one or more of the following sources: laboratory report form, physician form, and protocol of the patient interview ."
      ],
      "computed_relevance": 0.5714285714285714,
      "computed_utilization": 0.5714285714285714,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.25,
      "gt_utilization": 0.16666666666666666,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 64,
      "dataset_id": "39",
      "question": "How many antigens could be detected by Liew's multiplex ELISA test?",
      "ground_truth_answer": "Liew's multiplex ELISA test could detect 9 antigens.",
      "generated_response": "<think>\nOkay, let's see. The question is asking how many antigens Liew's multiplex ELISA test could detect. The context provided mentions that Liew validated one multiplex ELISA for the detection of 9 antigens. So right there, the answer should be 9. But wait, I need to make sure I'm not missing anything else.\n\nLooking at the other parts of the context, Anderson used microarray ELISA for antibodies to tumor antigens in breast cancer, but the question is specifically about Liew's test. The other passages talk about an ELISA-array for encephalitis viruses, but again, the question is about Liew's work. The key sentence is \"Liew validated one multiplex ELISA for the detection of 9 antigens.\" So that's straightforward. The answer is 9. I don't see any conflicting information here. The rest of the context is about different studies or other aspects of ELISA arrays, but the number 9 is directly stated for Liew's test. I think that's it.\n</think>\n\nThe answer is **9**. \n\nLiew's multiplex ELISA test was validated for the detection of **9 antigens**, as explicitly stated in the context. Other details in the passage discuss different studies (e.g., Anderson's microarray ELISA or the ELISA-array for encephalitis viruses) but do not pertain to Liew's specific work.",
      "retrieved_chunks": [
        "Liew validated one multiplex ELISA for the detection of 9 antigens; Anderson used microarray ELISA for multiplex detection of antibodies to tumor antigens in breast cancer, and demonstrated that ELISA-based array assays had the broadest dynamic range and lowest sample volume requirements compared with the other assays.",
        "Title: Development of an ELISA-array for simultaneous detection of five encephalitis viruses\nPassage: for printing than for coating ELISA plates.",
        "Title: Development of an ELISA-array for simultaneous detection of five encephalitis viruses\nPassage: Antibody arrays for simultaneous multiple antigen quantification are considered the most accurate methods .",
        "Title: Development of an ELISA-array for simultaneous detection of five encephalitis viruses\nPassage: antibodies demonstrated that 0.05 mg/ml was also suitable. Title: Development of an ELISA-array for simultaneous detection of five encephalitis viruses\nPassage: Antigen binding was performed in PBS at 37\u00b0C for 2 h, followed by washing 3 times. Incubation of ELISA plates with biotinylated detecting antibody cocktails was performed in PBS at 37\u00b0C for 2 h. After washing, specific binding of the detecting antibodies was reported by streptavidin-HRP and stained with Super Signal ELISA Femto Maximum sensitive substrate .",
        "Coating of a single well in microtiter plate requires 100 \u03bcl of a 1 \u03bcg/ml antibody solution, which is equivalent to 100 ng of IgG. For the ELISA-array, only 30 nl of a 50 \u03bcg/ml antibody solution is required for each spot, which is equivalent to 1.5 ng of IgG. With the characteristics of ease of use, sensitivity, specificity, and accuracy, the ELISA-array assay would be widely accepted for clinical use."
      ],
      "computed_relevance": 0.1,
      "computed_utilization": 0.1,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.0625,
      "gt_completeness": 0.5,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 65,
      "dataset_id": "1270",
      "question": "How were the radiology department areas divided?",
      "ground_truth_answer": "The radiology department areas were divided into contaminated, semicontaminated, and clean areas.",
      "generated_response": "<think>\nOkay, let's see. The user is asking how the radiology department areas were divided. The context provided has a few passages. The first one mentions that the radiology department was divided into four areas: contaminated, semicontaminated. Wait, the first passage says \"contaminated, semicontaminated,\" but it cuts off. Then the second passage starts with \"Figure 1. Diagram of the layout of our radiology department was divided into four areas: contaminated.\" Again, it seems like it's the same information but also cuts off. The third title is about reconfiguration, but the passage is just the title. The fourth passage mentions the number of staff but not the division.\n\nSo, putting it together, the key info is that the department was divided into four areas. The first two passages mention \"contaminated\" and \"semicontaminated,\" but the list is incomplete. However, in typical infection control zones, there are usually four areas: contaminated, semi-contaminated, clean, and maybe a buffer zone or something similar. But since the provided context only mentions two of the four areas explicitly, maybe the answer is that they were divided into four areas, specifically contaminated, semicontaminated, and possibly two others not mentioned here. But the user's answer should be based strictly on the given context. Since the context only lists two of the four areas, but the question is about how they were divided (i.e., into four areas), the answer should state that they were divided into four areas, naming the two mentioned and noting that the others aren't specified here. Wait, but maybe the original text in the figure or diagram had all four? But the user's context only shows parts of the passages. The first passage says \"divided into four areas: contaminated, semicontaminated,\" and the second passage says \"divided into four areas: contaminated.\" So maybe the full list is contaminated, semicontaminated, clean, and buffer? But since the context doesn't provide the full list, the answer should just state that the department was divided into four areas, with the first two being contaminated and semicontaminated. The answer should be concise and based on the given info.\n</think>\n\nThe radiology department was divided into four areas, specifically labeled as **contaminated** and **semicontaminated**, though the full list of all four areas is not explicitly provided in the given context. The",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: The radiology department was divided into four areas : contaminated, semicontaminated,\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Figure 1. Diagram of the layout of our radiology department was divided into four areas: contaminated\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Reconfiguration of the radiology department\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: The radiology department has 65 diagnostic radiologists and 161 other staff members"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.3333333333333333,
      "gt_utilization": 0.2222222222222222,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 66,
      "dataset_id": "1428",
      "question": "What is an example of this?",
      "ground_truth_answer": "An example of this is the transition from ice ages to interglacial periods, which is an Earth system threshold point and phase change.",
      "generated_response": "<think>\nOkay, let's see. The user is asking for an example of a social phase change based on the provided context. The context mentions that social phase changes occur when an audience stands to applaud or a crowd flees a storm. Also, there's a mention of \"eco-social\" changes.\n\nLooking at the answer examples given, the user provided a sample where the answer is \"an audience stands to applaud\" from the context. Now, the user wants me to answer the same question but with the new context provided.\n\nThe new context includes several titles and passages. The first one is about Chinese journals and a colonial legacy affecting language. The second is about interconnected risks of infectious diseases. The third is about Earth system tipping points. The fourth is \"Sounding the Alarm: Health in the Anthropocene\" with examples of phase changes like water freezing or waking up.\n\nWait, the question is asking for an example of a social phase change. The original context had examples like audience applauding. The new context's passages don't mention social phase changes directly. The only mention is in the first context paragraph. But the user provided the new context, so maybe I need to check if any of the new passages have examples.\n\nLooking again: The first passage is about Chinese journals and language heritage. The second is about interconnected risks of infectious diseases. The third is Earth system tipping points. The fourth passage says examples of phase changes are water freezing or waking up. But those are physical phase changes, not social. The original context's examples were social. The user's question is about social phase changes. The new context's passages don't provide new examples of social phase changes. The only examples are in the initial context provided in the first paragraph. So the answer should be from that part. The user's example answer was \"an audience stands to applaud,\" which is from the first context. So the answer here should be the same. The other passages don't mention social phase changes. Therefore, the correct answer is one of the examples given in the first context, like the audience standing to applaud or fleeing a storm.\n</think>\n\nAnswer: An audience stands to applaud.",
      "retrieved_chunks": [
        "Social phase changes also occur, such as when an audience stands to applaud, or when a crowd in an uncovered stadium flees a violent storm. The onset of open hostility is another example of a social phase change. \"Eco-social\" changes can also occur, and are discussed below.",
        "Title: Chinese journals: a guide for epidemiologists\nPassage: an example of how a colonial legacy has left a language heritage that fosters internationalisation in this globalising world.",
        "Examples include the transition to\n\nTitle: The interconnected and cross-border nature of risks posed by infectious diseases\nPassage: It is instructive to provide a few examples of how such risks are interconnected in the context of infectious disease.",
        "Earth system scientists have identified many potential future tipping points, including in the climate system.",
        "Title: Sounding the Alarm: Health in the Anthropocene\nPassage: Examples of phase changes are when water solidifies at freezing point or when we awaken."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.16666666666666666,
      "gt_utilization": 0.1111111111111111,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 67,
      "dataset_id": "959",
      "question": "What  did the first report on adenovirus as a vector demonstrate?",
      "ground_truth_answer": "The first report on adenovirus as a vector demonstrated its ability to stimulate both innate and adaptive immune responses and induce both T and B cell responses. Adenovirus vectors have been extensively examined as a delivery vector in several preclinical and clinical studies for infectious diseases.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what the first report on adenovirus as a vector demonstrated. The context provided includes three different passages, each discussing adenovirus vectors in the context of vaccines.\n\nFirst, I need to identify which part of the context refers to the first report. The first passage mentions \"Nasal Delivery of an Adenovirus-Based Vaccine...\" and talks about bypassing pre-existing immunity and improving immune response in mice. The second and third passages discuss a simian adenovirus vector, PanAd3, and its use in influenza vaccination, mentioning cross-blocking with other vectors. The third passage also talks about adenovirus vectors in general, their production, and use in various diseases.\n\nThe key here is to determine which part refers to the initial demonstration. The third passage states that adenovirus vectors are \"another of the most widely evaluated vectors to date to express heterologous antigens\" and lists reasons like ease of production, safety, etc. This seems to be a general overview. However, the first passage specifically mentions a study where nasal delivery bypasses pre-existing immunity. The second passage discusses cross-blocking with homologous vectors but refers to prior immunization with a GFP-expressing construct.\n\nThe question is about the first report. The first report would likely be the foundational study showing that adenovirus can be used as a vector. The third passage mentions that adenovirus vectors are widely evaluated, which implies they've been used for a while. However, the first passage's study might be a specific finding (nasal delivery bypassing pre-existing immunity), which could be a later study. The answer might be in the third passage's statement about the general properties of adenovirus vectors. But the user is asking for what the first report demonstrated. Since the context doesn't provide the very first study, but the third passage does mention that adenovirus vectors are widely evaluated due to their properties, perhaps the first report showed their ability to express antigens and stimulate immune responses. Alternatively, the first report might have demonstrated their use in vaccine delivery. The answer should be inferred from the context given. The third passage says they are \"most widely evaluated vectors to date to express heterologous antigens\" due to ease of production, safety, etc., and ability to stimulate both innate and adaptive immune responses. So the first report likely demonstrated these properties, showing that adenovirus can effectively deliver antigens",
      "retrieved_chunks": [
        "Title: Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice\nPassage: an affinity column according to the manufacturer's instructions.",
        "Title: Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus\nPassage: and four chimpanzee adenovirus vectors, prior immunization with a GFPexpressing construct blocked subsequent responses to the transgene product only for homologous vector; cross-blocking was minimal . Title: Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus\nPassage: Viral particle measurements of adenovirus stocks were made by measurement of absorbance at 260 nm as described .",
        "The adenovirus vector is another of the most widely evaluated vectors to date to express heterologous antigens, due to ease of production, safety profile, genetic stability, the ease of DNA genome manipulation, and the ability to stimulate both innate and adaptive immune responses and induce both T and B cell responses .",
        "Particle number and infectivity of vectors were determined by standard optical density reading and immunodetection of the hexon protein, respectively, following infection of 293 cells with limiting dilutions of each vector preparation according to the recommendations by the manufacturer .",
        "They have been extensively examined as a delivery vector in several preclinical and clinical studies for infectious diseases such as anthrax, hepatitis B, human immunodeficiency virus -1, influenza, measles, severe acute respiratory syndrome , malaria and tuberculosis M."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.23076923076923078,
      "gt_utilization": 0.15384615384615385,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 68,
      "dataset_id": "344",
      "question": "What has been correlated with the pathogenicity of the H5N1 infection?",
      "ground_truth_answer": "The pathogenicity of the H5N1 infection has been correlated with various factors, including viral replication overwhelming the host immune system, specific amino acid substitutions in PB2, and exposure to poultry. It has also been noted that comorbidities are a major risk for death from the H5N1 virus.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what has been correlated with the pathogenicity of H5N1 infection. I need to look through the provided context to find the relevant information.\n\nFirst, looking at the first passage, it mentions that the H5N1 virus is highly pathogenic in poultry and that there are differences in sensitivity among chicken breeds. The study compared genetically similar H5N1 strains in chickens, specifically White Leghorn and Thai indigenous chickens. They looked at pathogenicity and host responses. The passage also states that the mechanism of high pathogenicity isn't fully understood but suggests it's related to host and viral factors.\n\nThe second passage talks about human infections and mentions that severity is linked to host factors like chronic diseases, immunosuppressive disorders, delayed diagnosis, and late treatment, as well as virus factors such as pathogenicity, replication, and mutations. It also mentions specific amino acid substitutions in PB2, which might be a viral factor affecting pathogenicity. However, the question is about what's correlated with pathogenicity, not the factors causing severity in humans.\n\nThe third part of the context again discusses poultry exposure and comorbidities as major risks for death from H5N1, but again, that's about human outcomes, not the pathogenicity of the virus itself.\n\nThe key part here is the last sentence in the first passage: \"Various viral factors have been shown to be related to differences in pathogenicity.\" The passage also mentions that pathogenicity is thought to be related to viral replication, which can overwhelm the host's immune system or cause it to malfunction. So, viral replication is a key factor here. Additionally, the specific amino acid substitutions in PB2 (from the second passage) are viral factors that might influence pathogenicity. However, the answer should focus on what's directly mentioned in the context provided.\n\nThe question is about what's correlated with the pathogenicity of H5N1 infection. The context links pathogenicity to viral replication and host factors like chicken breed sensitivity. But the answer should be based on the provided passages. The first passage's last sentence says pathogenicity is related to viral replication overwhelming the host immune system or causing malfunction. Also, the study compared different chicken breeds, indicating host factors (like breed) affect pathogenicity. However, the question is about what's correlated, so the main points are viral replication and host factors",
      "retrieved_chunks": [
        "Title: Pathogenicity of Genetically Similar, H5N1 Highly Pathogenic Avian Influenza Virus Strains in Chicken and the Differences in Sensitivity among Different Chicken Breeds\nPassage: The H5N1 virus is endemic in poultry and has caused occasional infections in mammals.",
        "Title: Comparative Epidemiology of Human Fatal Infections with Novel, High (H5N6 and H5N1) and Low (H7N9 and H9N2) Pathogenicity Avian Influenza A Viruses\nPassage: Previous studies have shown that the severities of the illnesses caused by avian influenza are linked to host factors, including chronic diseases, immuno-suppressive disorders, delayed confirmation of infection and late antiviral treatment , as well as virus factors such as pathogenicity, replications and mutations .",
        "Specific amino acid substitutions in PB2 ,\n\nTitle: Comparative Epidemiology of Human Fatal Infections with Novel, High (H5N6 and H5N1) and Low (H7N9 and H9N2) Pathogenicity Avian Influenza A Viruses\nPassage: generally had significantly higher levels of exposure to poultry, while the secondary cases subsequently became infected after providing care for the ill index patients or after spending prolonged periods of time with them. These findings show that poultry exposure and comorbidities are the major risks of death from the H5N1 virus. Title: Pathogenicity of Genetically Similar, H5N1 Highly Pathogenic Avian Influenza Virus Strains in Chicken and the Differences in Sensitivity among Different Chicken Breeds\nPassage: As the pathogenesis of HPAIV is complicated and is dependent on various host and viral factors, in this study, we compared the pathogenicity of five genetically related H5N1 viruses isolated from wild birds in Thailand between 2004 and 2005 to that in a commercial chicken breed, White Leghorn. Then, Thai indigenous chickens were inoculated with an H5N1 virus, and their sensitivity to infection and the genetic components related to the host response were examined.",
        "However, the mechanism underlying the highly pathogenic manifestation of the H5N1 viruses in chickens has not been fully elucidated.",
        "Viruses like influenza are continually exposed to host immune systems, and their pathogenicity is thought to be related to viral replication, which either overwhelms the host immune system or causes it to malfunction. Various viral factors have been shown to be related to differences in pathogenicity."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.1111111111111111,
      "computed_completeness": 0.5,
      "computed_adherence": 0.0,
      "gt_relevance": 0.375,
      "gt_utilization": 0.125,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 69,
      "dataset_id": "674",
      "question": "What factors determine an effective mucosal immune response?",
      "ground_truth_answer": "The factors that determine an effective mucosal immune response include the induction of systemic antibody responses, the stability of the mucus barrier, the secretion of intact, gel-forming mucus, the availability of mucosal immune proteins, including immunoglobulins and trefoil factor peptides, and the regulation of the unfolded protein response at the mucosal barrier. Additionally, the presence of cytokines such as IL-4, IL-13, and IL-10 can also contribute to an effective mucosal immune response.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what factors determine an effective mucosal immune response. I need to base my answer on the provided context.\n\nFirst, I'll go through the context again to pick out relevant information. The context mentions several things. There's a mention of mucins and their role in NEC (Neonatal Necrotizing Enterocolitis), where Goblet cell depletion is observed. Then there's a part about immune regulation involving cytokines like IL-4, IL-13, and IL-10 boosting protein production in goblet cells. Also, there's a discussion about Th17 and Th2 immune responses, and the role of mucin glycosylation in infection clearance. The gut microbiota's interaction with the mucus barrier is also noted, emphasizing the importance of intact mucus and immune proteins like immunoglobulins and trefoil factors.\n\nSo, putting this together, effective mucosal immunity likely involves the proper functioning of goblet cells (since their depletion is linked to disease), the presence of specific cytokines that support mucus production, a balanced Th17/Th2 response, and the integrity of the mucus barrier with its associated immune proteins. Also, the unfolded protein response and microbial sensing by colonic goblet cells might play roles in maintaining homeostasis and preventing inflammation.\n\nI need to make sure I don't miss any key factors. The context also talks about the unfolded protein response in the title, which might relate to how cells handle stress, possibly affecting mucosal integrity. The interaction between the gut microbiota and the mucus barrier is another factor\u2014maintaining a healthy microbiota that doesn't trigger inappropriate immune responses through GAPs (goblet cell-associated epithelial passages) is important.\n\nSo the main factors would be: mucin production and glycosylation by goblet cells, cytokines like IL-4, IL-13, IL-10, Th17 and Th2 balance, mucus barrier integrity with immunoglobulins and trefoil factors, proper microbial sensing to prevent inflammation, and the unfolded protein response in managing stress. Also, the coordination between innate and adaptive immunity is crucial here.\n</think>\n\nAn effective mucosal immune response is determined by several interrelated factors:  \n1. **Mucin Production and Glycosylation**: Goblet cells secrete mucins, which form the mucus barrier. Altered glycosylation",
      "retrieved_chunks": [
        "Together these factors normally ensure mucosal cell integrity and epithelial homeostasis through restitution and regeneration processes.",
        "A role for the mucins in the pathogenesis of NEC is indicated by the depletion of Goblet cells seen in the mucosa of neonates with NEC and this is expected\n\nTitle: Immune regulation of the unfolded protein response at the mucosal barrier in viral infection\nPassage: of both innate and adaptive immunities with an IL-23/T H 17 phenotype. 28, 29 Immune-regulated alterations in mucin glycosylation following Trichuris muris infection contribute to clearance of parasitic infection.",
        "Furthermore, due to the default Th2oriented nature of mucosal immunity, mucosal immunization shows limited induction of Th1-related antibody subtypes , which are preferable for viral clearance .",
        "31 Overriding GC microbial sensing to open colonic GAPs or inappropriate delivery of luminal pathogens through GAPs resulted in the influx of leucocytes and the production of inflammatory cytokines in the setting of normal, non-pathogenic, microbiota. 31, 32 This microbial sensing by colonic GCs has a critical role\n\nTitle: Immune regulation of the unfolded protein response at the mucosal barrier in viral infection\nPassage: As discussed, cytokines such as IL-4, IL-13 and IL-10 can boost protein production in mucin-secreting goblet cells.",
        "Title: The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human\nPassage: The stability of the mucus barrier and the innate defense mechanisms rely on the secretion of intact, gel forming mucus and the availability of mucosal immune proteins, including immunoglobulins and the trefoil factor peptides."
      ],
      "computed_relevance": 0.7142857142857143,
      "computed_utilization": 0.7142857142857143,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4444444444444444,
      "gt_utilization": 0.3333333333333333,
      "gt_completeness": 0.75,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 70,
      "dataset_id": "843",
      "question": "What are potential vaccines based on?",
      "ground_truth_answer": "Potential vaccines are based on various platforms including viral vector-based vaccine, DNA vaccine, subunit vaccine, virus-like particles-based vaccine, inactivated whole-virus vaccine, and live attenuated vaccine.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What are potential vaccines based on?\" and they provided three different contexts.\n\nFirst, I need to look at each context to see what they mention about vaccines. \n\nThe first context is about viral vector-based influenza vaccines. It mentions that vector-based vaccines are being developed and tested, and the challenge is getting regulatory approval. So here, viral vectors are a basis for vaccines.\n\nThe second context is a systematic review about vaccines for 2019-nCoV. It lists several types of vaccine candidates: viral vector-based, DNA, subunit, virus-like particles, inactivated whole-virus, and live attenuated vaccines. These are all different platforms or bases for vaccines. The passage also mentions that these vaccines work by eliciting antibodies and other immune responses. Additionally, it talks about multivalent vaccines for pathogens with antigen variability.\n\nThe third context is about vaccines for the future, referencing the Yellow fever vaccine YF-17D. However, the passage here is cut off, so maybe not much info there. But since the question is about potential vaccines in general, the first two contexts are more relevant.\n\nPutting it all together, the answer should list the different types of vaccine platforms mentioned. The key ones are viral vector-based, DNA, subunit, virus-like particles, inactivated whole-virus, and live attenuated vaccines. Also, multivalent vaccines are mentioned as a solution for pathogens with multiple strains. The first context specifically talks about viral vectors for influenza, and the second one for coronavirus. So the answer should include all these types as potential bases for vaccines.\n</think>\n\nPotential vaccines are based on various platforms, including **viral vector-based vaccines**, **DNA vaccines**, **subunit vaccines**, **virus-like particles (VLPs)-based vaccines**, **inactivated whole-virus vaccines**, and **live attenuated vaccines**. These approaches aim to elicit immune responses such as neutralizing antibodies, opsono-phagocytosis, or complement-mediated pathogen clearance. Additionally, **multivalent vaccines** (combining multiple antigens) are developed to address pathogens with antigenic variability. The contexts highlight these strategies for influenza, coronaviruses (e.g., 2019-nCoV), and other diseases.",
      "retrieved_chunks": [
        "Title: Viral vector-based influenza vaccines\nPassage: In the future, more novel vector-based influenza candidate vaccines will be developed and tested in clinical trials.",
        "226, 227 The biggest challenge of taking vector-based vaccines to the market may be obtaining approval from the regulatory authorities.",
        "Only when their safety and superiority over existing vaccine formulations have been demonstrated, implementation of these\n\nTitle: Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review\nPassage: Based on the most recent MERS-CoV outbreak, there are already a number of vaccine candidates being developed but most are still in the preclinical testing stage.",
        "The vaccines in development include viral vector-based vaccine, DNA vaccine, subunit vaccine, virus-like particles -based vaccine, inactivated whole-virus vaccine and live attenuated vaccine. The latest findings for these vaccines arebased on the review by Yong et al.",
        "These vaccines work mainly by eliciting functional antibodies that can neutralize viral invasion, neutralize bacterial toxins and induce opsono-phagocytosis or complement-mediated killing of bacteria . It has also been possible to develop effective vaccines to prevent pathogens that have a moderate degree of antigen variability and exist in multiple strains. The problem has been solved by developing multivalent vaccines, which combine multiple antigens, each directed against\n\nTitle: Vaccines for the future: learning from human immunology\nPassage: vaccinated with the Yellow fever vaccine YF-17D ."
      ],
      "computed_relevance": 0.625,
      "computed_utilization": 0.625,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.18181818181818182,
      "gt_utilization": 0.045454545454545456,
      "gt_completeness": 0.25,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 71,
      "dataset_id": "383",
      "question": "What is the conclusion of this study?",
      "ground_truth_answer": "The conclusion of this study is that any conclusions drawn from the study should be considered tentative and further research is needed to explore the complexities involved in the way in which the framing of risk messages impacts on people's reactions.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking for the conclusion of the study based on the provided context. Let me look through the passages again.\n\nFirst, there's a study titled \"Community responses to communication campaigns for influenza A (H1N1): a focus group study.\" The passage says that conclusions should be tentative because the findings can't be generalized. So, they're saying their results might not apply to everyone.\n\nThen there's another study titled \"Estimating the number of infections and the impact of non-\" with a passage mentioning that the sample doesn't allow conclusions about socio-demographic factors like age or gender. The sample was diverse but still limited in some ways.\n\nAnother part from the same study mentions limitations in the appendix and general limitations in the conclusions. The third study, \"Outcome of paediatric intensive care survivors,\" states that strong conclusive statements are difficult.\n\nPutting this together, all the studies seem to highlight that their conclusions are limited. They can't generalize their findings to the broader population or specific groups. The key points are tentative conclusions, limitations in sample diversity not covering all factors, and difficulty in making strong statements. \n\nThe user's question is asking for the conclusion of \"this study,\" but there are three different studies mentioned. However, the question might be referring to the first one since it's the first context provided. But the answer needs to consider all contexts. Wait, the user provided three different studies. Each has their own conclusions and limitations. However, the question is phrased as \"What is the conclusion of this study?\" without specifying which one. But looking at the examples given in the problem, maybe the user expects a synthesis of all the conclusions mentioned across the contexts. \n\nBut the answer should be based on the provided contexts. Each study's conclusion is that their findings are limited. The first study says conclusions are tentative and not generalizable. The second study mentions that socio-demographic factors can't be concluded. The third says strong statements are difficult. So the overall conclusion across all studies is that their findings have limitations and can't be generalized broadly. Therefore, the answer should reflect that the studies' conclusions are tentative and have limitations preventing generalization.\n</think>\n\nThe conclusion of the studies presented in the context is that their findings are **tentative and limited in generalizability**. Each study acknowledges constraints such as:  \n1. **Sample limitations** (e.g., diverse cultural backgrounds but insufficient representation to draw conclusions",
      "retrieved_chunks": [
        "Title: Community responses to communication campaigns for influenza A (H1N1): a focus group study\nPassage: Any conclusions drawn from this study should be considered tentative as the findings cannot be generalised to the population at large.",
        "Further research is needed to explore the complexities involved in the way in which the framing of risk messages impacts on people's\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: 4 Conclusion and Limitations",
        "Whilst this study intentionally involved participants with diverse cultural and ethnic backgrounds, and included individuals from vulnerable groups, the sample does not permit conclusions regarding the effect of socio-demographic factors such as age or gender.",
        "Title: Estimating the number of infections and the impact of non-\nPassage: the appendix, and general limitations presented below in the conclusions.",
        "Title: Outcome of paediatric intensive care survivors\nPassage: and, therefore, strong conclusive statements difficult."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.4,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2727272727272727,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 72,
      "dataset_id": "453",
      "question": "What does ANFIS offer?",
      "ground_truth_answer": "ANFIS offers flexibility in determining nonlinearity in time series data and combines the properties of both artificial neural networks and fuzzy logic systems.",
      "generated_response": "<think>\nOkay, let's see. The question is asking what ANFIS offers. The context provided mentions several applications of ANFIS. First, Ekici and Aksoy used it for building energy consumption forecasting. Then it's mentioned again for forecasting electricity loads. There's also a part about estimating ANFIS parameters being a challenge. Then other researchers applied it to forecast return products, product development performance, and stock market close prices.\n\nSo ANFIS is being used in various forecasting models. The key here is to figure out what the common thread is. The context also says that ANFIS links fuzzy logic and neural networks. So combining those two technologies must be what it offers. The answer should probably mention that it's a hybrid model combining fuzzy logic and neural networks, which allows for forecasting in different areas like energy, electricity, products, and stock prices. Also, maybe mention that it's used for forecasting purposes. The challenge with parameter estimation is noted, but the question is about what it offers, not the challenges. So focus on the combination of the two technologies and the applications in forecasting.\n</think>\n\nANFIS offers a hybrid modeling approach that integrates **fuzzy logic** and **neural networks**, enabling effective forecasting across diverse domains such as energy consumption, electricity loads, product returns, product development performance, and stock market prices. By combining the interpretability of fuzzy logic with the learning capabilities of neural networks, ANFIS provides a flexible framework for handling complex, nonlinear relationships in data.",
      "retrieved_chunks": [
        "Ekici and Aksoy presented an ANFIS based building energy consumption forecasting model. More so, ANFIS is also applied to forecast electricity loads .",
        "However, estimating ANFIS parameters is a challenge that needs to be improved.",
        "proposed an ANFIS based model to forecast return products. Ho and Tsai applied ANFIS to forecast product development performance.",
        "proposed an ANFIS based forecasting model for close price indices for a stock market for five days.",
        "The ANFIS model links the fuzzy logic and neural networks ."
      ],
      "computed_relevance": 0.42857142857142855,
      "computed_utilization": 0.7142857142857143,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.10714285714285714,
      "gt_utilization": 0.07142857142857142,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 73,
      "dataset_id": "70",
      "question": "What medications have shown good promise to in vivo delivery via dry powder inhalers?",
      "ground_truth_answer": "Insulin and low-molecular-weight heparin have shown promise for in vivo delivery via dry powder inhalers.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what medications have shown good promise for in vivo delivery via dry powder inhalers (DPIs). I need to look through the provided context to find the answer.\n\nFirst, I'll check the first passage titled \"RNAi Therapeutic Platforms for Lung Diseases.\" The passage mentions that DPIs have shown promise for delivering therapeutic macromolecules like insulin and low-molecular-weight heparin. It also suggests that DPIs could be better for delivering siRNAs to the lungs. \n\nThen, looking at the second passage about lipid-based particles, it talks about lyophilized preparations and MDIs (metered dose inhalers) used for conditions like asthma and COPD. However, the question specifically asks about dry powder inhalers, so the relevant part is in the first passage.\n\nThe answer should include insulin and low-molecular-weight heparin as the medications that have shown promise with DPIs. The mention of siRNAs is a possibility but the question is about medications that have already shown promise, so maybe stick to the ones explicitly stated. The context also mentions dry powder nasal vaccines and sublingual immunotherapy tablets, but those are different routes (nasal, oral, sublingual) and not specifically via DPIs for in vivo delivery. So the key points are insulin and low-molecular-weight heparin.\n</think>\n\nThe medications that have shown good promise for in vivo delivery via dry powder inhalers (DPIs) are **insulin** and **low-molecular-weight heparin**. The passage highlights that DPIs have already demonstrated potential for delivering these therapeutic macromolecules, suggesting their suitability for such delivery methods.",
      "retrieved_chunks": [
        "Overall, great expectations are coming\n\nTitle: RNAi Therapeutic Platforms for Lung Diseases\nPassage: The use of aerosols to deliver medication to the lungs has a long history. Administration by inhalation is a popular and non-invasive method of delivering agents into the lungs. There are several inhalation devices available for the delivery of drugs into the lungs. Metered dose inhalers and dry powder inhalers are the most common modes of inhaled delivery.",
        "DPIs are devices that deliver medication to the lungs in the form of dry powder. The use of DPIs has already shown promise for the in vivo delivery of therapeutic macromolecules such as insulin and low-molecular-weight heparin ; thus, it could be a better device for delivering siRNAs to the lungs.",
        "Indeed, some of these formulations can be stored at room temperature for several months and can be administered in such form via the nasal, oral, or sublingual routes. Dry powder nasal vaccines have already been tested , oral delivery of capsules is not a problem , and many allergy-related immunotherapy tablets have been considered for sublingual administration .",
        "Conventional protein antigens must be specially formulated for delivery by EPI, and are spray dried into powders of suitable density and size . A clinical trial has been conducted evaluating delivery of a powdered inactivated influenza vaccine by EPI injection, which found that immunogenicity was\n\nTitle: Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection\nPassage: Some lipid-based preparations have the advantage of being lyophilized, thus allowing to simplify the logistics usually necessary for cold chain.",
        "MDIs are the most commonly used inhalers for several lung diseases, such as asthma, bronchitis, and chronic obstructive pulmonary disease , and a spacer is an external device that is attached to an MDI to allow for better drug delivery by enhanced"
      ],
      "computed_relevance": 0.18181818181818182,
      "computed_utilization": 0.18181818181818182,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.19230769230769232,
      "gt_utilization": 0.038461538461538464,
      "gt_completeness": 0.2,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 74,
      "dataset_id": "1135",
      "question": "What was demonstrated in deriving the equation for R 0?",
      "ground_truth_answer": "The passage demonstrates the derivation of the equation for R 0 and the sensitivity of R 0 to dispersion in the underlying distributions.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what was demonstrated in deriving the equation for R\u2080. The context provided mentions a graph-theoretic method for calculating R\u2080, starting from the definition R\u2080 = \u03c1. They derived rules to reduce the digraph associated with F\u03bb\u207b\u00b9 \u2212 V to a digraph with zero weight, leading to \u03bb = R\u2080. Also, they found limiting values of \u03c6 and used them to assess the sensitivity of R\u2080 to dispersion in distributions.\n\nThe passage titles all mention \"The Failure of R(0)\" and discuss methods for calculating R\u2080, their limitations, and a core problem with R\u2080. The question is about what was demonstrated in deriving the equation for R\u2080. The answer should connect the graph-theoretic approach and the sensitivity analysis mentioned. The key points are the method using digraph reduction and the sensitivity to distribution dispersion. The answer should state that the derivation showed a method using graph theory and highlighted R\u2080's sensitivity to distribution assumptions, possibly indicating its limitations.\n</think>\n\nThe derivation of the equation for $ R_0 $ demonstrated a **graph-theoretic method** to calculate $ R_0 $ by reducing the digraph associated with $ F\\lambda^{-1} - V $ to a zero-weight digraph, leading to $ \\lambda = R_0 $. Additionally, it highlighted the **sensitivity of $ R_0 $ to dispersion in the underlying distributions** (e.g., assumptions about exponential lifetimes) and exposed limitations in interpreting $ R_0 $ from mathematical models, as discussed in the context of its \"failure\" to account for such variability. This underscores challenges biologists face in applying $ R_0 $ meaningfully to real-world scenarios.",
      "retrieved_chunks": [
        ", a graph-theoretic method for calculating R 0 is given. Starting from the definition of R 0 = \u03c1, they derived a series of rules for reducing the digraph associated with F\u03bb \u22121 \u2212 V to a digraph with zero weight, from which \u03bb = R 0 .",
        "They were able to derive limiting values of \u03c6 and used this to gauge the sensitivity of R 0 to dispersion in the underlying distributions.",
        "Title: The Failure of R (0)\nPassage: that would be calculated assuming exponential lifetimes.",
        "Title: The Failure of R (0)\nPassage: In de Camino-Beck et al.",
        "Title: The Failure of R (0)\nPassage: In this section, we identify some of the more popular methods used to calculate R 0 . We also describe the limitations that each method presents and demonstrate one of the core problems with R 0 . Specifically, we address a key problem with R 0 : how do biologists make sense of it from mathematical models?"
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.375,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.3125,
      "gt_utilization": 0.0625,
      "gt_completeness": 0.2,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 75,
      "dataset_id": "235",
      "question": "What was the prevalence of Coronavirus OC 229 E/NL63 in clinical subjects in Ilorin, Nigeria?",
      "ground_truth_answer": "Coronavirus OC 229 E/NL63 was detected in 12.5% of the clinical subjects in Ilorin, Nigeria.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the prevalence of Coronavirus OC 229 E/NL63 in clinical subjects in Ilorin, Nigeria. I need to find the answer in the provided context.\n\nFirst, I'll scan through the context for mentions of OC 229 E/NL63. The first passage says, \"Coronavirus OC 229 E/NL63 was detected among subjects from the clinic and not detected in the community.\" Then, further down, there's a line: \"E/NL63 was detected in 12.5% of the clinical subjects and not detected in the community.\" \n\nSo, putting that together, the prevalence in clinical subjects is 12.5%. The key here is to make sure that OC 229 E/NL63 and E/NL63 are the same virus. The first mention uses the full name, and later it's abbreviated. The context also mentions that it wasn't found in the community, but the question is only about clinical subjects. \n\nAnother part mentions that some viruses detected in the study haven't been reported in Nigeria before, but that's about coronavirus in general. The specific number for E/NL63 is 12.5%. I don't see any conflicting numbers elsewhere. The answer should be 12.5%.\n</think>\n\nThe prevalence of Coronavirus OC 229 E/NL63 in clinical subjects in Ilorin, Nigeria, was **12.5%**, as explicitly stated in the passage: \"E/NL63 was detected in 12.5% of the clinical subjects.\"",
      "retrieved_chunks": [
        "Coronavirus OC43 was the most common virus detected in community members . A different strain, Coronavirus OC 229 E/NL63 was detected among subjects from the clinic and not detected in the community. This pilot study provides evidence that data from the community can potentially represent different information than that sourced clinically, suggesting the need for community surveillance to enhance public health efforts and scientific understanding of\n\nTitle: Etiology of respiratory tract infections in the community and clinic in Ilorin, Nigeria\nPassage: E/NL63 was detected in 12.5% of the clinical subjects and not detected in the community.",
        "Title: Etiology of respiratory tract infections in the community and clinic in Ilorin, Nigeria\nPassage: and 5 of quadruple.",
        "Title: Etiology of respiratory tract infections in the community and clinic in Ilorin, Nigeria\nPassage: viruses in the clinical sample and their prevalence in the community. Finally, some of the viruses detected in this study have not been detected and implicated with ARIs in Nigeria. There is no report, to the best of our knowledge, implicating coronavirus in ARIs in Nigeria, and it was detected in 12 subjects in this study.",
        "Although cases of double and triple infections were observed in a study in Nigeria in 2011 , as far as we are aware, reports of quadruple infections are rare and have not been reported in Nigeria previously. Title: Etiology of respiratory tract infections in the community and clinic in Ilorin, Nigeria\nPassage: Abstract: OBJECTIVE: Recognizing increasing interest in community disease surveillance globally, the goal of this study was to investigate whether respiratory viruses circulating in the community may be represented through clinical surveillance in Nigeria.",
        "Parainfluenza virus 4, respiratory syncytial virus B and enterovirus were the most common viruses in the clinical sample; present in 93.8% of clinical subjects, and 6.7% of community subjects ."
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.2,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.05,
      "gt_completeness": 0.25,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 76,
      "dataset_id": "585",
      "question": "How was HFRS  first brought to the attention of western medicine ?",
      "ground_truth_answer": "HFRS was first brought to the attention of western medicine in association with an outbreak that occurred among United Nations troops during the Korean conflict between 1951 and 1954, where more than 3,200 soldiers were afflicted.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how HFRS was first brought to the attention of Western medicine. I need to look at the provided context to find the answer.\n\nLooking at the first context paragraph: \"HFRS as a distinct syndrome, however, was first brought to the attention of western medicine in association with an outbreak that occurred among United Nations troops during the Korean conflict between 1951 and 1954, where more than 3,200 soldiers were afflicted.\"\n\nSo the key points here are the Korean conflict, United Nations troops, and the time frame 1951-1954. The answer should mention the outbreak among UN troops during the Korean War. The number of soldiers affected is also given, which is over 3,200. The main point is the outbreak in that specific context. The other passages talk about treatments and vaccines, but the question is about the initial recognition, so those parts aren't relevant here. I need to make sure the answer includes the outbreak among UN troops during the Korean conflict. Let me check again to confirm there's no other info. The title and other passages don't mention the initial attention, so the answer is definitely in the first context paragraph. Just rephrase that part concisely.\n</think>\n\nHFRS was first brought to the attention of Western medicine through an outbreak among United Nations troops during the Korean conflict between 1951 and 1954, which affected over 3,200 soldiers.",
      "retrieved_chunks": [
        "HFRS as a distinct syndrome, however, was first brought to the attention of western medicine in association with an outbreak that occurred among United Nations troops during the Korean conflict between 1951 and 1954, where more than 3,200 soldiers were afflicted .",
        "It took more than two decades until the etiologic agent, Hantaan virus , was isolated from the striped field mouse Apodemus agrarius, detected in part by the binding of antibodies from patient serum samples to\n\nTitle: Vaccines and Therapeutics Against Hantaviruses\nPassage: The initiation of careful observation and prompt but judicious supportive treatment is crucial to improve patient survival condition for both HFRS and HCPS .",
        "It has been demonstrated that admission to the ICU and supportive treatment could greatly reduce the mortality rate of HFRS . In general, the treatment principle for HFRS patients is using intravenous hydration and electrolyte therapy to maintain physiological blood pressure.",
        "Continuous\n\nTitle: Vaccines and Therapeutics Against Hantaviruses\nPassage: It is wildly accepted that HFRS and HCPS are caused by uncontrolled systemic inflammatory responses, in which multiple inflammatory cytokines, especially TNF-\u03b1, IL-8, and RANTES, contributed to disease progression ; however, immunoregulation treatment in HFRS or HCPS is undesirable.",
        "Similarly, another randomized prospective study did not show any benefit from corticosteroid treatment in HFRS patients ."
      ],
      "computed_relevance": 0.16666666666666666,
      "computed_utilization": 0.16666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.10526315789473684,
      "gt_utilization": 0.05263157894736842,
      "gt_completeness": 0.5,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 77,
      "dataset_id": "991",
      "question": "What is the Newcastle disease virus?",
      "ground_truth_answer": "The Newcastle disease virus is an avian paramyxovirus type I that causes a serious disease in chickens and other birds known as ND. It has caused several outbreaks in poultry and domestic pigeons in the last four decades, leading to the development of new vaccines and vaccination protocols.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is the Newcastle disease virus?\" I need to base my answer on the provided context.\n\nFirst, I'll look through the context passages. The first passage mentions that NDV is an avian paramyxovirus type I that causes a serious disease in chickens and other birds called ND. The title also refers to it as Newcastle Disease Virus. So that's a key point: it's a virus in the paramyxovirus family, type I, affecting birds.\n\nAnother part of the context says that NDV outbreaks were first reported in Indonesia and then in Newcastle-upon-Tyne in 1926. That gives some historical background. Also, there's mention of it causing epidemics in poultry and domestic pigeons in the last four decades. So it's a significant pathogen in birds, leading to economic losses.\n\nThe context also talks about using NDV for prophylactic vaccination in poultry and as an adjuvant in cancer patients. But the question is about what NDV is, so maybe that part is more about its applications rather than the definition. However, including that it's used in vaccines might add value.\n\nI should make sure not to include information that's not directly relevant. For example, the part about interferon regulatory factor IRF-9 and viral proteins might be more about the mechanisms rather than the definition. The user wants a concise answer based on the context provided.\n\nPutting it all together: NDV is an avian paramyxovirus type I causing Newcastle disease in birds, first reported in Indonesia and Newcastle-upon-Tyne in 1926. It's a serious disease leading to epidemics and economic losses, controlled through vaccines. The answer should mention its classification, the disease it causes, historical outbreaks, and maybe its impact and control measures.\n</think>\n\nThe Newcastle disease virus (NDV) is an avian paramyxovirus type I that causes a serious disease in chickens and other birds, known as Newcastle disease (ND). It was first reported in Indonesia and later in Newcastle-upon-Tyne in 1926. The virus is responsible for significant outbreaks in poultry and domestic pigeons, leading to public health concerns and economic losses. Efforts to control the disease include the development of vaccines and vaccination protocols. Additionally, NDV has been explored for its potential use in therapeutic vaccination for cancer patients.",
      "retrieved_chunks": [
        "Title: Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients\nPassage: NDV is an avian paramyxovirus type I which causes a serious disease in chickens and other birds known as ND . NDV outbreaks were first reported in Indonesia, and, subsequently, in Newcastle-upon-Tyne in the year 1926.",
        "Title: Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients\nPassage: the interferon regulatory factor IRF-9. Title: Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients\nPassage: New viruses or variants can cause epidemics and pose huge public health problems and economic losses within a short time. Title: Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients\nPassage: is transcribed into mRNAs and is translated into viral proteins .",
        "There have been several panzootics of this disease in poultry and in domestic pigeons during the last four decades .",
        "Efforts in controlling the disease involved the development of new vaccines and vaccination protocols ."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.45454545454545453,
      "gt_utilization": 0.36363636363636365,
      "gt_completeness": 0.8,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 78,
      "dataset_id": "561",
      "question": "What is the conclusion of this report?",
      "ground_truth_answer": "The conclusion of the report is that strong conclusive statements are difficult to make due to limitations presented in the conclusions.",
      "generated_response": "<think>\nOkay, let's see. The user is asking for the conclusion of the report based on the provided context. The context includes several titles and passages. \n\nFirst, there's a section titled \"4 Conclusion and Limitations\" with the passage \"Outcome of paediatric intensive care survivors and, therefore, strong conclusive statements difficult.\" That seems to indicate that the study or report might be about the outcomes of children who survived intensive care, but making strong conclusions is difficult. Maybe there are limitations in the data or the study design that prevent firm conclusions.\n\nThen there's another title \"Estimating the number of infections and the impact of non-\" with a passage mentioning \"the appendix, and general limitations presented below in the conclusions.\" This might be a different section or part of the same report. The mention of \"appendix\" could refer to supplementary information, and the general limitations are discussed in the conclusions. So perhaps the report is about estimating infections and the impact of non-pharmaceutical interventions or something similar, but the conclusions have limitations.\n\nAnother title is \"Globalization and emerging governance modalities\" with the passage \"me two conclusions.\" That seems like a typo or incomplete sentence. Maybe the user intended to write \"make two conclusions\" or something else. But given the context, maybe this is part of a different report or section, but the user is focusing on the first two contexts.\n\nThe question is asking for the conclusion of \"this report.\" Since there are multiple titles, it's possible that the user is referring to the first one, \"Estimating the number of infections...\" which has a section on conclusion and limitations. The passage there says that strong conclusive statements are difficult, which suggests that the conclusion is that the study couldn't make strong conclusions, possibly due to limitations. \n\nBut the user might be mixing different contexts. The answer needs to be based on the provided context. The first context's conclusion is that strong conclusions are difficult. The second context mentions limitations in the appendix. The third title is unrelated. So the main conclusion from the first context is that the study couldn't make strong conclusions, perhaps due to limitations in data or methodology. \n\nSo the answer should reflect that the conclusion is that strong conclusive statements are difficult due to the limitations mentioned. The user might be looking for that specific point from the first passage. The other contexts might be distractions, but the key is to focus on the first one since it's titled \"Conclusion and Limitations.\"\n</think>\n\nThe",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: 4 Conclusion and Limitations\n\nTitle: Outcome of paediatric intensive care survivors\nPassage: and, therefore, strong conclusive statements difficult.",
        "Title: Estimating the number of infections and the impact of non-\nPassage: the appendix, and general limitations presented below in the conclusions.",
        "Title: Globalization and emerging governance modalities\nPassage: me two conclusions."
      ],
      "computed_relevance": 0.6666666666666666,
      "computed_utilization": 0.6666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.375,
      "gt_utilization": 0.125,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 79,
      "dataset_id": "881",
      "question": "What factors make bacterial and viral co-infections so lethal?",
      "ground_truth_answer": "The synergy between bacterial and viral infectious agents is related to a variety of factors, including epithelial barrier damage, exaggerated innate immune response, and cytokine storm. These factors contribute to enhanced morbidity and mortality in co-infections of the respiratory tract.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what factors make bacterial and viral co-infections so lethal. I need to base my answer on the provided context.\n\nFirst, looking at the context, there are a few key points mentioned. The first passage says that synergistic mechanisms between viruses and bacteria leading to enhanced morbidity and mortality are poorly understood. That suggests that the interaction between the two isn't fully clear, but it's known to be harmful. \n\nThen, the second passage mentions that bacterial and viral co-infections of the respiratory tract are highly lethal and a big burden on global health. It also states that severe bacterial infections after a primary viral infection are well established, especially with viruses like influenza and RSV. This implies that the initial viral infection makes the patient more susceptible to bacterial infections, which then worsen the outcome.\n\nAnother point is that the interaction isn't always bad, but in many cases, it's dangerous. The third title talks about the confounding roles of type I interferons in both bacterial and viral pathogenesis, indicating that the immune response (specifically interferons) might play a role in how these co-infections affect the body. \n\nPutting this together, the factors would include the synergistic effects between the virus and bacteria, the compromised immune response due to the initial viral infection, and possibly the role of immune mediators like interferons. Also, the context mentions that in vivo studies in mice don't accurately model human physiology, which might mean that the mechanisms aren't fully understood yet, but the existing evidence points to these interactions being more severe than individual infections.\n\nI need to make sure I don't add any external information. The answer should focus on the factors mentioned: synergistic mechanisms, the primary viral infection paving the way for bacteria, and the role of immune responses like interferons. Also, the fact that these co-infections are more lethal in the respiratory tract and are a major health burden.\n</think>\n\nBacterial and viral co-infections are particularly lethal due to **synergistic mechanisms** between the pathogens, which exacerbate morbidity and mortality. Key factors include:  \n1. **Compromised Host Defenses**: Viruses like influenza or respiratory syncytial virus (RSV) weaken the host's immune response or damage respiratory epithelial barriers, creating an environment conducive to secondary bacterial infections.  \n2. **Immune System Dysregulation**: Interactions at the immune level (e.g.,",
      "retrieved_chunks": [
        "The synergistic mechanisms between viruses and bacteria leading to enhanced morbidity and mortality are poorly understood. In vivo characterizations of these severe infections are mainly performed in mice which poorly resemble the human physiology\n\nTitle: Port d\u2019Entr\u00e9e for Respiratory Infections \u2013 Does the Influenza A Virus Pave the Way for Bacteria? Passage: In summary, bacterial and viral co-infections of the respiratory tract are highly lethal and present a dramatic burden for the global health system.",
        "Title: Port d\u2019Entr\u00e9e for Respiratory Infections \u2013 Does the Influenza A Virus Pave the Way for Bacteria? Passage: In summary, bacterial and viral co-infections of the respiratory tract are highly lethal and present a dramatic burden for the global health system.",
        "The clinical importance of severe bacterial infections occurring after a primary viral infection is well established . Respiratory bacterial infections are more dangerous to patients when they occur following infection with viruses such as influenza and respiratory syncytial virus.",
        "However, the interaction between viral and bacterial infection is not always deleterious.",
        "Title: Confounding roles for type I interferons during bacterial and viral pathogenesis\nPassage: Another important area of research is the interface between viral and bacterial coinfections."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.2222222222222222,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.375,
      "gt_utilization": 0.16666666666666666,
      "gt_completeness": 0.4444444444444444,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 80,
      "dataset_id": "1728",
      "question": "How does COVID19 get spread?",
      "ground_truth_answer": "COVID-19 is suspected to be spread through contact with infected respiratory secretions, close contact with an infected person, and potentially through faecal-oral transmission. It can also be transmitted through large respiratory droplets and fine particle aerosols. There have been instances of sustained human-to-human transmission across generations of cases.",
      "generated_response": "<think>\nOkay, let's tackle this question about how COVID-19 spreads based on the provided context. First, I need to go through each of the given passages and extract relevant information.\n\nStarting with the first context: It mentions that 2019-nCoV (which is the same as COVID-19) is suspected to spread through contact with infected respiratory secretions, similar to other coronaviruses. Then there's a part about the SARS-CoV superspreading event at Amoy Gardens, which was attributed to fecal-oral and then airborne spread through plumbing systems. This suggests that while respiratory droplets are a primary method, there might be other routes like fecal-oral and airborne via specific environmental factors.\n\nThe next CDC summary from March 21, 2020, states that the virus spreads easily from person to person. It also mentions that people with fever or cough should consider possible infection based on their location, travel, or exposure. This reinforces the person-to-person transmission but doesn't specify the exact methods beyond that.\n\nThe epidemiological research priorities passage says that respiratory viruses generally spread through large droplets, but some can spread via aerosols and fomites. It also notes that coronaviruses can infect the gastrointestinal tract, so fecal-oral transmission might be a factor. This adds aerosols and fomites as possible transmission routes, along with fecal-oral.\n\nAnother CDC summary from the same date mentions that the virus is spreading easily between people. It doesn't add new transmission methods beyond person-to-person, but the previous context already covered droplets, aerosols, fomites, and fecal-oral.\n\nPutting this all together, the main transmission routes mentioned are respiratory droplets, aerosols, fomites (indirect contact), and possibly fecal-oral. The Amoy Gardens example with SARS-CoV suggests that in certain conditions (like plumbing systems), airborne spread might occur. However, the context for 2019-nCoV (COVID-19) states that it's suspected to spread through respiratory secretions, similar to other coronaviruses. The research priorities passage also brings up aerosols and fomites as possible, and fecal-oral for coronaviruses in general.\n\nSo the answer should include respiratory droplets as the primary method, mention aerosols and fomites as possible, and note that fecal-oral",
      "retrieved_chunks": [
        "Title: 2019-nCoV: The Identify-Isolate-Inform (3I) Tool Applied to a Novel Emerging Coronavirus\nPassage: It is currently unclear how 2019-nCoV is spread, but it is suspected to be transmitted through contact with infected respiratory secretions, like other known coronaviruses.",
        "is seeing some level of community spread of COVID-19. Testing for COVID-19 may be accessed through medical providers or public health departments, but there is no treatment for this virus.",
        "The SARS-CoV superspreading event at Amoy Gardens where more than 300 cases were infected was attributed to faecal-oral, then airborne, spread through pressure differentials between contaminated effluent pipes, bathroom floor drains and flushing toilets . The first large identifiable superspreading event during the present 2019-nCoV outbreak has apparently taken\n\nTitle: CDC Summary 21 MAR 2020,\nPassage: People who get a fever or cough should consider whether they might have COVID-19, depending on where they live, their travel history or other exposures.",
        "Healthcare facilities in China have reported spread from person to\n\nTitle: Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak\nPassage: Transmission of respiratory viruses generally happens through large respiratory droplets, but some respiratory viruses can spread through fine particle aerosols , and indirect transmission via fomites can also play a role. Coronaviruses can also infect the human gastrointestinal tract , and faecal-oral transmission might also play a role in this instance.",
        "Title: CDC Summary 21 MAR 2020,\nPassage: The virus that causes COVID-19 is infecting people and spreading easily from person-to-person."
      ],
      "computed_relevance": 0.5,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4,
      "gt_utilization": 0.25,
      "gt_completeness": 0.625,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 81,
      "dataset_id": "1421",
      "question": "Which viruses may not cause prolonged inflammation due to strong induction of antiviral clearance?",
      "ground_truth_answer": "The viruses that may not cause prolonged inflammation due to strong induction of antiviral clearance are murine norovirus, human astrovirus, and murine cytomegalovirus.",
      "generated_response": "<think>\nOkay, let's try to figure out the answer to this question. The question is asking which viruses may not cause prolonged inflammation because they have a strong induction of antiviral clearance. \n\nFirst, I need to look at the context provided. The context mentions several viruses and their interactions with the immune system. Let me go through each part step by step.\n\nThe first part of the context says: \"Persistence of other continuously replicating RNA viruses, such as chikungunya, measles, polyomavirus, may be similarly due to ineffective innate responses.\" So, these viruses (chikungunya, measles, polyomavirus) are mentioned in the context of persistence because the innate immune response isn't effective. If the innate response is ineffective, that might mean the virus isn't cleared quickly, leading to prolonged infection or inflammation. But the question is about viruses that don't cause prolonged inflammation because they have strong antiviral clearance. So maybe these viruses are the opposite? Wait, the context says their persistence is due to ineffective innate responses, implying that if the innate response were effective, they might be cleared. But the question is about viruses that do have strong antiviral clearance, so maybe these viruses aren't the answer.\n\nNext, there's a passage about HuNV (probably human norovirus) infection being rapid, with symptoms developing quickly and lasting a few days. That suggests that the infection is acute and not prolonged. If the infection is cleared quickly, then maybe norovirus is a candidate for the answer. The title mentions mechanisms responsible for vaccination and clearance, which implies that the immune response is effective in clearing it.\n\nAnother passage talks about HCV (hepatitis C virus) persistence being due to loss of innate immune function. The treatment for HCV involves circumventing the virus's inhibition of IFN (interferon) induction. So HCV is a persistent virus because it inhibits the innate response. Therefore, HCV would be a virus that causes prolonged infection, not the answer to the question.\n\nThen there's a part about the adaptive immune response components (B cells, CD4 T cells, CD8 T cells) being necessary for vaccine effects and viral clearance. If any of these are lacking, vaccine effects are diminished and clearance is delayed. This suggests that when these components are present, the virus is cleared effectively. But which virus is this referring to? The context mentions norovirus in the title, so maybe the adaptive",
      "retrieved_chunks": [
        "Persistence of other continuously replicating RNA viruses, such as chikungunya, measles, polyomavirus, may be similarly due to ineffective innate responses.",
        "Title: Immune Mechanisms Responsible for Vaccination against and Clearance of Mucosal and Lymphatic Norovirus Infection\nPassage: HuNV infection and disease is rapid, with symptoms developing within 24-48 hours of infection and lasting for a few days.",
        "Title: Type I Interferon Receptor Deficiency in Dendritic Cells Facilitates Systemic Murine Norovirus Persistence Despite Enhanced Adaptive Immunity\nPassage: successful treatment for HCV serves to circumvent the viral inhibition of IFN induction. Thus, HCV may be an example of a medically relevant persistent viral infection that persists due, in part, to loss of innate immune function.",
        "Lack of any of the three components of the adaptive response: B cells, CD4 T cells, or CD8 T cells significantly diminished vaccine effects generated by either live virus or VP1 capsid protein immunization, and delayed viral clearance during primary infection.",
        "As expected, antiviral activity in the supernatant of cultures at 32 hpi could only be detected in cells transfected with polyI:C, and the response could only be reduced by the presence of rotavirus infection ."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.4117647058823529,
      "gt_utilization": 0.17647058823529413,
      "gt_completeness": 0.42857142857142855,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 82,
      "dataset_id": "189",
      "question": "When was HBoV1 first identified?",
      "ground_truth_answer": "HBoV1 was first identified in respiratory secretions of children with respiratory tract disease in 2005.",
      "generated_response": "<think>\nOkay, let's see. The question is asking when HBoV1 was first identified. I need to look through the provided context to find the answer.\n\nLooking at the first passage under the first title, the text says: \"Human bocavirus 1, which belongs to family Parvoviridae, was firstly identified in respiratory secretions of children with respiratory tract disease in 2005.\" So that seems to directly answer the question. The key sentence here is that it was first identified in 2005. \n\nI should check the other passages to make sure there's no conflicting information, but the other sections talk about the study's findings, like the number of patients, age distribution, and co-infections. None of those mention the discovery date. So the answer should be 2005.\n</think>\n\nHBoV1 was first identified in 2005. \n\n**Answer:** 2005.",
      "retrieved_chunks": [
        "Title: Epidemiology of HBoV1 infection and relationship with meteorological conditions in hospitalized pediatric patients with acute respiratory illness: a 7-year study in a subtropical region\nPassage: Text: Human bocavirus 1 , which belongs to family Parvoviridae, was firstly identified in respiratory secretions of children with respiratory tract disease in 2005 . HBoV1 has been confirmed as an important respiratory pathogen and is found in respiratory infections in children and adults worldwide. The prevalence of HBoV1 nucleic acid detection varies from 1.5 to 33% in patients with acute respiratory illness , according to different studies . Serological and nucleic acid test results are generally consistent , showing HBoV1 infection is very common. HBoV1 can cause both upper respiratory illness and lower respiratory illness . Infection with HBoV1\n\nTitle: Epidemiology of HBoV1 infection and relationship with meteorological conditions in hospitalized pediatric patients with acute respiratory illness: a 7-year study in a subtropical region\nPassage: Two hundred forty-eight of 11,399 patients tested positive for HBoV1 infection. Of the HBoV1-positive patients, 112 were co-infected with other pathogens, most frequently with RSV .",
        "The male-to-female ratio was 2.54:1 in HBoV1-positive patients and 1.81:1 in HBoV1-negative patients .",
        "Title: Epidemiology of HBoV1 infection and relationship with meteorological conditions in hospitalized pediatric patients with acute respiratory illness: a 7-year study in a subtropical region\nPassage: To clarify the age distribution of HBoV1, patients were divided into seven age groups; 0-3 months, 4-6 months, 7-12 months, 1-2 years, 3-5 years, 6-10 years and 11-14 years old. There was a significant difference in the prevalence of HBoV1 in patients in different age groups and the peak prevalence was found in patients aged 7-12 months . Title: Epidemiology of HBoV1 infection and relationship with meteorological conditions in hospitalized pediatric patients with acute respiratory illness: a 7-year study in a subtropical region\nPassage: and analyzed immediately or stored at \u2212 80\u00b0C before analysis, as described previously .",
        "The median age was 1 year ."
      ],
      "computed_relevance": 0.08333333333333333,
      "computed_utilization": 0.16666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.058823529411764705,
      "gt_utilization": 0.058823529411764705,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 83,
      "dataset_id": "1081",
      "question": "What explains the pain associated with CHIKV?",
      "ground_truth_answer": "The passage \"can explain pain associated with CHIKF\" from the title \"Chikungunya: A Potentially Emerging Epidemic?\" suggests that the pain associated with CHIKV (Chikungunya virus) is due to the sudden appearance of high fever, rash, headache, nausea, vomiting, myalgia and arthalgia or severe joint pain. Joint pain is a defining symptom of CHIKV disease, and the word \"Chikungunya\" originated from the Tanzanian and Mozambique region of Africa, meaning \"that which bends up,\" indicating the bent posture often taken by those experiencing severe joint pain after being infected with CHIKV. It is also mentioned that blood samples were analyzed for cytokine profiles during the acute phase and disease convalescence, indicating a potential link between inflammatory cytokine expression and the pain associated with CHIKV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what explains the pain associated with CHIKV, which is the Chikungunya virus. Let me look through the provided context to find the answer.\n\nFirst, the context mentions that a bent posture is common in people with severe joint pain after CHIKV infection. The symptoms start 4-7 days post-exposure and usually resolve in two weeks, but joint pain can linger. The title of one passage says inflammatory cytokine expression is linked to the resolution and severity of symptoms. \n\nIn the passages, they talk about patients from Italy with symptoms like myalgia, joint pain, headache, and rash. The infection is confirmed through tests. Another part states that CHIKV is characterized by high fever, rash, headache, nausea, vomiting, myalgia, and arthalgia or severe joint pain. It specifically notes that severe joint pain is the defining symptom. \n\nThere's also a part about blood samples being collected to analyze cytokines during the acute phase and convalescence. The clinical criteria include acute fever and severe arthralgia not explained by other conditions. The origin of the name \"Chikungunya\" refers to something that bends up, which might relate to the bent posture from joint pain.\n\nPutting this together, the pain is likely due to the virus causing inflammation. The mention of inflammatory cytokines in the title and passages suggests that these cytokines are involved in the immune response, leading to joint and muscle pain. The key point is that the inflammatory cytokines are associated with both the severity of symptoms and how the disease resolves. So the answer should connect the pain to inflammatory cytokine expression.\n</think>\n\nThe pain associated with Chikungunya virus (CHIKV) is primarily explained by **inflammatory cytokine expression**, which is linked to both the resolution of the virus and the severity of symptoms. The context highlights that CHIKV infection causes severe joint pain (arthralgia/arthritis) and myalgia, which are hallmark symptoms. The passage explicitly states that **inflammatory cytokines** play a role in the immune response during the acute phase of the disease and its convalescence. These cytokines contribute to inflammation, leading to the characteristic joint and muscle pain. Additionally, the persistent joint pain beyond the acute phase (up to weeks or months) is tied to this inflammatory process, as cytokine profiles during the acute stage correlate with symptom severity.",
      "retrieved_chunks": [
        "A bent posture is often taken by those in severe joint pain after being infected with CHIKV. CHIKV symptoms start 4 to 7 days after exposure and most resolve within the acute phase of the disease. Although the acute phase lasts approximately 2 weeks, joint pain can persist for\n\nTitle: Inflammatory Cytokine Expression Is Associated with Chikungunya Virus Resolution and Symptom Severity\nPassage: Included patients were from the region of Emilia-Romagna in north-east Italy suspected to be infected with CHIKV since they showed symptoms such as myalgia, severe back and joint pain, headache, and skin rash. Collaboration with the regional microbiology reference laboratory of Bologna University and the Department of Infectious and Parasitic Diseases of the National Institute of Health in Rome was initiated and identified the patients as having CHIKV.",
        "Passage: can explain pain associated with CHIKF . Title: Inflammatory Cytokine Expression Is Associated with Chikungunya Virus Resolution and Symptom Severity\nPassage: CHIKV infection is clinically characterized by the sudden appearance of high fever, rash, headache, nausea, vomiting, myalgia and arthalgia or severe joint pain. Severe joint pain is the defining symptom of CHIKV disease .",
        "CHIKV infection was confirmed by one or more of the acute phase tests:\n\nTitle: Inflammatory Cytokine Expression Is Associated with Chikungunya Virus Resolution and Symptom Severity\nPassage: following persistent joint pain and/or disease resolution. Blood samples were collected from 50 patients suffering from CHIKV infections during the 2007 Italian outbreak. Serum separated from whole blood was analyzed by cytokine bead analysis for 13 cytokines with the intention of determining a cytokine profile during CHIKV acute phase and disease convalescence.",
        "The clinical criteria was described as acute onset of fever and severe arthralgia not explained by other medical conditions.",
        "The word Chikungunya originated from the Tanzanian and Mozambique region of Africa meaning that which bends up."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.3333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.3157894736842105,
      "gt_utilization": 0.2631578947368421,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 84,
      "dataset_id": "590",
      "question": "What was the hairpin morphology first described for?",
      "ground_truth_answer": "The hairpin morphology was first described for the design of b-hairpin mimetics based on motifs seen in protein crystal structures and their role in mediating protein-protein and protein-nucleic acid interactions.",
      "generated_response": "<think>\nOkay, let's try to figure out the answer to this question. The question is asking, \"What was the hairpin morphology first described for?\" The answer needs to be based on the provided context.\n\nFirst, I'll look through the context given. The first passage mentions a type I 0 b-turn observed in a 12-residue \u03b2-hairpin mimetic derived from the Tat protein, which binds to HIV-1's transactivation response element RNA. The mimetic forms stable \u03b2-hairpin structures both freely and when bound to TAR RNA. \n\nThe other passages talk about \u03b2-hairpin motifs in proteins, their role in interactions, loop lengths, and some studies on RNA structures like hairpins and pseudoknots. There's mention of \u03b2-hairpin mimetics being designed based on protein crystal structures. Also, in two-residue loops, certain b-turn types are favored.\n\nThe question is about the first description of hairpin morphology. The key here is to find where the \u03b2-hairpin structure was first described. The first passage says that the work has focused on designing \u03b2-hairpin mimetics based on motifs seen in protein crystal structures. Another part states that most \u03b2-hairpins in known 3D structures have loops of \u22645 residues. \n\nBut the question is about when the morphology was first described. The context doesn't explicitly mention the original discovery of \u03b2-hairpins, but it does reference their use in mimetics derived from the Tat protein. However, the general knowledge is that \u03b2-hairpins were first described in the context of protein structures. Since the passage mentions that the design is based on motifs seen in protein crystal structures, it's likely that the hairpin morphology was first described in proteins. \n\nBut the answer might be more specific. The first passage's context is about a mimetic derived from the Tat protein, which binds to RNA. However, the question is about the first description of the hairpin morphology. The passage says that much of the work is on designing \u03b2-hairpin mimetics based on motifs from protein crystal structures. So the original description would be in proteins. However, the answer might be in the context of protein-nucleic acid interactions, but the first description is likely in proteins in general. \n\nWait, the first sentence of the first passage says that the mimetic was derived from the Tat protein, which binds to RNA. But the hairpin morphology itself is a",
      "retrieved_chunks": [
        "A type I 0 b-turn was observed at the tip of a 12-residue b-hairpin mimetic derived initially from the Tat protein, which binds to a nucleic acid target, the transactivation response element RNA of HIV-1 . The mimetic was found to adopt stable b-hairpin structures in free solution and when bound in the major groove of the TAR RNA hairpin .",
        "Title: Max Bergmann lecture Protein epitope mimetics in the age of structural vaccinology\u2021\nPassage: Much of the work reviewed here has been focused upon the design of b-hairpin mimetics, based on motifs seen in protein crystal structures. b-Hairpin motifs are often found in proteins to mediate protein-protein and protein-nucleic acid interactions. A b-hairpin is comprised of two consecutive hydrogenbonded antiparallel b-strands connected by a loop sequence. Many variations are observed in backbone conformation in b-hairpin loops in folded proteins, depending upon the hydrogen bonding pattern between the two antiparallel b-strands and the loop length ). This structural diversity can be captured, at least to some extent, in b-hairpin mimetics designed by transplanting the hairpin\n\nTitle: Max Bergmann lecture Protein epitope mimetics in the age of structural vaccinology\u2021\nPassage: Most b-hairpins in proteins of known 3D structure have loops of \u22645 residues .",
        "In the RNA-peptidomimetic\n\nTitle: Folding behavior of a T-shaped, ribosome-binding translation enhancer implicated in a wide-spread conformational switch\nPassage: hairpins and pseudoknots, function as a structural domain or subdomain . Title: Stem\u2013loop structures can effectively substitute for an RNA pseudoknot in \u22121 ribosomal frameshifting\nPassage: the overall destabilizing effect of mismatches in DNA hairpins. In a pioneer singlemolecule pulling study, it was shown that introducing a mismatch in a 20 bp DNA hairpin shifted its transition state close to the location of the mismatch .",
        "In two residue hairpin loops, type I 0 and II 0 b-turns are strongly favored over type I and type II b-turns.",
        "Our data also comply with this mechanical study and suggest that mechanical stability may be a better parameter than thermodynamic stability to describe the frameshift efficiency of hairpins."
      ],
      "computed_relevance": 0.16666666666666666,
      "computed_utilization": 0.16666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2777777777777778,
      "gt_utilization": 0.1111111111111111,
      "gt_completeness": 0.4,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 85,
      "dataset_id": "1070",
      "question": "hen did Asian genotype emerge?",
      "ground_truth_answer": "The Asian genotype emerged between 1998 and 2007.",
      "generated_response": "<think>\nOkay, let's try to figure out when the Asian genotype emerged based on the provided context. The user is asking specifically about the emergence of the Asian genotype, so I need to look through the passages to find any dates or timeframes mentioned related to genotype changes.\n\nFirst, looking at the first passage: It mentions that from 1998 to 2007, the dominant genotype in Asia was Cosmopolitan. However, in Indochina countries, the major genotypes were different. Then, in the second passage, it says that Asian I was predominant in Thailand, while Asian American was in Cambodia and Vietnam. From 2001, Asian I increased in Cambodia and Vietnam until 2007 when Asian I became predominant in Indochina. The third passage talks about genotype distribution borders in Asia from 2000 to 2014.\n\nSo, the key points here are the transition from Cosmopolitan to Asian I in Indochina. The Asian I genotype started increasing in Cambodia and Vietnam from 2001 and became predominant by 2007. The question is about when the Asian genotype emerged. The Asian genotype here refers to Asian I, which became dominant in 2007 in Indochina. However, the emergence might be when it started to increase, which is 2001. But the exact emergence date isn't specified. The answer should probably state the timeframe when it became predominant, which is 2007. Wait, but the question is about when it emerged, not when it became dominant. The emergence could be earlier. The passage says that Asian I was already predominant in Thailand, so maybe it emerged before 2001. However, the context doesn't mention when it first appeared. The answer might need to be based on the information given. Since the data from 2000 to 2014 shows distribution, but the specific emergence of Asian I in Indochina is noted as starting to increase in 2001. So the answer would be that the Asian genotype (Asian I) emerged in Indochina around 2001, becoming predominant by 2007. But the question is phrased as \"when did Asian genotype emerge?\" The answer should probably state the timeframe when it started to become significant, which is 2001. Alternatively, if the emergence",
      "retrieved_chunks": [
        "This example also suggests the idea of genotype transition, which probably reflects the mosquito vector habitat and human activities in\n\nTitle: DGV: Dengue Genographic Viewer\nPassage: We also found a timeline change in the predominant genotypes.",
        "The query was assigned as the Env region of DENV-1 genotype I.",
        "From 1998 to 2007, the dominant genotype in Asia was Cosmopolitan, although India-Pakistan-Sri Lanka and Southeast-Oceania belonged to different lineages . The major genotypes in the Indochina countries were different from those of the other Asian countries; genotype FIGURE 4 | A screenshot of the DENV sequence similarity search.",
        "Title: DGV: Dengue Genographic Viewer\nPassage: Asian I was predominant in Thailand, whereas genotype Asian American was predominant in Cambodia and Vietnam . From 2001, Asian I increased in Cambodia and Vietnam until finally in 2007 Asian I became the predominant genotype in Indochina. The genotype Asian I viruses in Thailand seemed to be widely disseminated into Vietnam via Cambodia but did not reach Malaysia and Bangladesh . Thus, the Asian American genotype was replaced by Asian I in Cambodia and Vietnam between 1998 and 2011.",
        "Title: DGV: Dengue Genographic Viewer\nPassage: Intriguingly, when focusing on the genotype instead of the serotype, the data from 2000 to 2014 showed at least three potential geographical genotype distribution border lines in Asia . The first border is between the American continents and other regions , the second is located between Bangladesh and Myanmar for the genotype distributions of DENV-1 and -2 and India and Myanmar for DENV-3, and the third is located between Indochina and the Malay Peninsula ."
      ],
      "computed_relevance": 0.3,
      "computed_utilization": 0.4,
      "computed_completeness": 0.6666666666666666,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.14285714285714285,
      "gt_completeness": 0.5,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 86,
      "dataset_id": "88",
      "question": "What followed the reverse transcription step in the analysis?",
      "ground_truth_answer": "In the first and fourth passages, the next step after reverse transcription was real-time PCR analysis using Taqman RT-qPCR and TaqR mastermix, respectively. In the second passage, the next step after reverse transcription was RT-qPCR analysis with SYBR green. In the third passage, the next step after reverse transcription was real-time PCR analysis using the TaqMan Gene Expression Assays.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what followed the reverse transcription step in the analysis. The context provided mentions that reverse transcription was done using AMV reverse transcriptase and random hexamers, following the manufacturer's protocol. Then, they tested the efficiency and reproducibility using 18S rRNA TaqMan probes.\n\nLooking at the other passages provided in the context, there are different methods mentioned. For example, one passage talks about using PrimeScript Reverse Transcriptase with modifications. Another mentions Sequenase enzyme and a specific incubation protocol. Another uses the high-capacity cDNA archive kit. However, the main context here is the first one about MS2 phage-like particles. \n\nThe key part is that after reverse transcription, they used TaqMan probes for testing efficiency. TaqMan is typically used in qPCR (quantitative PCR) assays. So after reverse transcription (which converts RNA to cDNA), the next step would logically be PCR to amplify the cDNA. Since they specifically mention using TaqMan probes, which are used in real-time PCR, the next step is likely real-time PCR. \n\nThe other passages also mention PCR-related steps, like threshold cycle values (Ct values) in real-time PCR. The question is about what follows reverse transcription. In molecular biology workflows, after making cDNA via reverse transcription, the next common step is PCR to amplify specific targets. Since the context mentions using TaqMan probes for testing, which are used in real-time PCR, that's probably the answer here. The answer should be that real-time PCR (or qPCR) using TaqMan probes followed the reverse transcription step.\n</think>\n\nThe reverse transcription step was followed by **real-time PCR (qPCR) using TaqMan probes** to assess the efficiency and reproducibility of the cDNA synthesis. This is indicated by the context's mention of testing with 18S rRNA TaqMan probes, which are specific to qPCR for quantifying target sequences. Other passages also reference qPCR-related steps (e.g., threshold cycle values, duplicate runs), confirming that PCR amplification is the subsequent analytical step after reverse transcription. \n\n**Answer:** Real-time PCR (qPCR) using TaqMan probes followed the reverse transcription step to evaluate efficiency and reproducibility.",
      "retrieved_chunks": [
        "Reverse transcription of 400ng total RNA was performed using AMV reverse transcriptase and random hexamers according to the manufacturer's protocol.",
        "The efficiency and reproducibility of the reverse transcription were tested using 18S rRNA TaqMan probes.",
        "Title: Preparation of MS2 Phage-Like Particles and Their Use As Potential Process Control Viruses for Detection and Quantification of Enteric RNA Viruses in Different Matrices\nPassage: Reverse transcription was carried out using PrimeScript Reverse Transcriptase with slight modifications to the manufacturer's protocol.",
        "In each case, duplicate threshold cycle values\n\nTitle: Real-Time Reverse Transcription PCR Assay for Detection of Senecavirus A in Swine Vesicular Diagnostic Specimens\nPassage: strand synthesis was performed by addition of Sequenase enzyme ; followed by a ramped incubation to 37\u00b0C for 16 min followed by 2 min at 94\u00b0C.",
        "All samples were run in duplicates and unless stated otherwise the human GAPDH\n\nTitle: Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces\nPassage: An homogeneous quantity of the RNA samples was subjected to a reverse transcription step using the highcapacity cDNA archive kit as described by the manufacturer."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.4,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.19047619047619047,
      "gt_utilization": 0.14285714285714285,
      "gt_completeness": 0.75,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 87,
      "dataset_id": "1462",
      "question": "What analysis functions may be useful?",
      "ground_truth_answer": "The analysis functions that may be useful include hierarchical cluster analysis, response ratios, t-tests, ANOVA, dissimilarity tests, constrained ordination, distance-based redundancy analysis, variation partitioning analysis, Mantel test, random matrix theory-based neural network analysis, descriptive statistics, unconstrained ordination, correspondence analysis, qualitative risk-benefit analysis, and quantitative risk-benefit analysis.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What analysis functions may be useful?\" based on the provided context. Let me go through the context step by step.\n\nFirst, the context mentions a pipeline that assists with data analysis steps, performing many common analyses. Then there's a new method called random matrix theory-based neural network analysis. But I need to focus on the analysis functions mentioned in the passages.\n\nLooking at the first passage under \"Use of functional gene arrays...\" it talks about GeoChip data analysis challenges. The analysis methods listed here include constrained ordination techniques like canonical correspondence analysis, distance-based redundancy analysis, variation partitioning analysis, and the Mantel test. These are all statistical methods used in multivariate analysis, probably for ecological or genetic data.\n\nThe next part mentions maximizing visible variability with hierarchical cluster analysis, which groups communities based on gene profile similarity. Then there's mention of unconstrained ordination and correspondence analysis for reducing dimensionality. So these are dimensionality reduction techniques, similar to PCA but maybe specific ones like PCA or CA (correspondence analysis).\n\nIn the other section about Gain-of-Function Research, there's a discussion on qualitative vs. quantitative risk-benefit analysis. But the question is about analysis functions, so maybe those are less relevant unless they count as analysis types. However, the main answer should focus on the data analysis methods from the first part.\n\nPutting it all together, the useful analysis functions would be the ones listed in the functional gene arrays context. So constrained ordination methods (canonical correspondence analysis, distance-based redundancy analysis, variation partitioning, Mantel test), hierarchical cluster analysis, unconstrained ordination, correspondence analysis, and maybe the random matrix theory-based neural network analysis as a newer method. Also, the pipeline mentioned might include common analyses, but the specific ones are listed in the passages.\n\nI need to make sure I don't miss any. Let me check again. The first passage lists constrained ordination (CCA, dbRDA, variation partitioning, Mantel). Then hierarchical cluster analysis. Then to compare community structure, unconstrained ordination and correspondence analysis. The new method is random matrix theory-based neural network analysis. The answer should list all these functions.\n</think>\n\nThe analysis functions that may be useful include:  \n1. **Constrained ordination** techniques such as **canonical correspondence analysis (CCA)**, **distance-based redundancy analysis (dbRDA)**, **variation partitioning analysis**, and",
      "retrieved_chunks": [
        "To assist users with data analysis steps, a pipeline is available which performs many of the common analyses 3 .",
        "A relatively new analysis method is the random matrix theorybased neural network analysis used to\n\nTitle: Use of functional gene arrays for elucidating in situ biodegradation\nPassage: Due to the large volume of data obtained from GeoChip, data analysis can be very challenging.",
        "These include constrained ordination, such as canonical correspondence analysis , distance-based redundancy analysis , variation partitioning analysis , and Mantel test.",
        "Title: Use of functional gene arrays for elucidating in situ biodegradation\nPassage: to maximize the visible variability of the data or hierarchical cluster analysis , which groups communities based on the similarity of their gene profiles, can be used.",
        "To compare the overall community structure, unconstrained ordination and correspondence analysis ] to reduce the dimensionality of variables in order\n\nTitle: Gain-of-Function Research: Ethical Analysis\nPassage: While Kirsten Jacobson and colleagues suggest that, in light of measurement difficulties, '' qualitative risk-benefit analysis framework for assessing research\u2026would be the most decisive tool for asking the hardest and most important questions'' , Marc Lipsitch and Thomas Inglesby argue that risk-benefit analysis can and should be quantitative because ''xtensive qualitative arguments have not provided sufficient clarity or evidence to resolve concerns or identify a consensus path forward \u2026 this process should be quantitative, rather than relying on unquantified and unverifiable assurances that particular laboratories are safe'' . Though they admit measurement challenges associated with objective quantitative risk-benefit analysis, Arturo\n\nTitle: Gain-of-Function Research: Ethical Analysis\nPassage: There may be cases where the very same option promotes all three of these things at the very same time-and in cases like that it might be quite obvious what should be done."
      ],
      "computed_relevance": 0.5,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4,
      "gt_utilization": 0.3,
      "gt_completeness": 0.75,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 88,
      "dataset_id": "1495",
      "question": "What is France's estimated mean percentage [95% credible interval] of total population infected as of 28th March?",
      "ground_truth_answer": "The estimated mean percentage of the total population infected in France as of 28th March is 3.0% with a 95% credible interval.",
      "generated_response": "<think>\nOkay, let's see. The user is asking for France's estimated mean percentage of the total population infected as of March 28th, along with the 95% credible interval. The context provided includes several passages related to this.\n\nFirst, looking at the passages under the \"France\" section. The first passage mentions \"France 3.0%\". That seems like the mean percentage. Then there's another passage that says \"as of March 28th, giving an attack rate of 9.8% of the population.\" Wait, but that's under the \"Wikimedia Foundation\" title. Wait, the titles are all \"Estimating the number of infections and the impact of non-\", maybe that's a typo. But the first passage under the first title says \"France 3.0%\". Then another passage under the same title says \"France measures Advice at the time of lockdown.32 16/03/2020\". Not sure if that's relevant. Then another passage says \"30. 2020 coronavirus pandemic in France. Wikipedia. Spain\". Maybe that's not helpful.\n\nWait, the user is specifically asking about France's estimate as of March 28th. The first passage under the first title says \"as of March 28th, giving an attack rate of 9.8% of the population.\" But that's under the \"Wikimedia Foundation\" title. Wait, maybe there's confusion here. Let me check again.\n\nLooking at the context again:\n\n- The first passage under the first title (Wikimedia Foundation) says \"as of March 28th, giving an attack rate of 9.8% of the population.\" But then another passage under the same title says \"France 3.0%\". So which one is correct? The user is asking about France's estimate. The 9.8% might be for another country, but the next passage says \"France 3.0%\". Also, the other passages mention France measures and dates. The 3.0% seems to be the relevant number here. But why is there a 9.8% mentioned? Maybe that's a different country or a different part of the text. Since the user is asking specifically about France, the 3.0% is likely the mean percentage. However, the question also asks for the 95% credible interval. The provided",
      "retrieved_chunks": [
        "Wikimedia Foundation\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: infected as of March 28th, giving an attack rate of 9.8% of the population .",
        "Title: Estimating the number of infections and the impact of non-\nPassage: France 3.0%\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: France measures Advice at the time of lockdown.32 16/03/2020\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: 30.",
        "2020 coronavirus pandemic in France.",
        "Wikipedia.",
        "Spain"
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.4,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.25,
      "gt_utilization": 0.25,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 89,
      "dataset_id": "549",
      "question": "Why does the claim lack any scientific  basis?",
      "ground_truth_answer": "The claim lacks any scientific basis because there is no credible evidence supporting the claims of the laboratory engineering of SARS-CoV-2, as stated in the passages from the provided sources.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking why the claim about the laboratory engineering of SARS-CoV-2 lacks scientific basis. The context provided includes several sources, all titled \"No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2\" and one other about SARS transmission.\n\nFirst, I need to look at the authors mentioned: Liu, Shan-Lu; Saif, Linda J.; Weiss, Susan R.; Su, Lishan. These are likely experts in virology or related fields. Their work probably reviews existing evidence and finds no support for lab-engineered origins. The PMC and DOI links suggest peer-reviewed articles, which adds credibility.\n\nThe other passage mentions preparation for sustained transmission of the 2019 novel coronavirus. The quote there says that claiming lack of transmissibility ended SARS isn't evidence-based and ignores control measures. This might be a red herring, but maybe it's relevant if the question is about transmission vs. origin. However, the main focus here is on the lab-engineering claim.\n\nThe key points from the context are that there's no credible evidence supporting the lab-engineered claim. The authors probably analyzed genetic sequences, compared them to related viruses, and found no signs of human manipulation. Common arguments against lab origins include the presence of natural mutations, lack of specific genetic markers that would indicate engineering, and the fact that similar viruses exist in nature.\n\nI should also consider that the question is about why the claim lacks scientific basis. The answer would need to reference the absence of evidence from these studies. Maybe the authors point out that the virus's genome doesn't have any unnatural features that would suggest it was created in a lab. Also, natural evolution is a more plausible explanation given the existing data on related coronaviruses.\n\nI need to make sure the answer is concise and directly addresses the lack of evidence. The user probably wants a clear, evidence-based reason based on the provided sources. Since the sources are from reputable journals and authors, citing their conclusion that there's no credible evidence is essential.\n</think>\n\nThe claim that SARS-CoV-2 was laboratory-engineered lacks scientific basis because multiple peer-reviewed studies, including those by Liu et al. (PMC: PMC7054935; DOI: 10.1080/22221751.2020.1733440",
      "retrieved_chunks": [
        "Title: No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2\nPassage: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054935/\n\nTitle: No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2\nPassage: DOI: 10.1080/22221751.2020.1733440\n\nTitle: Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus\nPassage: To claim that it was the lack of transmissibility, rather than the control measures that ended SARS, is not based on any evidence.",
        "And it ignores the heroic efforts of affected countries.",
        "Title: No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2\nPassage: Authors: Liu, Shan-Lu; Saif, Linda J.; Weiss, Susan R.; Su, Lishan"
      ],
      "computed_relevance": 0.6666666666666666,
      "computed_utilization": 0.6666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.625,
      "gt_utilization": 0.625,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 90,
      "dataset_id": "350",
      "question": "What is the mean time from onset of symptoms to dyspnea in human adenovirus type 55 (HAdV-55)?",
      "ground_truth_answer": "The mean time from onset of symptoms to dyspnea in HAdV-55 is 5 days.",
      "generated_response": "<think>\nOkay, let's see. The user is asking for the mean time from the onset of symptoms to dyspnea in patients with HAdV-55. I need to look through the provided context to find the answer.\n\nLooking at the first passage, it mentions \"The mean time from onset to dyspnea was 5 days.\" That seems straightforward. The other passages talk about symptoms like fever and cough initially, and that all patients had dyspnea. The study is about severe ARDS caused by adenovirus type 55. \n\nWait, the key sentence is repeated in the first and third passages. The title of the study is the same each time, so it's the same study. The mean time is clearly stated as 5 days. The other details about viral load and progression to respiratory failure might be extra info but not relevant to the question. \n\nI should make sure there's no conflicting information. All the passages are from the same study, so the 5 days is the correct answer. The answer should be 5 days.\n</think>\n\nThe mean time from the onset of symptoms to dyspnea in patients with human adenovirus type 55 (HAdV-55) is **5 days**, as explicitly stated in the provided context.",
      "retrieved_chunks": [
        "The mean time from onset to dyspnea was 5 days.",
        "All patients had\n\nTitle: Emergent severe acute respiratory distress syndrome caused by adenovirus type 55 in immunocompetent adults in 2013: a prospective observational study\nPassage: Flulike symptoms, such as fever, cough and little sputum, were commonly observed at the onset of illness.",
        "Title: Emergent severe acute respiratory distress syndrome caused by adenovirus type 55 in immunocompetent adults in 2013: a prospective observational study\nPassage: five consecutive patients with severe ARDS with confirmed HAdV-55 infection were included.",
        "The viral load was higher than 1 \u00d7 10 copies in three patients and was\n\nTitle: Emergent severe acute respiratory distress syndrome caused by adenovirus type 55 in immunocompetent adults in 2013: a prospective observational study\nPassage: Flulike symptoms, such as fever, cough and little sputum, were commonly observed at the onset of illness.",
        "All patients had dyspnea. The mean time from onset to dyspnea was 5 days . After the onset of dyspnea, patients usually progressed to respiratory failure or hypoxemia."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.05405405405405406,
      "gt_utilization": 0.05405405405405406,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 91,
      "dataset_id": "1223",
      "question": "What   has prevented worldwide spread of MERS-COV?",
      "ground_truth_answer": "The high severity and low transmissibility of MERS-CoV have prevented its worldwide spread. Additionally, control measures and vigilance have also contributed to containing the virus.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what has prevented the worldwide spread of MERS-CoV. Let me look through the provided context to find the answer.\n\nFirst, the context mentions that there's no vaccine for MERS-CoV. Then, in one of the passages, it says that MERS-CoV has high severity but low transmissibility. The R0 (basic reproduction number) is less than 1, which means each infected person infects less than one other person on average. That would make it harder for the virus to spread widely. Also, it's noted that MERS-CoV outbreaks have been mainly in hospitals in specific countries like Saudi Arabia, Jordan, and South Korea, but it hasn't sustained transmission beyond that. The preparedness plans including surveillance, lab testing, and contact tracing might have helped contain it. Additionally, the genetic instability of the virus could play a role, as mentioned in another passage. So combining these factors: low transmissibility (R0 <1), containment measures like surveillance and contact tracing, and maybe the virus's genetic instability. The main points from the context are the low transmissibility and the containment efforts. The answer should focus on those aspects.\n</think>\n\nThe worldwide spread of MERS-CoV has been prevented primarily due to its **low transmissibility** (with an estimated basic reproduction number, R\u2080, less than 1) and effective **containment measures**. The virus's limited ability to sustain transmission (as indicated by its low R\u2080) means each infected person typically infects fewer than one other person, hindering widespread outbreaks. Additionally, preparedness strategies such as surveillance, laboratory testing, contact tracing, and hospital infection control measures have been critical in containing outbreaks, particularly in regions where cases were reported (e.g., Saudi Arabia, Jordan, South Korea). These combined factors have prevented MERS-CoV from establishing sustained global transmission.",
      "retrieved_chunks": [
        "At present, no vaccine exists for preventing the infections of MERS-CoV.",
        "MERS-CoV was thought to be severe and control measures relied on\n\nTitle: Demographic Variations of MERS-CoV Infection among Suspected and Confirmed Cases: An Epidemiological Analysis of Laboratory-Based Data from Riyadh Regional Laboratory\nPassage: ere is no specific treatment for MERS-CoV.",
        "Title: Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus\nPassage: Similarly, MERS-CoV appears to have high severity and low transmissibility. Since 2012, MERS-CoV has caused 2494 reported cases and 858 deaths in 27 countries. MERS-CoV has also caused some rapid outbreaks, mainly in hospitals in Saudi Arabia, Jordan, and South Korea, but estimates of MERS-CoV R0 are less than 1, and thus far it has been contained.5",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus\nPassage: With the emergence of MERS-CoV in the Middle East, a preparedness plan was developed that included a surveillance plan, laboratory testing, and contact tracing guidance.",
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.3333333333333333,
      "gt_utilization": 0.3333333333333333,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 92,
      "dataset_id": "1000",
      "question": "What vaccinia vectors were created to address safety concerns?",
      "ground_truth_answer": "The modified vaccinia virus Ankara strain and the New York vaccinia virus were developed to address safety concerns with vaccinia virus vectors.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking which vaccinia vectors were created to address safety concerns. The context provided mentions a few different vectors.\n\nFirst, in the first passage, it says that early work with intact vaccinia virus vectors had safety issues, so two vaccinia vectors were developed. Then it mentions attenuated derivatives of vaccinia virus and NYVAC strains as promising. \n\nLooking further, the modified vaccinia virus Ankara (MVA) strain was attenuated by passing it 530 times in chick embryos. Another one is the New York attenuated vaccinia virus NYVAC, which was a plaque-purified clone of the Copenhagen strain, attenuated by deleting 18 open reading frames. \n\nSo the two vectors created to address safety concerns are MVA and NYVAC. The answer should list both of these. Let me check if there are any others mentioned. The other passages talk about pre-existing immunity but don't mention other vectors. So the answer is MVA and NYVAC.\n</think>\n\nThe vaccinia vectors created to address safety concerns are the **modified vaccinia virus Ankara (MVA)** and the **New York attenuated vaccinia virus (NYVAC)**. \n\n- **MVA** was attenuated through 530 passages in chick embryo fibroblast cultures.  \n- **NYVAC** is a plaque-purified clone of the Copenhagen vaccine strain, rationally attenuated by deleting 18 open reading frames.  \n\nThese vectors were developed to reduce reactogenicity and improve safety while retaining efficacy for vaccine applications.",
      "retrieved_chunks": [
        "Title: Virus-Vectored Influenza Virus Vaccines\nPassage: Early work with intact vaccinia virus vectors raised safety concerns, as there was substantial reactogenicity that hindered recombinant vaccine development . Two vaccinia vectors were developed to address these safety concerns.",
        "Poxviruses are also studied extensively as candidate vectors for human use, among which attenuated derivatives of vaccinia virus and New York attenuated vaccinia virus NYVAC strains] are the most promising vectors .",
        "The modified vaccinia virus Ankara strain was attenuated by passage 530 times in chick embryo fibroblasts cultures. The second, New York vaccinia virus was a plaque-purified clone of the Copenhagen vaccine strain rationally attenuated by deletion of 18 open reading frames . Title: Virus-Vectored Influenza Virus Vaccines\nPassage: vectors with extensive animal safety and efficacy data may address the issues with preexisting immunity to the human vaccine strains, although the cross-reactivity originally described with cowpox could also limit use. Title: Pre-existing immunity against vaccine vectors \u2013 friend or foe?",
        "They are ideal candidate vectors due to their large DNA-packing capacity and their thermal and genetic stability .",
        "The NYVAC vector has been shown to induce CD4 + T cell-dominant responses, and MVA induces\n\nTitle: Virus-Vectored Influenza Virus Vaccines\nPassage: While there is strong safety and efficacy data for use of NYVAC or MVA-vectored influenza vaccines, preexisting immunity remains a concern. Although the smallpox vaccination campaign has resulted in a population of poxvirus-na\u00ef ve people, the initiation of an MVA or NYVAC vaccination program for HIV, influenza or other pathogens will rapidly reduce this susceptible population. While there is significant interest in development of pox-vectored influenza virus vaccines, current influenza vaccination strategies rely upon regular immunization with vaccines matched to circulating strains. This would likely limit the use and/or efficacy of poxvirus-vectored influenza virus vaccines for regular and seasonal use"
      ],
      "computed_relevance": 0.16666666666666666,
      "computed_utilization": 0.16666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.35294117647058826,
      "gt_utilization": 0.23529411764705882,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 93,
      "dataset_id": "204",
      "question": "How many control samples were used in this study?",
      "ground_truth_answer": "There were a total of three control samples used in the study. The first control sample was a Haitian positive serum control pool created using country-wide DBS samples from RDT positive individuals. The second control sample was the WHO Pf 10/198 NIBSC standard 22, and the third control sample was created using country-wide DBS samples from individuals with confirmed malaria previously collected during healthcare visits.",
      "generated_response": "<think>\nOkay, let's try to figure out how many control samples were used in this study based on the provided context. \n\nFirst, I need to look at the information given. The user provided three passages from the same paper titled \"Quality control of multiplex antibody detection in samples from large-scale surveys: the example of malaria in Haiti.\" \n\nLooking at the first passage: It mentions a \"6-point titration curve of the Haitian hyperimmune sera\" created in bulk and stored at 4\u00b0C for each assay plate. So that's one control\u2014the Haitian hyperimmune sera used for a standard curve.\n\nThe second passage talks about \"Assay standards. A Haitian positive serum control pool\" made from DBS samples of RDT positive individuals. They also prepared a 6-point curve of 5-fold dilutions in bulk, stored at 4\u00b0C. So that's another control\u2014the Haitian positive serum control pool (HP).\n\nThen there's a mention of the NIBSC positive control standard curves. The text says both the HP and NIBSC standards were used, with the NIBSC showing higher responses. So NIBSC is a third control.\n\nWait, but the question is asking how many control samples. Let me check again. The first passage mentions the Haitian hyperimmune sera (HP curve), the second passage introduces the Haitian positive serum control pool (HP) and the NIBSC standard. Wait, maybe the HP is the same as the Haitian hyperimmune sera? Or are they separate?\n\nWait, the first passage says \"Haitian hyperimmune sera\" was used for a 6-point titration curve. The second passage says a Haitian positive serum control pool (HP) was created. Then they mention both HP and NIBSC. So that's two separate controls: HP (Haitian) and NIBSC. But the first passage's hyperimmune sera might be part of the same HP? Or is it another one?\n\nWait, maybe the first passage's \"Haitian hyperimmune sera\" is the same as the \"Haitian positive serum control pool\" mentioned in the second passage. Let me check the exact wording.\n\nFirst passage: \"A 6-point titration curve of the Haitian hyperimmune sera was created in bulk...\" \n\nSecond passage: \"A Haitian positive serum control pool was created using country-wide DBS samples from RDT positive individuals...\" \n\nSo they are two different",
      "retrieved_chunks": [
        "As samples and controls were\n\nTitle: Quality control of multiplex antibody detection in samples from large-scale surveys: the example of malaria in Haiti\nPassage: was created using country-wide DBS samples from individuals with confirmed malaria previously collected during healthcare visits.",
        "A 6-point titration\n\nTitle: Quality control of multiplex antibody detection in samples from large-scale surveys: the example of malaria in Haiti\nPassage: curve of the Haitian hyperimmune sera was created in bulk, stored at 4 \u00b0C and used on each assay plate.",
        "Following these QC checks, there\n\nTitle: Quality control of multiplex antibody detection in samples from large-scale surveys: the example of malaria in Haiti\nPassage: Assay standards. A Haitian positive serum control pool was created using country-wide DBS samples from RDT positive individuals collected during healthcare visits.",
        "As with the HP curve, a 6-point curve of 5-fold dilutions was prepared in bulk for use throughout the whole study and stored at 4 \u00b0C.",
        "The highest concentrations of both the HP and the NIBSC positive control standard curves showed robust IgG responses for nearly all of the included Pf antigens . Generally higher MFI responses were seen in the NIBSC standard, likely due in part to the higher serum concentration."
      ],
      "computed_relevance": 0.42857142857142855,
      "computed_utilization": 0.42857142857142855,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 94,
      "dataset_id": "831",
      "question": "What was the purpose of the search?",
      "ground_truth_answer": "The purpose of the search was to monitor diseases and track trends in the pilot study area, Guangdong Province, and to examine the predictive effects of the revised search volume.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What was the purpose of the search?\" and they provided some context from different passages. Let me go through each part carefully.\n\nFirst, looking at the first context: the title is about identifying and reducing bias in disease information from search engine data. The passage mentions \"revised search volume to examine the predictive effects of the revised search volume.\" Then there's a question about whether search engine data can track HFMD trends in Guangdong Province. Another part of the same title's passage says \"used to monitor diseases.\"\n\nThe second context's title talks about gaps in public health literature reviews. The passage lists criteria for methodological quality, like having a focused question, inclusion criteria, search strategy, etc. But this might be more about evaluating studies rather than the purpose of a search itself.\n\nThe third context again mentions the same title about search engine data and HFMD in Guangdong. The purpose here seems to be assessing if search data can track disease trends. The other part says search engines are used to monitor diseases, which aligns with that.\n\nPutting it together, the main purpose of the search in the contexts provided is to evaluate whether search engine data can effectively track or monitor disease trends, specifically HFMD in Guangdong. The studies are looking into the reliability and potential biases of using such data for public health monitoring. The answer should reflect that the purpose was to assess the suitability of search engine data for tracking disease trends, possibly to reduce bias and improve accuracy in public health surveillance.\n</think>\n\nThe purpose of the search was to evaluate the suitability and reliability of using **search engine data** (such as search volume) as a tool for **tracking and monitoring disease trends**, specifically **Hand, Foot, and Mouth Disease (HFMD)** in **Guangdong Province**. The studies aimed to assess whether such data could effectively predict or reflect real-world disease patterns while identifying and addressing potential biases in the information extracted. This aligns with broader goals of improving public health surveillance through digital tools.",
      "retrieved_chunks": [
        "Title: Towards Identifying and Reducing the Bias of Disease Information Extracted from Search Engine Data\nPassage: and real cases?",
        "Title: Missing and accounted for: gaps and areas of wealth in the public health review literature\nPassage: evidence on health outcomes is reported; and 5) the search strategy is described .",
        "To assess the methodological quality, the following ten criteria are used: 1) a clearly focused question was stated; 2) inclusion criteria were explicitly stated; 3) a comprehensive search strategy was described; 4) an adequate number of years were covered in the search; 5) a description of the level of evidence was provided; 6) the methodological rigor of primary studies was conducted and results were described; 7) the methodological quality of primary studies was assessed by two reviewers and the level of agreement was provided; 8) tests\n\nTitle: Towards Identifying and Reducing the Bias of Disease Information Extracted from Search Engine Data\nPassage: revised search volume to examine the predictive effects of the revised search volume.",
        "Can search engine data serve as a suitable tool for tracking HFMD trends in our pilot study area, Guangdong Province?",
        "Title: Towards Identifying and Reducing the Bias of Disease Information Extracted from Search Engine Data\nPassage: used to monitor diseases."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.4,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.3,
      "gt_utilization": 0.3,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 95,
      "dataset_id": "1400",
      "question": "What is the result of increased eosinophilia?",
      "ground_truth_answer": "The increased eosinophilia results in a >40-fold increase in the ability to detect tissue infiltrating eosinophils, a >2-fold increase in the level of eosinophil degranulation compared to control subjects, and significantly higher levels of degranulation in ALI patients surviving their hospitalization compared to non-surviving patients.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is the result of increased eosinophilia?\" based on the provided context. First, I need to understand what the context is saying.\n\nLooking at the passages, the main topic is about detecting eosinophils in lung tissue biopsies of patients with acute lung injury (ALI). The key points mentioned are:\n\n1. ALI patients had a >2-fold increase in eosinophil degranulation compared to controls.\n2. Survivors had significantly higher levels of degranulation than non-survivors.\n3. EPX-mAb immunohistochemistry is more sensitive than H&E staining for detecting eosinophils.\n4. There's a grading system for degranulation levels, with higher levels indicating more extensive degranulation.\n\nThe question is about the result of increased eosinophilia. Eosinophilia refers to an increased number of eosinophils. However, the context specifically talks about eosinophil degranulation levels. The study suggests that higher degranulation levels in ALI patients are associated with better survival rates. So, increased degranulation (which might be a result of eosinophilia) is linked to improved survival. \n\nWait, but the question is about the result of increased eosinophilia. The context doesn't directly say that more eosinophils (eosinophilia) lead to something, but rather that higher degranulation levels (which could be a result of active eosinophils) correlate with survival. The answer should connect increased degranulation (as a result of eosinophilia) to predicting survival. The main conclusion from the context is that higher degranulation levels in ALI patients are associated with better survival outcomes. Therefore, the result of increased eosinophilia (as indicated by degranulation) is that it may help predict survival in ALI patients. Survivors had higher degranulation levels than non-survivors. So the answer should state that increased eosinophil degranulation is associated with better survival in ALI patients.\n</think>\n\nThe result of increased eosinophilia, as indicated by elevated eosinophil degranulation levels in lung tissue biopsies of acute lung injury (ALI) patients, is **improved survival outcomes**. The context highlights that ALI patients who survived hospitalization exhibited **significantly higher levels of eosinophil degranulation** compared to non-sur",
      "retrieved_chunks": [
        "Title: Immunodetection of occult eosinophils in lung tissue biopsies may help predict survival in acute lung injury\nPassage: disease progression in these subjects was such that nineteen of the twenty patients received corticosteroid therapy during their course of treatment. Title: Immunodetection of occult eosinophils in lung tissue biopsies may help predict survival in acute lung injury\nPassage: group of ALI patients, the collective group also evidenced a >2-fold increase in the level of eosinophil degranulation compared to control subjects .",
        "More importantly, quantitative assessments of degranulation based on EPX-mAb immunohistochemistry revealed that ALI patients surviving their hospitalization also displayed significantly higher levels of degranulation compared to non-surviving patients .",
        "Title: Immunodetection of occult eosinophils in lung tissue biopsies may help predict survival in acute lung injury\nPassage: an enhanced sensitivity to detect eosinophils in these lung tissue sections. Specifically, evaluations of the lungs of control subjects using EPX-mAb immunohistochemistry revealed a >40-fold increase in the ability to detect tissue infiltrating eosinophils relative to H&E staining . Title: Immunodetection of occult eosinophils in lung tissue biopsies may help predict survival in acute lung injury\nPassage: elevated level of eosinophil degranulation representing \u22653 areas of granule protein release that again is <10% of the field of view. Level 2a: Significant level of eosinophil degranulation that includes 10-50% of the field of view. Level 2b: Significant level of eosinophil degranulation that includes extracellular release of EPX, enucleated eosinophils , and/or the presence of free granules .",
        "The extent of degranulation represents >50% of the field's total area.",
        "Scale bar = 50 \u03bcm."
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.3,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.35714285714285715,
      "gt_utilization": 0.21428571428571427,
      "gt_completeness": 0.6,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 96,
      "dataset_id": "1102",
      "question": "What is a conclusion of this report?",
      "ground_truth_answer": "The conclusion of the report is that strong conclusive statements are difficult to make.",
      "generated_response": "<think>\nOkay, let's see. The user is asking for a conclusion of the report based on the provided context. The context includes several passages from different documents. Let me go through each one carefully.\n\nFirst, there's a passage from \"Estimating the number of infections and the impact of non-\" with the passage text \"4 Conclusion and Limitations\". Then another passage from the same title mentions \"the appendix, and general limitations presented below in the conclusions.\" So maybe this document has a section on conclusions and limitations, but the actual content isn't provided here. \n\nNext, there's a passage from \"Outcome of paediatric intensive care survivors\" stating \"and, therefore, strong conclusive statements difficult.\" This suggests that making strong conclusions is challenging, possibly due to limitations in the study. \n\nAnother passage from \"Globalization and emerging governance modalities\" says \"me two conclusions.\" That's a bit confusing. Maybe it's a typo or a request for two conclusions? But the user is asking for a conclusion from the report, so perhaps the answer should combine elements from these different contexts.\n\nPutting it all together, the main points are about limitations in making strong conclusions, the presence of a conclusion and limitations section in one report, and a mention of two conclusions in another. Since the user's question is about \"this report,\" but there are multiple titles here, I need to see which one is relevant. The first two titles seem related to infections and pediatric care, while the third is about globalization. The answer should probably focus on the limitations mentioned in the first two contexts. The key takeaway is that the report's conclusions are limited, making strong statements difficult. So the answer would be that the conclusion is that strong conclusive statements are difficult due to limitations.\n</think>\n\nThe conclusion of the report is that **strong conclusive statements are difficult due to limitations** in the study or data, as indicated by the mention of challenges in drawing definitive conclusions from the outcomes of pediatric intensive care survivors and the general limitations outlined in the report's conclusion section.",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: 4 Conclusion and Limitations\n\nTitle: Outcome of paediatric intensive care survivors\nPassage: and, therefore, strong conclusive statements difficult.",
        "Title: Estimating the number of infections and the impact of non-\nPassage: the appendix, and general limitations presented below in the conclusions.",
        "Title: Globalization and emerging governance modalities\nPassage: me two conclusions."
      ],
      "computed_relevance": 0.6666666666666666,
      "computed_utilization": 0.6666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 97,
      "dataset_id": "300",
      "question": "What was used to measure the performance of the NINA heaters?",
      "ground_truth_answer": "The performance of the NINA heaters was measured by comparing replicate temperature profiles, demonstrating the ability to support isothermal nucleic acid amplification assays, and showing minimal variation in temperature from run to run within the reaction tubes.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what was used to measure the performance of the NINA heaters. I need to look through the provided context to find the answer.\n\nFirst, I'll scan through the passages. The first passage mentions that the NINA heater was tested for incubating isothermal reactions and used for LAMP assays. It compares the NINA heater to two reference heaters: the GeneAmpH 9600 and the ESE-Quant Tube Scanner. The comparison shows there's no discernible difference when using the NINA heater versus these reference devices. So, those two commercial heaters were probably used as benchmarks to measure performance.\n\nAnother part of the context talks about temperature profiles and replicate runs showing minimal variation. They did ten replicate runs of the optimized prototype, which indicates that they tested the consistency of the heater by running it multiple times and checking temperature variations. So, temperature measurements and replicate runs are part of the methods used to assess performance.\n\nAdditionally, the CaO temperature traces are mentioned, which show rapid heat generation. This might be part of the testing process to monitor how the heater performs in terms of temperature over time. However, the main comparison seems to be against the GeneAmpH 9600 and ESE-Quant. \n\nPutting this together, the performance of the NINA heater was measured by comparing it to these two commercial heaters and by analyzing temperature consistency across multiple runs. The answer should include both the reference heaters and the replicate temperature tests.\n</think>\n\nThe performance of the NINA heaters was measured by comparing them to two reference heaters\u2014**the GeneAmpH 9600 and the ESE-Quant Tube Scanner**\u2014and evaluating their ability to incubate isothermal reactions predictably. Additionally, **replicate temperature profiles** (ten runs of the optimized prototype) were analyzed to assess consistency, showing minimal variation in temperature. These comparisons and tests demonstrated the NINA heater's equivalence to commercial instruments and its reliability for nucleic acid amplification without electricity.",
      "retrieved_chunks": [
        "When combined with other innovations in development that eliminate power requirements for sample preparation, cold reagent storage, and readout, the NINA heater will comprise part of a kit that enables electricity-free NA testing for many important analytes. Replicate temperature profiles display minimal variation between runs and far less variation\n\nTitle: A Simple, Inexpensive Device for Nucleic Acid Amplification without Electricity\u2014Toward Instrument-Free Molecular Diagnostics in Low-Resource Settings\nPassage: These results clearly show that the NINA heater can incubate isothermal reactions predictably and precisely with no electricity and without any form of closed-loop control. We also demonstrate that it can be used for LAMP assays, with no discernable difference when compared to two reference heaters, the GeneAmpH 9600 and the ESE-Quant Tube Scanner. There is a bias between the NINA heater and the ESE-Quant , but this is not a significant finding considering we are comparing FIU without any assay calibration.",
        "Although we did not intend to rigorously\n\nTitle: A Simple, Inexpensive Device for Nucleic Acid Amplification without Electricity\u2014Toward Instrument-Free Molecular Diagnostics in Low-Resource Settings\nPassage: Heat Production and Temperature in the NINA Heater Ten replicate runs of the optimized prototype displayed minimal variation in temperature from run to run within the reaction tubes .",
        "More compelling is the potential of the NINA heater as the core component of a stand-alone assay kit, capable of providing a result without external electrical power, a reader instrument, or any complex ancillaries. Such a device might include the NINA heater, reaction chambers containing lyophilized reagents, sample metering devices, a readout chamber or lateral flow strip for visible interrogation,",
        "Title: A Simple, Inexpensive Device for Nucleic Acid Amplification without Electricity\u2014Toward Instrument-Free Molecular Diagnostics in Low-Resource Settings\nPassage: We have demonstrated the ability of an optimized NINA heater prototype, based on exothermic chemical reactions and EPCM, to support isothermal NA amplification assays and established its equivalence to commercially available PCR instruments. The disposable heater described is a component of an instrument-free point of care molecular diagnostics system under development.",
        "The CaO temperature traces show rapid and poorly controlled heat generation, with maximum temperatures exceeding 100uC."
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.2,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.09523809523809523,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 98,
      "dataset_id": "450",
      "question": "What did the comparison of  the FPASSA-ANFIS model with several existing models, show?",
      "ground_truth_answer": "The comparison of the FPASSA-ANFIS model with several existing models showed that it had better performance in terms of Mean Absolute Percentage Error, Root Mean Squared Relative Error, and Root Mean Squared.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the comparison of the FPASSA-ANFIS model with existing models based on the provided context.\n\nFirst, I need to look through the passage to find relevant information. The context mentions that the FPASSA-ANFIS model was compared with other methods like ANFIS and trained ANFIS models using PSO, GA, ABC, FPA, and FPASSA. The main point here is the evaluation of performance.\n\nThe passage states that the FPASSA-ANFIS showed better performance in terms of specific error metrics: Mean Absolute Percentage Error (MAPE) and Root Mean Squared Relative Error (RMSRE). Also, it's mentioned that combining the improved FPA method with ANFIS helps avoid some limitations of traditional ANFIS. However, there's a note that the computational time of FPASSA still needs improvement.\n\nSo the answer should highlight that the FPASSA-ANFIS outperformed existing models in those error metrics. I need to make sure to mention the specific metrics and the comparison models. Also, note that while performance is better, computational time is an area needing improvement. But the question specifically asks what the comparison showed, so focus on the positive results from the comparison.\n</think>\n\nThe comparison of the FPASSA-ANFIS model with several existing models demonstrated that it showed **better performance** in terms of **Mean Absolute Percentage Error (MAPE)** and **Root Mean Squared Relative Error (RMSRE)**. This improvement is attributed to the integration of the modified Flower Pollination Algorithm (FPA) for optimizing the ANFIS parameters, which overcomes limitations of traditional ANFIS models. However, the passage also notes that the computational time of the FPASSA method requires further improvements.",
      "retrieved_chunks": [
        "Title: Optimization Method for Forecasting Confirmed Cases of COVID-19 in China\nPassage: This paper aims to assess the ability of the FPASSA to forecast the COVID-19 by comparing its performance with other methods, namely the ANFIS and the trained ANFIS models using PSO, GA, ABC, FPA, and FPASSA.",
        "The FPASSA-ANFIS utilizes the improved FPA to train the ANFIS model by optimizing its parameters. The FPASSA-ANFIS contains five layers as the classic ANFIS model.",
        "These results avoid the limitations of traditional ANFIS because of the combination with the modified FPA method.",
        "However, the time computational of the proposed FPASSA method still requires more improvements.",
        "The main idea of the proposed model, called FPASSA-ANFIS, is to improve the performance of ANFIS by determining the parameters of ANFIS using FPASSA. The FPASSA-ANFIS model is evaluated using the World Health Organization official data of the outbreak of the COVID-19 to forecast the confirmed cases of the upcoming ten days. More so, the FPASSA-ANFIS model is compared to several existing models, and it showed better performance in terms of Mean Absolute Percentage Error , Root Mean Squared Relative Error , Root Mean Squared\n\nTitle: Optimization Method for Forecasting Confirmed Cases of COVID-19 in China\nPassage: This section explains the proposed FPASSA-ANFIS method."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.17391304347826086,
      "gt_utilization": 0.043478260869565216,
      "gt_completeness": 0.25,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 99,
      "dataset_id": "363",
      "question": "When did WHO declare a pandemic of pH1N1/2009v influenza?",
      "ground_truth_answer": "The World Health Organization declared a pandemic of pH1N1/2009v influenza on June 11, 2009.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking when the World Health Organization (WHO) declared a pandemic of pH1N1/2009v influenza. I need to find the correct date from the provided contexts.\n\nLooking at the first context, the title mentions that the WHO declared the spread of the virus as a pandemic on June 11, 2009. The passage also states that the declaration was made on that date, even though conditions were met earlier. \n\nThe second context's passage also refers to the WHO declaring the pandemic on June 11, 2009. It mentions the virus first appearing in April 2009 in Mexico and the US, leading to the declaration in June. \n\nThe third and fourth contexts don't mention the declaration date directly. The third one talks about data collection in Taiwan, and the fourth discusses Hong Kong's response, noting the peak in September and the end of the first wave by November. However, the key date is in the first two contexts. \n\nSo, the answer should be June 11, 2009. I need to confirm there's no conflicting information. All the relevant passages point to June 11, 2009, as the official declaration date by WHO. The fact that conditions were met earlier isn't the focus here; the actual declaration date is what's being asked. Therefore, the answer is June 11, 2009.\n</think>\n\nThe World Health Organization declared a pandemic of pH1N1/2009v influenza on **June 11, 2009**. This is explicitly stated in the first and second contexts, which note that the WHO determined the virus's spread met pandemic criteria on this date, despite conditions being met weeks earlier.",
      "retrieved_chunks": [
        "Title: We should not be complacent about our population-based public health response to the first influenza pandemic of the 21(st )century\nPassage: The World Health Organization declared that spread of the newly recognised quadruple reassortant influenza A H1N1 virus satisfied the criteria for a pandemic on June 11, 2009 , although technically conditions for declaring a pandemic had been met some weeks earlier. The virus, generally referred to as pandemic influenza H1N1 2009 , had first been recognised in Mexico and the United States in late April 2009.",
        "Title: Pandemic Influenza Due to pH1N1/2009 Virus: Estimation of Infection Burden in Reunion Island through a Prospective Serosurvey, Austral Winter 2009\nPassage: Text: In April 2009, the first cases of acute respiratory infections caused by a novel triple-reassortant influenza virus, pH1N1/ 2009v, occurred in Mexico and the United States . The rapid spread of infection to other continents led the World Health Organization to declare on 11 June 2009 that a pandemic of pH1N1/2009v influenza was under way, which raised major international concern about the risk of high morbidity and lethality and the potential for severe socio-economic impact. Actually, the potential impact of this first third-millenium influenza pandemic has been revisited downwards as morbidity and case-fatality rates were less severe than initially\n\nTitle: Transmissibility and temporal changes of 2009 pH1N1 pandemic during summer and fall/winter waves\nPassage: The data was accessed from the Central Epidemic Command Center website of the Taiwan Centers for Disease Control . Samples were collected from hospitals and clinics participating in the Taiwan Influenza surveillance system under the Taiwan National Influenza Center , which was established in 2006 to integrate all existing efforts of influenza surveillance and notification with laboratory analysis systems throughout Taiwan in order to enhance the epidemic data collection capacity in Taiwan . The weekly laboratory confirmed pH1N1 case data and the weekly hospitalization data from June 28, 2009 to March 27, 2010 was accessed from the weekly Influenza Express\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: identified.",
        "Confirmed pH1N1 infection was a notifiable disease throughout the first wave. Figure 1 summarizes a timeline of the first wave of pH1N1 in Hong Kong.",
        "More than a year later, WHO has declared the pandemic to be over and early assessments of the global response have commenced .",
        "Incidence peaked in September, and the first wave petered out by early November."
      ],
      "computed_relevance": 0.18181818181818182,
      "computed_utilization": 0.45454545454545453,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}